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Summary 
Background:  Trachoma, a blinding bacterial disease of the ocular surface, is the leading 
cause of infectious blindness, responsible for the visual impairment of 2.2 million people 
worldwide and an estimated economic loss of US$ 5.3 billion annually. Blinding trachoma, 
considered a neglected tropical disease, is targeted for global elimination as a public health 
problem by the year 2020. To achieve elimination, the World Health Organization (WHO) 
recommends implementing an integrated intervention package of surgery, antibiotics, facial 
cleanliness, and environmental improvement, known as the SAFE strategy. Surgery aims to 
correct trichiasis, the blinding anatomical condition of inward turning lashes touching the eye. 
Antibiotics are distributed annually to endemic communities to treat relatively asymptomatic 
ocular Chlamydia trachomatis infections to reduce the infectious reservoir. The promotion of 
facial cleanliness and environmental improvements, use of water and latrines for hygiene 
and sanitation, both target interrupting transmission of the infection. Of the 325 million 
persons estimated living in trachoma endemic communities, over 70% reside in sub-Saharan 
Africa. Within the region, Ethiopia, Nigeria, and South Sudan are estimated to have the 
highest burden of disease. The SAFE strategy in Ethiopia has been implemented since 2007 
targeting all 17 million residents of the Amhara National Regional State. 
 
Goals and specific objectives:  The goal of this PhD thesis was to investigate novel 
approaches of measuring the impact of SAFE interventions on trachoma and other 
neglected tropical diseases within the context of a national elimination programme as 
implemented in the Amhara National Regional State of Ethiopia. The specific operational 
research objectives were to determine whether areas receiving 3-5 years of interventions 
had achieved elimination by applying new evaluation guidelines; whether new electronic 
data collection technology could facilitate impact evaluation; whether SAFE interventions 
had any impact on trachomatous scarring (TS) among children; whether school-based 
surveys might serve as an alternative method to assess trachoma; and whether SAFE 
interventions have had any impact on intestinal parasitic infections.  
 
Methods:  Data collection for the thesis project occurred in three phases. The first phase 
involved the implementation of a population-based, cross-sectional study utilising a cluster 
random sampling design to survey 360 communities in South Wollo zone to estimate 
prevalence of trachoma after three years of SAFE interventions. Data was collected using 
standard paper-based questionnaires. The second phase involved the development and 
field-testing of a new electronic data collection system in a pilot study utilising a mixed, 
quantitative and qualitative, study design. The last phase involved the implementation of 
another population-based cross-sectional study in South Gondar zone after receiving five 
Summary 
 
X 
 
years of SAFE interventions. The same sampling methodology was used to survey another 
360 communities, yet integrating both assessment of trachoma and intestinal parasitic 
infections. Additionally, data was collected strictly by the newly developed electronic system. 
Clinical signs of trachoma were individually assessed using the WHO simplified trachoma 
grading system. Intestinal parasitic infections among children aged 2-15 years were 
determined by concentrating preserved stool specimens with ether for microscopic 
examination.  
 
Results:  From 714 communities in the two zones, 72,452 persons were examined for 
trachoma. The prevalence of trachomatous inflammation follicular (TF) among children aged 
1-9 years was 26.4% in South Wollo and 25.9% in South Gondar zone. Trachomatous 
inflammation intense (TI) was less prevalent than TF; 4.3% and 7.0% in South Wollo and 
South Gondar respectively. TT prevalence in the two zones suggest that over 59,000 
persons are estimated to have trichiasis and in need of surgery. In South Gondar the 
prevalence of TS among children under the age of 11 years has declined from 24.9% in 
2000 to 2.2% in 2011. While declines in intense inflammation and scarring were observed 
among children since intervention, the WHO targets for elimination have not been achieved.  
 The android-based tablet computer and the standard paper questionnaire were 
comparable in regards to time required to collect data during the pilot study, proportion of 
mistakes made while recording data and costs when considering data entry of paper 
questionnaires. Data recorders preferred to collect data electronically even though initially 
they felt the tablet interrupted their connection with the interview respondents. Electronic 
data collection resulted in completion of the large-scale surveys from preparation to 
presentation of results in 35% less time (one month earlier) than the standard paper-based 
surveys. 
 An analysis of 75,864 children examined in community-based surveys in Ethiopia 
(from field work described in this thesis), Mali, Niger, and Nigeria found that differences 
between children who attend and do not attend school varies across survey settings in 
regards to age, gender, having a clean face, and participation in antibiotic distribution for 
trachoma control. Meta-analysis of the data found that TF was less likely (odds ratio=0.71) 
among school-attendees than non-attendees when controlling for age, sex, and clustering at 
the household and community levels. Children attending school did not represent the target 
age group recommended for assessment of trachoma prevalence. 
 Stool specimens from 2,338 children aged 2-15 years from 99 communities in South 
Gondar were assessed for intestinal parasites. The prevalence of any helminth infection was 
24.2%, which represented a 50% reduction from a previously published study prior to the 
SAFE interventions. Over 70% of children had at least one type of intestinal protozoan 
Summary 
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infection. Significant increases were observed in household latrine ownership, access to 
water, use of an improved water source for drinking, and face washing behaviour since the 
start of the interventions.  
 
Conclusions: Trachoma remains a public health problem in South Wollo and South Gondar 
zones of the Amhara National Regional State of Ethiopia and ongoing interventions are 
warranted to control transmission to prevent incident blinding disease and provide surgery 
for prevalent and incident cases of trichiasis. The application of new WHO guidelines to 
evaluate trachoma at the sub-district level was feasible, but required significant resources. 
Electronic data capture facilitates the implementation of such large-scale impact evaluation 
surveys for neglected tropical diseases allowing the results to be generated immediately with 
as few mistakes as were made with paper-based data collection. Measuring prevalence of 
TS among children over time offers an additional way to monitor impact of the SAFE 
strategy. Children under the age of 11 years have substantially benefited from having lived in 
an environment where the SAFE strategy has been implemented for five years. The use of 
school-based sampling approaches for assessing trachoma prevalence risks 
underestimating true prevalence in the community. The prevalence of intestinal helminths 
among school-aged children has declined alongside significant increases in household-level 
indicators of water, sanitation, and hygiene since the implementation of the SAFE strategy in 
South Gondar. Yet, there is ongoing transmission of intestinal parasitic infections warranting 
improved control interventions. Integrating both the assessment of trachoma and intestinal 
parasitic infections in community-based surveys was a feasible approach to evaluate a 
broader impact of the SAFE strategy in a programmatic setting. Overall, the operational 
research presented in this thesis successfully generated evidence for health system 
decisions, contributed new information to the respective scientific fields, and identified areas 
warranting additional research. 
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Figure 1.1. An Ethiopian woman with trichiasis waiting for surgery (courtesy of The Carter 
Center) 
 
 
 
 
“I feel as if someone’s pricking my eyes with a thorn.” - Woman with trichiasis;  
quote courtesy of The Carter Center, Stephanie Palmer 
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1. Introduction 
1.1.  Blinding trachoma – global public health problem 
In some of the world’s poorest communities, what starts as uncomfortable, but mostly 
asymptomatic childhood eye infections, may over time lead to a painful, disabling disease 
resulting in blindness. Trachoma, the world’s leading cause of avoidable, infectious 
blindness is responsible for 3% of global blindness and in 2012 an estimated 334,000 
disability-adjusted life years (DALYs) (WHO (2012a; Murray et al., 2013)). An estimated 325 
million people are living in areas where trachoma is suspected but the true extent of the 
disease is unknown because trachoma has not been assessed in all countries or within all 
regions of known endemic countries (WHO, 2012b). An estimated 1.2 million persons are 
irreversibly blind from trachoma and an additional one million are visually impaired by the 
disease (Pascolini and Mariotti, 2012). An estimated 7.3 million persons have trichiasis, the 
disabling stage of disease leading to blindness, and who could benefit from surgery (WHO, 
2012b). The economic loss due to trachoma impaired vision and blindness is estimated to be 
US$ 5.3 billion annually, of which 10% is due to the requirement of a sighted household 
resident to care for the person with trachoma, clearly demonstrating that trachoma not only 
impacts the potential economic productivity of the individual, but of the entire family unit 
(Frick et al., 2003). If potential productivity losses were to include persons with trichiasis, the 
economic loss could be as high as US$ 8 billion (Burton and Mabey, 2009).  
 Figure 1.2 displays the global distribution of trachoma with 53 countries considered 
trachoma endemic, of which 29 (55%) are located in the Africa region where >70% of the 
total endemic population reside (WHO, 2012b). Within the Africa region, Ethiopia, Nigeria, 
and South Sudan have the highest burden of infection (ITFDE, 2011). Yet, adequate data 
remain unavailable for Nigeria in addition to India and China, which together could greatly 
influence the global estimates of trachoma. Efforts are currently underway to assess 
suspected areas to complete the map. 
 
1.2.  Aetiology 
Blinding trachoma begins by ocular infection with Chlamydia trachomatis (Ct) serovars A, B, 
Ba and C. These gram-negative bacteria typically remain localised to epithelial surfaces of 
the conjunctiva and mucous membranes of the genital tract (genital serovars D-K) (Mabey et 
al., 2003). The development cycle of Ct involves two stages (Figure 1.3), the infectious 
elementary bodies and the metabolically active reticulate bodies. Elementary bodies are 
transmitted when carried from an infected eye to uninfected susceptible host, become 
metabolically active and initiate a new infection. 
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Chlamydiae are obligate intracellular pathogens which, upon elementary body inclusion of 
host epithelial cells in the conjunctiva, transform to reticulate bodies for replication through 
binary fission. New reticulate bodies transform back to elementary bodies, which are 
expelled upon lysis of the host cell. Released Ct elementary bodies make their way into the 
environment mainly through ocular discharge. This development process of internalisation, 
replication and release takes about two to three days (Barron, 1988).  
 
 
Figure 1.3. Developmental cycle of Chlamydia trachomatis. EB, elementary body (red dots); RB, 
reticulate body (green dots) (source: http://chlamydiae.com/twiki/bin/view/Cell_Biology/GrowthCycle 
diagram by Dr. Karin D. Everett) 
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1.3.  Pathology 
Trachoma is an immunopathogenic disease with severity and progression being driven by 
multiple bouts of infection, reinfection, and inflammation due to the host immune response 
(Grayston et al., 1985). With the first infection, trachoma manifests as a self-limiting 
conjunctivitis that takes several months to resolve. Subsequent infections trigger an 
immunopathogenic response resulting in chronic inflammation characterised by lymphoid 
follicles (Figure 1.4.B.) and papillary hypertrophy (Figure 1.4.C.) seen in the tarsal 
conjunctiva, follicles along the limbus and possible vascularisation of the cornea (Mabey et 
al., 2003). Inactive reticulate bodies may persist and continue to present antigen, but 
whether these antigens continue to provoke chronic inflammation, is not clearly understood 
(Taylor, 2008). As the inflammatory response resolves, emerging scar tissue distorts the 
anatomy of the eyelid. It is the development and progression of scarring (Figure 1.4.D.) that 
leads to trichiasis and then corneal damage and blindness. 
 After repeat exposure and infection with Ct there is an acquired immunity which 
shortens the time required for clearance of the infection but does not protect from reinfection 
(Bailey et al., 1999; Grassly et al., 2008). Chlamydial antigens have been targeted for 
vaccine development, but so far none have shown promise. Given the immunopathology, the 
concern is that the antigens targeted in the vaccine must not promote the deleterious 
immune response.  
 Cellular mediated and innate immune responses are likely involved in both protective 
and pathogenic effects. T-helper lymphocytes and natural killer cells produce IFNߛ which is 
thought to be involved in clearing Ct infection. The T-cell responses, while helpful in clearing 
Ct infection, may also lead to tissue damage and stimulate fibrosis within the conjunctiva, but 
the evidence is inconclusive (Abu el-Asrar et al., 1998; Hu et al., 2013). An alternate 
explanation of trachoma pathology suggests that the pro-inflammatory cytokines of the 
infected epithelial cells that recruit a cellular infiltrate of macrophages, neutrophils and 
natural killer cells to aid in clearing infection, bring about prolonged inflammation and 
potential scarring development (Stephens, 2003). Thus, scar tissue formation in the 
conjunctivae is brought about by tissue damage and stimulation of fibroblasts during the 
immune response to infection.  
 Progressive scarring of the subtarsal conjunctiva deforms the lid margin causing the 
eyelid to fold inwards directing lashes towards and touching the eye, a condition known as 
trichiasis (Figure 1.4.E.). In addition, the protective tear film is disrupted as goblet cells and 
meibomian glands are damaged as well as the lacrimal glands, leading to “dry eye” (Tabbara 
and Bobb, 1980; Blodi et al., 1988; al-Rajhi et al., 1993).
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 The absence of the tear film alone leaves the cornea susceptible to infection, but in 
trichiasis, lashes abrade the cornea with each blink or movement of the eye. This chronic 
scratching makes the cornea susceptible to bacterial, viral and fungal infections, which result 
in corneal ulcers (Bowman et al., 2001, 2002; Rajak et al., 2010, 2012b). The resolution of 
these ulcers causes scarring directly within the cornea which is observed as clouds or 
opacities (Figure 1.4.F.). Opacities in the cornea covering the pupil margin cause severe 
visual impairment and blindness. If nothing is done for the patient, severe trichiasis can end 
with Phthisis Bulbi (Figure 1.4.G.), the complete loss of the eye.   
 
1.4.  Diagnosis of trachoma in public health programmes 
1.4.1.  Natural history of infection and disease 
When discussing diagnosis of trachoma, it is important to note the natural history of Ct 
infection. The relationship of infection and disease has been modeled using prospective data 
from The Gambia (Grassly et al., 2008). Figure 1.5 describes the natural history of duration 
of infection with Ct, and subsequent disease presentation. Clinical presentation of active 
disease (follicular and intense inflammatory response, Figures 1.4 B and C) occurs 
approximately 2-3 weeks after infection and persists several weeks after infection has 
cleared. Infection is present before development of clinical signs in a short latent phase, 
infection and signs seen together in a patent phase and finally in the recovery phase, 
infection has resolved, but clinical signs persist. Therefore, it is not surprising that studies 
have often found a lack of good correlation between clinical signs of trachoma and evidence 
of infection (Miller et al., 2004b; Wright and Taylor, 2005; See et al., 2011). The persistence 
of clinical signs might also suggest that Ct may not be the only pathogen to elicit such 
inflammatory response (Burton et al., 2011a). 
 
1.4.2. Current laboratory diagnostic methods 
Highly sensitive and specific laboratory diagnostic methods are available to detect 
C. trachomatis (Bailey et al., 1994; Mabey and Solomon, 2003). The current methods most 
frequently used by trachoma researchers are nucleic acid amplification techniques for 
ribosomal RNA and DNA from the common cryptic plasmid (Yang et al., 2009). Recent field 
research in Ethiopia suggests that RNA assays are more sensitive than, and as specific as, 
the DNA tests (Keenan et al., 2012b). Typically, these assays are performed on ocular 
swabs taken in the field under non-sterile conditions. There is no single standardised 
protocol for collection of ocular swabs, transport of specimens to equipped laboratories or 
procedures. These techniques are used in the context of research, are cost-prohibitive on a 
large scale, and currently are not recommended by the World Health Organization (WHO) 
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for use in national trachoma programmes (Solomon et al., 2004b). However, detecting little 
or no infection in areas that have had mass drug administration (MDA) of antibiotics would 
indicate impact of successful interventions. Additionally, in some settings, the cost of 
employing these tests to evaluate prevalence of infection is hypothesised to save resources 
in the long run by avoiding additional, unnecessary rounds of MDA where Ct infection cannot 
be detected (Yohannan et al., 2013). A point-of-care test to detect Ct antigen has been 
developed but the current formulation did not perform well under field environmental 
conditions (Michel et al., 2006; Harding-Esch et al., 2011). Currently, antibody-based tests 
are under investigation that can be integrated with other disease assessments and might 
prove to be valuable for trachoma surveillance once interventions have stopped (Goodhew 
et al., 2012). A rapid, field diagnostic assay to detect Ct infection would be invaluable in 
supporting decisions concerning MDA. 
 
 
Figure 1.5. Natural history of Chlamydia trachomatis infection and clinical response  
(modified from Grassly et al., 2008) 
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1.4.3. Clinical diagnosis 
The classification systems to diagnose the clinical manifestations of trachoma have been 
reviewed in detail (Solomon et al., 2004b). The required clinical skills of an ophthalmologist 
and, in some instances, the use of a slit lamp are among the limitations of the earlier 
trachoma grading systems particularly prohibitive to large-scale programmatic utilisation. In 
1987, the detailed classification of trachoma clinical signs was simplified into a standardised 
classification of five, differentiated clinical signs of trachoma. This became known as the 
WHO Simplified Trachoma Grading System, which remains the recommended tool for 
national trachoma elimination programs because of feasibility and comparability across 
programs (Thylefors et al., 1987).  
 Grading signs of trachoma using this WHO recommended diagnostic system limits 
signs visible within the central area of the tarsal conjunctiva where clinical signs of 
inflammation due to trachoma are most evident (Figure 1.4.A.). As mentioned in the previous 
section, lymphoid follicles are characteristic of inflammation due to Ct infection. They are 
elevated collections of lymphoid cells that range in size from 0.2 to 2 mm in diameter. While 
just a few follicles may be indicative of trachoma, the simplified grading system limits the 
definition of trachomatous inflammation follicular (grade “TF”, Figure 1.4.B.) to five or more 
follicles each greater than 0.5 mm in diameter. Intense inflammation is marked by 
pronounced vascular engorgement where the conjunctiva is bound to the tarsal plate. The 
combination of vascularisation and thickening of the conjunctiva obscures the large 
underlying blood vessels. Trachomatous inflammation intense (grade “TI”, Figure 1.4.C.) in 
the simplified grading system is defined as such vascularisation and thickening that 
obscures more than half of the underlying vessels. Trachomatous scarring (grade “TS”, 
Figure 1.4.D.), can be seen as white lines, bands or sheets and may obscure underlying 
blood vessels. At least one eyelash touching the globe or evidence of removal of inturned 
lashes is defined as trachomatous trichiasis (grade “TT”, Figure 1.4.E.). Corneal opacity 
(grade “CO”, Figure 1.4.F.) is defined as visible opacities in the cornea that cover all or part 
of the pupil.  
 The system is easy to learn and it is relatively simple to assess the capacity of newly 
trained examiners to apply the system. At the systems inception, inter-observer reliability 
was measured and very good agreement among multiple examiners was documented for TF 
(kappa=0.70, range 0.66-0.74), TS (kappa=0.75, range 0.67-0.79) and TT (kappa=0.76, 
range 0.68-0.81). Agreement on TI among multiple observers in the first studies was not as 
good (kappa=0.45, range 0.38-0.49) (Thylefors et al., 1987). A validation study thereafter in 
Tanzania reported substantial agreement among examiners on TF (kappa=0.79), TI 
(kappa=0.95), and TS (kappa=0.87) after extensive training (Taylor et al., 1987). However, 
clinical grading will always be limited by the fact that the grade is subjective to the 
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determination of the examiner. While the system is capable of identifying areas with endemic 
trachoma warranting interventions, further research is needed to determine the ability of the 
system to detect rare disease, on which decisions to withdraw interventions will be made.  
 
1.4.4. Interpretation of the WHO Simplified Trachoma Grading System 
It is the simplicity, repeatability and transferability of the simplified system that makes it 
currently, the best clinical diagnostic system for large-scale public health programmes. 
Additionally, each grade is differentiated from the other and can be interpreted to provide 
informative information about trachoma in the community. The presence of active trachoma 
(TF and/or TI) serves as a proxy for recent or current infection in a patient and a community 
indicating transmission of Ct and a need for control interventions. As patients, they should be 
treated with antibiotics. Separately, TI is more severe than TF, given that it is seen with 
severe inflammatory response and persons with persistent TI in longitudinal studies are 
more likely to progress to scarring than those with TF (MacCAllan, 1931; West et al., 2001a). 
Detecting the presence and a greater quantifiable load of Ct is more common from ocular 
swabs of patients with TI than from patients with TF alone (Burton et al., 2003; Solomon et 
al., 2003, 2004b).  
 The observed decline of TF prevalence after control interventions has been variable 
and seems to be related to the level of TF at baseline (WHO, 2010). Recent prospective 
studies measuring impact of mass drug administration (MDA) of antibiotics on trachoma in 
hyper-endemic areas of Ethiopia have observed a slower decline in TF than in Ct infection 
(Gebre et al., 2012). Additionally, observed declines in TI have been greater than declines in 
TF in South Sudan and Ethiopia following control interventions (Ngondi et al., 2006b, 
2009a). There is new evidence that TF is associated with non-Ct bacterial infections and the 
impact this might have on TF prevalence in control programmes should be investigated 
(Burton et al., 2011a). 
 TS in a trachoma endemic area demonstrates that the patient has or has had 
repeated inflammation due to Ct infection and infers risk of progression to TT. The presence 
of TT identifies persons who are disabled and will develop corneal opacity and visual loss. 
TT indicates a need for corrective surgical intervention. 
 
1.5.  Epidemiology of trachoma 
1.5.1. Age and gender-specific patterns 
Clinical signs of trachoma are associated with age and gender. For example, TF and TI are 
most prevalent in children aged 1-9 years (Dawson et al., 1976; West et al., 1991). Figure 
1.6 demonstrates the typical relationship observed between trachoma and age. Infection 
tends to follow the pattern of active trachoma, is most prevalent among those under five 
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years of age, but is not uncommon in adults (Bailey et al., 1999; West et al., 2005; Grassly et 
al., 2008; House et al., 2009). TS, TT, and CO appear to be irreversible and accumulate with 
age. Not all persons with scarring will progress to TT and CO (Burton et al., 2006; Ngondi et 
al., 2009c). Typically, the higher endemicity of TF and TI among children relates to a greater 
burden of blinding trachoma in adults. Also, where trachoma is hyper-endemic and 
transmission abounds, younger age groups have likely experienced more repeated 
infections and present with blinding trachoma at an earlier age than persons living in a low- 
endemic setting (Ngondi et al., 2006a; King et al., 2008). With gender, a recent meta-
analysis of 25 cross-sectional studies found that women are nearly two times more likely 
than men to have trichiasis (Cromwell et al., 2009a). This gender disparity has almost 
always been reported in any trachoma assessment and is possibly due to increased 
exposure and reinfection experienced during childcare. Disparities in active disease between 
girls and boys have been inconsistent, but Ct infection may be more common in girls than 
boys (Courtright and West, 2004). 
 
1.5.2.  Transmission 
Ct is transmitted by fingers, fomites, and flies. Infectious Ct elementary bodies are shed in 
ocular discharge and nasal discharge which can be wiped directly from one child to the next 
by dirty hands or indirectly by shared towels and also by eye-seeking flies. Musca sorbens 
are vectors of trachoma and are prevalent nearly worldwide, thriving in areas without basic 
sanitation (Emerson et al., 2000a). Ct has been isolated by polymerase chain reaction (PCR) 
from flies captured on the faces of children (Miller et al., 2004a; Lee et al., 2007). Reductions 
in the density of the M. sorbens population have been associated with decreased trachoma 
prevalence (Emerson et al., 1999, 2004).  
 
1.5.3. Risk factors 
The association of clinical signs of trachoma with various other individual and household 
factors has been assessed in multiple studies and reviewed (Emerson et al., 2000b; Taylor, 
2008). Most of the analyses are limited to cross-sectional data and thus temporality and 
measures of risk are difficult to determine. The statistical significance of associations is not 
always consistent between studies.
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Figure 1.7. Child in South Sudan with active trachoma and M. sorbens feeding on ocular 
and nasal discharge (courtesy of The Carter Center South Sudan) 
 
 Table 1.1 lists some of the risk factors assessed and the consistency of their reported 
relationship with TF. Various indicators of low socio-economic status, lack of parental 
education, household size, and crowding are usually associated with increased odds of 
trachoma in children but not always statistically significant. We know that trachoma 
transmission clusters within a household and having a sibling with TF is always associated 
with increased odds of having TF (Barenfanger, 1975; Burton et al., 2003; Polack et al., 
2005). Owning animals, keeping farm animals close to the living quarters, presence of flies, 
absence of a household latrine, distance to a water source, and the time to collect water 
have in some studies been shown to be associated with increased odds of trachoma in 
children. Ocular discharge has consistently been shown to be associated with trachoma in 
children likely because it is a direct result of the inflammatory response; not that it is a risk 
factor; although ocular discharge not related to trachoma may attract eye-seeking flies 
(Abdou et al., 2007). Studies have shown a reduced odds of trachoma in children with a 
sustained clean face and increased observed or reported frequency of face washing or 
bathing (West et al., 1996; Schemann et al., 2002, 2003). While typically trachoma is found 
endemic in hot, dry undeveloped areas, it was not always the case as at the turn of the 19th 
century, trachoma caused blindness in the slums of London, Dublin and Paris (Taylor, 2008). 
Few studies have assessed indicators of climate and geography with trachoma and the 
relationships have not been well established. 
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Table 1.1. Relationship of individual and household factors with TF.  
Factor Relationship with TF Consistency 
Poverty (various SES indicators) Increased odds Usually 
Lack of paternal education Increased odds Usually 
Household size Increased odds Usually 
Crowding Increased odds Usually 
Sibling with trachoma Increased odds Always 
Animal ownership Increased odds Sometimes 
Animals in compound Increased odds Sometimes 
Absence of household latrine Increased odds Sometimes 
Presence of flies Increased odds Sometimes 
Time to collect water Increased odds Sometimes 
Ocular discharge on face Increased odds Always 
Nasal discharge on face Increased odds Usually 
Frequency of face washing Decreased odds Usually 
Frequency of bathing Decreased odds  Usually 
Water use for washing Decreased odds Usually 
Climate (various indicators) Not established - 
 
 
 
1.6. The SAFE strategy 
SAFE is an acronym for the integrated package of measures to treat, control and ultimately 
prevent any new blinding case of trachoma, namely through Surgery, Antibiotic distribution, 
Facial cleanliness, and Environmental improvement (Francis and Turner, 1993). The SAFE 
strategy was adopted by WHO in 1996 as a result of recent developments in trachoma 
control, specifically: a standardised surgical procedure for trichiasis, development of 
strategies of community-based control activities, new information on risk factors of trachoma, 
and research showing effective treatment of active trachoma with azithromycin (WHO, 
1997a).   
 
1.6.1.  Surgery 
The aim of the surgery component (S) is to reverse the pathological anatomical condition, 
correcting the eyelid to keep the lashes from touching the eye. In major trichiasis cases, 
corrective surgery has been shown to improve comfort and visual acuity in patients (Reacher 
1. Introduction 
 
16 
 
et al., 1992; Burton et al., 2005a). There are multiple procedures, some of which do not 
require a surgical theatre and can be conducted in the field. The procedures can be taught to 
and effectively performed by nurses or integrated eye care workers (Alemayehu et al., 
2004). National programmes often implement the surgery component of SAFE through 
community outreach campaigns in addition to providing surgery in tertiary hospitals or 
specialty eye care clinics (Rajak et al., 2012a). Regardless of the location of surgery or 
technique, in the best outcomes, approximately 10% of patients will have recurrence of 
trichiasis after surgery, but a range from 7% to 62% of operated trichiasis cases have been 
reported to have at least one recurrent lash after three years of follow-up (Rajak et al., 
2012a). Despite variable recurrence rates, surgery improves visual outcomes and reduces 
pain and photophobia among trichiasis patients (Woreta et al., 2009). Recent qualitative 
research in Niger suggests that operated patients have a high level of tolerance, regardless 
of recurrence (Palmer, 2013). The factors related to recurrence are not fully understood and 
are currently being investigated. 
 
1.6.2.  Antibiotics 
Antibiotic therapy (A) resolves Ct infection in the individual patient in >90% of cases. The 
aim of MDA with antibiotic in trachoma control is to treat all persons in a defined 
geographical area where signs of disease exceed a predetermined threshold. MDA is 
conducted without knowledge of and regard to whether persons are actually infected or not, 
in the anticipation that infected persons serving as the reservoirs of Chlamydia in the 
community will receive treatment. This was determined to be more effective at preventing 
reinfection than individual treatment (Schachter et al., 1999). A recent review found 
antibiotics to reduce both the risk and prevalence of infection and clinically active trachoma 
according to currently recommended regimens (Evans and Solomon, 2011). The current 
regimens recommended by WHO are: 1% tetracycline eye ointment applied twice per day for 
six weeks or a single, oral dose of azithromycin 20 mg/kg up to 1 g given annually for at 
least 3-5 years through MDA depending on prevalence of TF among children aged 1-9 years 
(WHO, 2006b, 2010). Recent research on the optimal frequency of MDA found no added 
benefit of biannual treatment over the current annual MDA recommendation (Gebre et al., 
2012). Pfizer Inc. donates azithromycin (Zithromax®) to national programmes for the 
elimination of blinding trachoma (Mecaskey et al., 2003). Investigation of the use of topical 
azithromycin 1.5% ophthalmic solution for trachoma control is ongoing, but the multi-dose 
regimen (one drop twice a day for three days) may be challenging to implement on a 
programmatic scale (Amza et al., 2010; Huguet et al., 2010). 
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1.6.3.  Facial cleanliness 
The aim of the “F” component is to reduce contamination by keeping faces, and thus, hands 
and household items such as towels and washcloths free of infectious discharge. This 
strategy involves promoting behaviour change. There is some evidence that the promotion of 
face washing relates to changed behavior and decrease in prevalence of severe 
inflammatory trachoma compared to villages where face washing was not promoted (Lynch 
et al., 1994; West et al., 1995). But, as mentioned before, it has been difficult to establish a 
causal relationship as inflammation due to Ct infection produces ocular discharge. This 
inherent relationship also makes it difficult to monitor uptake of the promoted behaviour. In 
an earlier study not included in this thesis, we attempted to develop a standardised, 
repeatable definition of a clean face that programmes could employ to measure face 
washing behaviour. Unfortunately, ocular and dry nasal discharge were the only signs 
assessed that had some correlation with the face being washed and only moderate inter-
observer agreement (King et al., 2011a). Thus, the monitoring of facial cleanliness has been 
limited to keeping record of the number of communities in which active promotion of face 
washing is occurring. 
 
1.6.4.  Environmental improvement 
The “E” component aims to improve sanitation and hygiene in communities to reduce 
transmission of trachoma and prevent reinfection. Trachoma elimination from North America 
and Europe was not due to intervention with mass distribution of antibiotics, rather 
improvements in development (Taylor, 2008). M. sorbens preferentially oviposit in human 
faeces on the soil surface and do not oviposit in faeces within pit latrines (Emerson et al., 
2001). Fly control with insecticide has been demonstrated to reduce trachoma and diarrhea 
in the Gambia (Emerson et al., 1999). Latrine construction and use are promoted due to 
evidence that populations of M. sorbens may be reduced, reducing fly-to-eye contacts and 
the transmission of trachoma (Emerson et al., 2004). It is unclear what additional effects 
latrines may have on controlling trachoma in areas receiving MDA or after MDA has been 
ceased (Stoller et al., 2011), but it is plausible that increasing use of latrines will help sustain 
reduction of transmission where antibiotics have reduced Ct infection in the community. 
 While accessibility of water is important, whether or not the water is used for hygiene 
seems to be most important in trachoma prevention. Where water is not accessible, 
household use of a limited supply of water may not be prioritised for bathing (West et al., 
1989; Bailey et al., 1991; Polack et al., 2006). Where water is available, it must be used for 
hygiene to reduce transmission of trachoma. The low allocation of scarce potable water for 
hygiene purposes might explain the identification of trachoma in the Pacific Islands 
(Dethlefs, 1982; Mathew et al., 2009; Kline et al., 2013).  
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1.6.5.  Potential ancillary benefits 
The SAFE strategy is an integrated control strategy that likely has impact beyond control of 
blinding trachoma. Surprisingly, research to document these collateral impacts, until 
recently, has been scarce and most of the potential benefits discussed here are 
hypothesised. Benefits from the SAFE strategy are thought to include improvements in 
household economy, education, and both physical and mental health. Improvement in 
physical function has been documented among patients receiving surgery to correct 
trichiasis (Wolle et al., 2011). The reduction in disability probably decreases the risk of injury 
or perhaps mortality and might allow the patients and their caretakers to resume work 
contributing to the household income and shrinking the economic losses estimated in section 
1.1. A successfully operated patient is likely to experience reduced stigma and improved 
self-perception as a contributor to the economic well-being of the household. These potential 
social impacts deserve documentation through qualitative research to define the extent of 
the benefits experienced by the patients and their families. 
 Mass distribution of azithromycin to children and adults is effective against trachoma, 
but also may reduce morbidity and mortality from other infections such as pneumonia, 
Haemophilus influenzae, bacterial dermatitis, and sexually transmitted infections (STIs). One 
study in Ethiopia found a 50% (95% confidence limit was 10-70%) lower rate of mortality 
among children less than five years of age who took azithromycin compared to children who 
did not receive azithromycin (Porco et al., 2009). Currently, a trial designed to reproduce this 
finding and specifically identify which factors of mortality are impacted is in preparation. Any 
reduced morbidity among treated children may lessen the number of school days missed 
improving learning. There has been some evidence that children receiving azithromycin in 
MDA have lower rates of diarrhea than children not receiving MDA for up to three months 
after the distribution (Coles et al., 2011). Therefore, it is not unreasonable to postulate that 
persons with resolved infections may have lower healthcare expenditures and experience 
feelings of increased vigor, which may explain anecdotal field reports of demand for 
continued antibiotic distribution.  
 The promotion of facial hygiene involves washing the face to prevent transmission of 
Ct, and perhaps as a result, reduce infectious ocular and nasal discharge of other ocular and 
respiratory infections. If in the process of face washing, the hands are also washed, 
transmission of other infections spread by contact with infectious material would be 
prevented, particularly respiratory and faecal-oral transmitted infections. Pneumonia and 
diarrhea are the leading causes of mortality among children aged 1-5 years and nearly half 
of the deaths due to these diseases occur in Sub-Saharan Africa where trachoma is highly 
endemic (Liu et al., 2012). Hand washing can reduce diarrheal illness by 47% and thus avert 
a significant burden of mortality due to diarrhea (Curtis and Cairncross, 2003). One could 
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assess whether households in trachoma endemic areas that prioritise water for face washing 
are more likely to prioritise water use for overall hygiene including hand washing.  
 The Millennium Development Goal 7c, to reduce by half the proportion of households 
that lack basic sanitation, is directly addressed through the E component in trachoma 
endemic areas where SAFE is being implemented (Emerson et al., 2012). Globally in rural 
areas, it is estimated that nearly one billion people practice open defecation and 1.8 billion 
lack access to an improved sanitation facility (UNICEF, 2012). This lack of sanitation is a 
major contributing factor to child mortality due to diarrheal disease. Managing human waste 
through household latrine use reduces contamination of the environment and reduces 
transmission and new infections of faecal-oral diseases (Mara et al., 2010). Recent meta-
analysis found significant protective effect of household sanitation on soil-transmitted 
helminths (Ziegelbauer et al., 2012). The availability of water improves the chances of water 
use for bathing as mentioned in 1.6.4. Availability of potable water when used for drinking 
reduces risk of infection from water-borne diseases (Prüss-Üstün et al., 2008). Together, 
these environmental improvements in water and sanitation should impact transmission of 
guinea worm, diarrheal diseases, respiratory tract infections and intestinal parasites 
(helminths and pathogenic intestinal protozoa) (Esrey et al., 1991). While these collateral 
benefits are hypothesised, little research has been conducted to document such benefits as 
an effect of the SAFE strategy.  
 
1.7. Global elimination of blinding trachoma 
In 1997 The Global Alliance for the Elimination of Blinding Trachoma (GET 2020), a 
collaborative force of donors, international NGOs, academic institutions, corporate sponsors, 
and national governments, met to bring about the realisation of global trachoma elimination. 
Shortly after their first meeting, recognising the severe health burden due to trachoma and 
that the disease is preventable through simple and available strategies, the World Health 
Assembly (WHA) called for the global elimination of blinding trachoma as a public health 
problem by the year 2020 in WHA resolution 51.11 adopted in May 1998 (WHO, 1998). 
Specifically, the resolution called on member states to map blinding trachoma in the 
remaining endemic areas and where needed, implement the SAFE strategy to achieve 
elimination. A recent review of trachoma elimination by the International Task Force for 
Disease Eradication highlighted that trachoma elimination, as defined, was achievable 
(ITFDE, 2011). 
 
1.7.1. Elimination defined 
The aim of the global programme is interpreted as the ‘elimination of blinding trachoma as a 
public health problem’ and targets neither ocular Ct nor the disease for elimination. Low 
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levels of active trachoma (TF and/or TI) felt to no longer contribute to chronic reinfection and 
inflammation leading to the deleterious anatomical condition and few incident cases of TT 
will be acceptable. Therefore, the term ‘elimination’ in this thesis will be used to align with 
WHO terminology, but essentially this is a global control programme. The proxy targets 
assumed to meet this aim are together: the existence of less than one case of TT per 1,000 
population and <5% prevalence of TF among children aged 1-9 years (Resnikoff et al., 2007; 
WHO, 2010). Currently, there are no recommended measures of elimination for infection 
with Ct or for any other clinical signs of the simplified trachoma grading system such as TI 
and TS.  
 
1.7.2.  Programme strategy as recommended by WHO  
A surgical backlog is calculated to be the total number of persons with TT based on the most 
recent prevalence estimates. Where the prevalence of TT is >1% among adults, surgical 
interventions should be prioritised including outreach campaigns in combination with the 
existing eye care services. According to WHO guidelines, areas with ≥10% TF among 
children 1-9 years of age (TF1-9) warrant behaviour change communication to promote the F 
and E components and at least three rounds of annual MDA with azithromycin (WHO, 
2006b). Where district-level prevalence of TF1-9 is <10%, prevalence at the sub-district level 
should be assessed (WHO, 2010). Sub-districts having ≥10% TF1-9 warrant MDA for at least 
three years. F and E interventions, at minimum, and targeted MDA are recommended for 
sub-districts having 5-9% TF1-9 (WHO, 2010). Where TF1-9 is <5% no MDA is needed, but 
efforts should be made to ensure that F and E are being implemented (WHO, 2006b).  
 Trachoma elimination programmes should aim to achieve 100% coverage of the total 
population targeted with the SAFE interventions (WHO, 2010). Specifically the targets are as 
follows: 100% of TT cases (total estimated backlog) registered and offered surgery; 100% of 
persons taking antibiotics during MDA; 100% of communities receiving behaviour change 
communication on facial cleanliness and environmental improvements; 100% of households 
with basic sanitation (latrine); 100% of households with access to water within 30 minutes 
round-trip collection. These targets are referred to as the ultimate intervention goals (UIG). 
 Evaluation of disease outcomes is not necessary before three years of intervention 
with SAFE in areas with a baseline prevalence of TF1-9 between 10-30%, whilst evaluation is 
not necessary before five years in areas with a baseline prevalence of TF1-9 >30%. Modeling 
of the natural history of trachoma in The Gambia and recent analysis of data from Ethiopia 
suggest the timing of the outcome evaluation should be no earlier than six months since the 
last round of MDA (Grassly et al., 2008; Ngondi et al., 2010). In areas (districts) that have 
been receiving mass antibiotic distribution, if the evaluation survey finds that TF1-9 is >10%, 
then A, F, and E interventions should continue for an additional three years.  
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 Previous guidelines (WHO, 2006b) had indicated decisions to stop MDA be made at 
the community level, implying that each community need be assessed. Realising the 
logistical challenges this would present programmes, a consensus was reached that the 
sub-district level is the unit on which stopping interventions be made (WHO, 2010). In sub-
districts where TF1-9 is between 5-9%, targeted MDA in combination with F and E should 
continue for an additional three years. Where TF1-9 is <5% at the sub-district, MDA is no 
longer warranted, but F and E interventions should continue whilst post-endemic 
surveillance activities are put in place.  
 
1.7.3. Recommended “post-endemic” surveillance  
As countries implementing SAFE start to see levels of blinding trachoma decline, national 
programmes must plan activities to ensure the achievements are sustained. The objective of 
trachoma surveillance is to monitor the presence of active disease and TT incidence to 
detect and respond to potential resurgence. Additionally, eye care services must continue to 
identify and operate new and recurrent TT cases. Surveillance activities should be planned 
and tested in some of the first “post-endemic” areas that achieve <5% TF1-9 and 
subsequently implement the activities as other districts become post-endemic. At minimum, 
WHO recommends selecting two communities per district per year biased to the least 
developed and suspected most endemic. In these communities, all school entrance-aged 
children (5-6 years) in school are to be examined for TF where attendance is >90% and 
there is no gender bias (WHO, 2008). In areas with lower attendance, at least 50 children 
aged 5-6 years in the community may be examined. Where TF among the sample of 
children is >5%, a series of further investigations and response with A, F, and E activities is 
suggested cascading from community level back to the district if necessary (WHO, 2008). To 
monitor incidence of TT, national programmes are recommended to continue collection and 
analysis of TT surgical output data and to incorporate TT into existing national health 
information systems. TT cases identified and reported through the health systems should be 
classified as recurrent, prevalent (already offered surgery), or incident (not yet offered 
surgery). This health system surveillance for trachoma should be maintained for at least 10 
years (WHO, 2008). Additionally, in each community assessed for TF, TT should also be 
assessed in adults and any cases should be classified and offered surgery. Active 
surveillance for TF can be stopped if after three years an additional prevalence survey were 
to find TF1-9 to remain <5% (WHO, 2008, 2010). 
 
1.7.4. Progress towards elimination 
Currently, of the 53 trachoma endemic countries, 36 are implementing the SAFE strategy 
(WHO, 2012b). Nine countries (Algeria, Ghana, Iran, Libya, Mexico, Morocco, Oman, The 
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Gambia, and Vietnam) have reached their elimination targets and are in the post-endemic 
surveillance phase (WHO, 2012b).  Of these nine, Ghana and The Gambia give great hope 
that elimination of trachoma in Sub-Saharan Africa is feasible through concerted efforts to 
implement the SAFE strategy.  
 A third of the estimated 325 million persons at risk for trachoma are living in districts 
where trachoma has been mapped and confirmed endemic. For the remaining two-thirds, 
the estimates will be made clearer as a current grant from the UK government is supporting 
mapping surveys in the remaining 1,293 districts to be completed by 2015. In all suspected 
endemic areas, 80% of the populations at risk live in 14 countries and with the exception of 
Pakistan, all are located in Sub-Saharan Africa (ICTC, 2011). Ethiopia alone accounts for 
22% of the global population at risk. Since the inception of GET 2020 until 2010, 
approximately 900,000 persons have received surgery for trichiasis and 250 million antibiotic 
treatments have been distributed (WHO, 2012b). To meet the 2020 goal, an estimated 
500,000 persons with TT need be operated per year to clear the estimated backlog of 4.6 
million persons with TT and up to 380 million doses of antibiotic would be warranted for 
distribution in the confirmed endemic areas (ICTC, 2011). Clearly, there is much work to be 
done and continued collaborative efforts are needed as well as financial resources to 
achieve elimination. An important first step is to confirm all suspected areas and establish 
the true targets on which to measure progress. 
 
1.8. Methods for mapping trachoma and evaluating impact of the SAFE strategy 
1.8.1.  Objectives of the trachoma assessment 
“The epidemiology of the disease is such that only population-based assessments are 
relevant” (WHO, 1997a). This quote from the first global scientific meeting on trachoma 
clearly indicates the type of data needed for trachoma control programmes. The goal of the 
trachoma assessment is to identify endemic areas warranting interventions. The specific 
aims are to: 
1. Determine prevalence of TF1-9 on which to plan interventions and use as a 
baseline on which to measure programme success 
2. Determine prevalence of TT in the population on which to estimate the total 
backlog of cases to be operated and to prioritise areas for surgical outreach 
3. Measure the facial cleanliness of children1-9 and the reported frequency of face 
washing  
4. Measure the existing household sanitation coverage (proportion of households 
with at minimum, a household latrine) 
5. Measure household access to water (proportion of households within 30 minutes 
round-trip collection to water source) 
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 Regardless of whether the assessment is for initiating a programme (mapping), 
monitoring the progress or evaluating the impact after interventions have been implemented, 
the above objectives remain consistent. After MDA, surveys may include measurement of 
reported antibiotic coverage, defined as the proportion of the total surveyed population that 
reported taking antibiotics when distributed during the campaign (WHO, 2006b). Estimating 
prevalence in each time point allows the same repeated measures to be compared over time 
to interpret success of the interventions. 
 
1.8.2. WHO recommendations 
Currently, WHO recommends national programmes conduct baseline prevalence surveys to 
identify endemic areas. There are three WHO manuals providing guidelines for assessing 
trachoma in the community. The first from 1993, Trachoma Epidemiological Survey Protocol, 
recommends population-based, cluster surveys be conducted (WHO, 1993b). The method 
adheres to the principles of random probability sampling where 20 clusters are selected with 
probability proportionate to population size (PPS) and households are selected through 
random systematic sampling. It suggests all residents of selected households be examined 
for all clinical signs of the simplified trachoma grading system. Finally, it calls for the 
estimation of prevalence of active trachoma (TF and/or TI and TI alone) among children 
aged ≤10 years and TT among women at the district level.  
 The second manual, Guidelines for the Rapid Assessment for Blinding Trachoma, 
came in response to the perception that population-based cluster surveys were difficult to 
conduct in resource-poor settings. The idea behind the trachoma rapid assessment (TRA) 
was to prioritise trachoma endemic areas for intervention as quickly as possible without 
having to conduct prevalence surveys in all areas (Negrel AD, 2001). Instead of district-level 
surveys, TRA involves two phases, desk-top review of any existing data including key 
informant interviews to categorise areas, and then field assessments to confirm reports. The 
TRA assumes that reports including trachoma data are available and that people interviewed 
will be knowledgeable about trachoma in the community. The field assessments are biased 
to the suspected most endemic sites or least developed areas in order to confirm 
endemicity. Once areas of trachoma have been identified, there is additional need to 
determine the level of facial cleanliness and coverage of water and sanitation. The assumed 
advantages are that large areas can be classified and prioritised for intervention rapidly. The 
disadvantages are that active and blinding trachoma prevalence in a district cannot be 
estimated upon which to make intervention decisions or measure progress according to 
WHO recommendations.  
 Trachoma Control: a guide for programme managers contains the most recent 
guidelines for conducting trachoma assessments (WHO, 2006b). Similarly to the 1993 
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protocol, population-based prevalence estimates of active and blinding trachoma are 
generated at the district level from cluster random sampling (CRS). Communities are also 
similarly selected via PPS, but suggested household selection is performed via spinning a 
bottle and surveying households in the direction of the bottle top until the desired sample 
size of children is met. Different from the original protocol, only children under 10 years of 
age and adults 15 years of age and older are suggested for examination. The limitations of 
this current approach is that using the bottle spin approach with a rule for stopping once the 
sample size is achieved, violates the principles of probability sampling. The probability that a 
person is examined cannot be calculated and is different from cluster to cluster. Additionally, 
limiting the examination to only adults prevents the direct estimation of the prevalence of TT 
in the total population on which the elimination target is defined. 
 
1.8.3. Alternative and integrated methods applied 
Population-based prevalence surveys are considered the gold standard and, for the most 
part, are currently being applied in the field (Wright et al., 2005; Ngondi et al., 2009b). 
However, there have been methods, influenced by quality assurance strategies in the 
manufacturing industry, applied in trachoma mapping surveys that determine whether an 
unacceptable threshold of trachoma in the community has been exceeded (Myatt et al., 
2003, 2005). These lot quality assurance sampling (LQAS) designs are able to determine 
the need for trachoma interventions and may require smaller sample sizes, but require strict 
adherence to simple random sampling from complete population census data. Additionally, 
these methods are unable to provide population-based prevalence estimates on which 
programmes monitor success (Ngondi et al., 2009b). A modification of the LQAS method 
was applied in Senegal which allowed an estimation of community-level prevalence by 
examining all targeted children without stopping at a given threshold of positives (Faye et al., 
2006). The modified method was quite similar to CRS, yet the number of clusters sampled 
was more than what would have been in a recommended cluster survey. Additionally, a 
limited age range was randomly sampled and the method did not generate TT prevalence 
through random sampling of the population.   
 The recent global push for an integrated approach to NTD control programmes 
prompted discussion of integrated methods for mapping, monitoring, and evaluation (Baker 
et al., 2010). The strengths of integrated disease assessment are that efforts can be 
harmonised into one field activity to conserve limited resources. The challenges to 
integration are that the recommended methodologies of each programme have different 
target populations and different venues of sample selection. For instance, the 
schistosomiasis and soil-transmitted helminthiasis control programmes assess disease 
burden in school-aged children through a random sample of 50 children in schools (WHO, 
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2002a). As mentioned previously, the recommended age group for assessing trachoma 
prevalence and basing intervention decisions is children aged 1-9 years and blinding 
disease in adults.  
 Despite these differences, efforts have been made to align surveys of multiple NTDs. 
Children in all government primary schools in eight districts of central Nigeria were randomly 
selected for either urine analysis for schistosomiasis or active trachoma depending on their 
ages (King et al., 2009). In that specific setting, integrating trachoma examinations in 
schools was useful in identifying endemic communities that were not identified through the 
recommended population-based cluster survey, yet no estimates of trichiasis were possible 
through the approach. Also, the method employed allowed district-level estimates of TF 
prevalence to be generated that were not different than estimates generated by the 
recommended methodology assessing all children in the community. In the same study, 
efforts to assess urinary schistosomiasis through community-based CRS method of the 
trachoma programme were not as successful given the focal nature of schistosomiasis and 
the fact that the school-aged children in this area were in school when survey teams were in 
the community and thus very small sample sizes were achieved. School-based integrated 
NTD assessments have also been conducted in Burkina Faso to serve as baseline data for 
programme decisions and to serve as sentinel sites on which to monitor schistosomiasis and 
trachoma control programmes (Koukounari et al., 2011).  
 Schools have also served as the sampling venue of another integrated disease 
survey approach, Integrated Threshold Mapping, whereby trachoma, soil-transmitted 
helminths, schistosomiasis and lymphatic filariasis are assessed (Pelletreau et al., 2011; 
Dorkenoo et al., 2012). Intervention decisions are made based on whether the proportion of 
positive children examined for each disease in four communities (two purposefully selected 
for schistosomiasis and two randomly selected) per sub-district exceeds the prevalence 
thresholds recommended in WHO guidelines for identifying areas warranting interventions. 
However, this method employs neither LQAS, random or population-based sampling 
strategies and is unable to generate estimates of prevalence of any of the diseases.  
 The key to integrated disease assessment is to align methods where it makes sense 
and coordinate where there is no compromise. However, further research is warranted to 
identify the right compromise of existing programme standards, but yet maintain the 
principles of random sampling and provision of prevalence estimates which can be 
consistently measured over time to determine programme success.  
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2. Goal 
The investigations included in this thesis are aimed to address relevant programmatic 
issues, solutions to which would improve the ability of national trachoma elimination 
programmes to measure success of interventions. The overarching goal of this PhD project 
was to investigate novel approaches for evaluating the impact of the SAFE strategy, 
primarily on trachoma, but also other neglected tropical diseases (NTDs), namely intestinal 
helminth infections. This operational research was designed and carried out in the context of 
a national trachoma elimination programme.  
 
2.1. Specific objectives and research needs addressed 
Objective 1. Determine whether implementation of the SAFE strategy in South Wollo and 
South Gondar has reduced the prevalence of TF1-9 below 5% at the sub-district level and 
MDA can be stopped.  
 National programmes implementing the SAFE strategy to eliminate blinding trachoma 
need guidance in determining when mass distribution of antibiotics can be stopped. When 
starting MDA is based upon prevalence estimates at the district level (population 100,000-
250,000), new guidelines from the WHO state that MDA can stop if the programme 
demonstrates that TF1-9 has fallen below 5% (defined as 4±2%) at the sub-district level 
(population ~50,000) (WHO, 2010). The feasibility of conducting such sub-district level 
surveys in large population areas has not been established and there is no standard 
methodology (i.e. parameters recommended most recently have yet to be applied in 
programmatic settings). Additionally, a reduction in TF1-9 to below 5% has yet to be observed 
in such hyper-endemic areas as the Amhara region of Ethiopia. 
Null hypothesis: There is no difference between prevalence of TF1-9  prior to and post 
intervention with the SAFE strategy. 
 Alternate hypothesis: The prevalence of TF1-9 at the sub-district level is less than 5% 
in South Wollo and South Gondar after the implementation of the SAFE strategy. 
 
Objective 2. Determine whether a novel electronic data management and collection tool can 
facilitate the completion of surveys to evaluate the impact of the SAFE strategy.  
 The requirement of greater precision (i.e. from district-level to sub-district-level 
prevalence estimates) upon evaluating impact of interventions inevitably will require more 
data to be collected and substantial resources required for data management. The 
application of new technology for the electronic collection of trachoma survey data might be 
feasible to reduce time and costs in managing such large data collection activities.  
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Null hypothesis: There is no difference in cost, time to survey completion, data entry 
errors, or respondent participation rates between a novel electronic data collection 
system and standard paper-based surveys.  
 
Objective 3. Determine whether children exposed to SAFE interventions are less likely to 
present with trachomatous scarring (TS) than children having never been exposed.  
 Currently WHO recommends assessing TF as an outcome measure to evaluate 
impact of the SAFE strategy. As mentioned before, the clinical sign of TF serves as a proxy 
for infection and indicator of transmission. However, research in high trachoma prevalence 
areas has shown that TF prevalence may not decline after several rounds of MDA with 
antibiotics even when Ct infection in the community is low to nearly undetectable. This 
generates great concerns that even after concerted efforts have been put forth to implement 
the SAFE strategy, national programmes may not meet their elimination targets and MDA 
will continue after ocular Ct has been eliminated. The impact of SAFE interventions on other 
clinical signs, particularly scarring among children, would suggest that the interventions are 
having immediate and long-term effects on averting blindness, but this has not been 
investigated. 
Null hypothesis: There is no difference in the risk of presenting TS between children 
exposed and not exposed to the SAFE strategy. 
 
Objective 4. Determine whether school-based surveys might serve as a valid, alternative 
approach to assess the impact of the SAFE strategy on trachoma. 
 Realising the substantial resources likely to be required for generating prevalence 
estimates at the sub-district level to evaluate the SAFE interventions on a programmatic 
scale, ways to simplify sampling methods should be explored. Schools have been used as 
primary sampling units on which to estimate community prevalence of schistosomiasis and 
soil-transmitted helminthiasis. Currently, schools are being used to assess and monitor 
integrated NTD programmes. Yet, it has not been clearly determined whether children who 
attend school are representative of children in the community and whether their disease 
prevalence is similar to children who do not attend school. Any differences between these 
groups might affect the validity of disease prevalence estimates derived from school-based 
survey methods. 
Null hypothesis: There is no difference in active trachoma between children who 
attend and do not attend school.  
 
Objective 5. Determine whether the prevalence of intestinal helminths among children has 
declined in an area where the SAFE strategy has been implemented. 
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 Theoretically, trachoma disappeared from industrialised nations due to improvements 
in hygiene and sanitation, yet the evidence of the impact of improved sanitation on trachoma 
has been demonstrated only in few studies. Unfortunately, current programmes pertaining to 
NTDs primarily focus on preventive chemotherapy dependent on pharmaceutical donations 
rather than efforts to improve sanitation. While hygiene behaviour and latrine construction 
are being promoted through the SAFE strategy, national programmes could strengthen 
advocacy efforts by documenting potential collateral benefits of household latrine use such 
as reduced prevalence of soil-transmitted helminth infections. Combining the assessment of 
intestinal parasites with trachoma impact evaluations also establishes the proof of concept 
that integration of NTD assessments is feasible in community-based surveys. 
Null hypothesis: There is no difference between the prevalence of intestinal 
helminthiasis among school-aged children prior to and post implementation of the 
SAFE strategy 
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3.  Study site 
The study site of this project is the Amhara National Regional State of Ethiopia. The state 
has a total population of 17,232,709 persons living in 3,468 kebeles (clusters of villages) in 
151 woredas (administrative districts) from 10 zones (Ethiopia, 2007). People from the ethnic 
group Amhara make up the majority of residents and Amharic is the official language. 
Additionally, English is taught within the education system. Persons living in the regional 
capital, Bahir Dar, and other large zonal towns are considered to be at little or no risk of 
trachoma, but this has not been well established. An estimated 16,591,836 persons within 
the region are living in known trachoma endemic areas. The specific locations of data 
collection were all woredas (equivalent to a district) of South Gondar and 13 woredas from 
South Wollo zones of the Amhara National Regional State (Figure 3.1.). The estimated total 
population living in South Gondar zone in 2007 was about 2 million and 2.5 million total 
population live in South Wollo (Ethiopia Central Statistical Agency).  
 A country-wide blindness and low vision survey conducted in 2006 found trachoma, 
both TT among adults (5.2%) and TF (39.1%) or TF/TI (62.6%) among children, to be 
highest in Amhara compared to the other regional states (Berhane et al., 2006). Shortly after 
the survey, The Federal Ministry of Health with Regional State Health Bureaus developed a 
strategic plan outlying full implementation of the SAFE strategy to eliminate blinding 
trachoma by 2015. Although pilot trachoma interventions were initiated within four woredas 
of Amhara in 2001, it was not until a recent collaboration in 2006 between The Carter 
Center, Lions Clubs International Foundation and the Amhara National Regional State 
Health Bureau that has allowed the widespread implementation of the full SAFE strategy to 
all endemic areas in Amhara. Surgery for trichiasis is conducted at static health facilities and 
during mobile outreach campaigns. Mass antibiotic distribution is carried out solely through 
integrated mass campaigns called MalTra weeks. MalTra weeks involve short, intense 
periods of community mobilisation and mass antibiotic distribution as well as fever screening 
febrile patients, testing, and treatment for malaria at central distribution sites. The extensive 
network of Health Extension Workers (HEWs) and health volunteers provide the human 
resources to reach millions of residents within two weeks. HEWs are year-round health 
education and service providers of the health system, who also promote the F and E 
components of the SAFE strategy. Facial cleanliness and hygiene are part of a trachoma 
specific primary school health curriculum. Additionally, HEWs demonstrate construction and 
promote use of household latrines using local materials. 
 The implementation of SAFE interventions in Amhara represents a model effort for 
the global trachoma elimination programme given the high endemicity of disease, investment 
of resources, partnerships, political commitment, and magnitude of output. The total 
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cumulative output of SAFE activities through December 2010 (the date prior to initiating field 
work for the thesis project) in Amhara as reported by the Health Bureau include:  
 220,333 persons operated to correct trichiasis  
 59,227,132 doses of antibiotic distributed 
 3,468 kebeles with ongoing trachoma specific health education 
 2,021,382 household latrines constructed 
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Figure 4.1. The author demonstrates how to hold small children for trachoma examinations 
during the survey training in South Wollo Zone, Ethiopia (courtesy of Mary Rose King) 
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4.1.  Abstract 
Background: To eliminate blinding trachoma, the World Health Organization recommends 
implementing the SAFE strategy which includes annual mass drug administration (MDA) 
with azithromycin to the whole population of endemic districts. Proposed impact assessment 
guidelines suggest stopping MDA when the prevalence of trachomatous inflammation 
follicular (TF) among children aged 1-9 years is below 5% at the sub-implementation unit 
(sub-district). We conducted surveys powered to estimate prevalence simultaneously at the 
sub-district and district in two zones of Amhara, Ethiopia to determine whether MDA could 
be stopped.  
Methodology: Seventy-two separate sub-district surveys were conducted in 25 districts. In 
each survey all residents from 10 randomly selected clusters were screened for clinical signs 
of trachoma. Data were weighted according to selection probabilities and adjusted for 
correlation due to clustering. 
Principal Findings: Overall, 89,735 residents were registered from 21,327 households of 
whom 72,452 (80.7%) were examined. District-level prevalence of TF in children aged 1-9 
years ranged from 0.9% to 67.0% and 0.9-76.9% at the sub-district level. Six sub-districts 
and two districts were below the stopping threshold of 5% TF in children aged 1-9 years. TF 
in none of the districts receiving at least five rounds of MDA was reduced below 5% among 
children. In only one district was the prevalence of trichiasis below 0.1%. 
Conclusions/Significance: The experience from these zones in Ethiopia demonstrates that 
impact evaluation designed to give a prevalence estimate of TF at sub-district level are 
possible, although the scale of the work was challenging. Interpretation was not as simple as 
stopping MDA in sub-districts below 5% given programmatic challenges of exempting sub-
districts from a highly-regarded programme and the proximity of hyper-endemic sub-districts. 
Analysis of the spatial distribution of trachoma between sub-districts and prevalence of 
Chlamydia trachomatis infection may be useful additional evidence for MDA-stopping 
decisions. 
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4.2.  Author Summary 
Trachoma, the leading cause of preventable blindness, is targeted for elimination by the year 
2020. National programmes are implementing the recommended strategy of surgery, 
antibiotics, facial cleanliness, and environmental improvement (SAFE) to meet the target. 
Many programmes are currently facing the decision of when to scale down interventions, 
particularly mass drug administration (MDA) of azithromycin. We implemented large 
population-based surveys in two different zones of the Amhara National Regional State of 
Ethiopia following a novel approach to measure the prevalence of trachoma at sub-district 
level and to determine whether to stop MDA according to World Health Organization 
guidelines. We compared the current disease situation with that of the trachoma situation 
before the full implementation of the SAFE strategy. Over 72,000 people in 714 communities 
in 72 sub-districts were examined for clinical signs of trachoma. The clinical data suggest 
some decline in trachoma within these areas since the SAFE strategy was implemented. 
However, we identified only six sub-districts that met criteria for being able to stop MDA. The 
study demonstrates that determining the prevalence of trachoma at sub-district level is 
feasible but requires significant resources.  
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4.3. Introduction 
Trachoma accounts for 3% of global blindness and is targeted for elimination as a public 
health problem by the year 2020 (WHO,1998,  2012a). Trachoma is estimated to be 
endemic in 53 countries of which 35 have begun scaling-up or have fully implemented the 
recommended SAFE strategy for reaching the elimination targets (WHO, 2012b). SAFE is 
the acronym for an integrated package of interventions to treat, control and ultimately 
prevent new cases of blinding trachoma through surgery (S), antibiotic distribution (A), facial 
cleanliness (F), and environmental improvements (E) (Francis and Turner, 1993). 
Elimination as a public health problem, the ultimate intervention goal (UIG), is defined as 
achieving a transmission target: trachomatous inflammation follicular (TF), in children aged 
1-9 years to less than 5%, and a morbidity target: less than 1 case of trachomatous trichiasis 
(TT) per 1,000 population (Resnikoff et al., 2007).   
The World Health Organization (WHO) recommends annual mass drug 
administration (MDA) with azithromycin or tetracycline ophthalmic ointment in areas where 
the district-level prevalence of TF among children aged 1-9 years is greater than 10% 
(WHO, 2006b). A major challenge faced by national programmes currently implementing 
SAFE is determining when to stop MDA. According to guidelines issued after the 2nd global 
scientific meeting (GSM) on trachoma in 2003, the impact of SAFE on the prevalence of 
trachoma should be assessed after at least three years of implementation and MDA stopped 
where the prevalence of TF in children aged 1-9 years is determined to be less than 5% in 
any community (WHO, 2004, 2006b). 
Realising that estimating trachoma prevalence in every community in sub-Saharan 
Africa places a heavy burden on resource-limited programmes, the 3rd GSM on trachoma 
was convened by WHO in July 2010 with the purpose of reviewing and clarifying guidelines 
for the implementation of impact assessment surveys, including the administrative level at 
which impact must be measured to stop MDA. These new guidelines state that a district is 
the largest unit on which to estimate trachoma prevalence for outcome surveys and 
specifically that “outcome surveys can be used to pronounce achievement of UIG for TF, if 
the sample size is powered to calculate estimates at the sub-district level” (WHO, 2010). The 
purpose of this study was to apply this recommendation from the 3rd GSM in two different 
programmatic settings in the Amhara region of Ethiopia by conducting trachoma outcome 
surveys at the sub-district level to determine where MDA might be stopped. Secondary aims 
of the study were to compare current estimates to baseline prevalence and to estimate 
blinding trachoma, defined as TT in the total population to calculate the remaining backlog of 
TT patients requiring surgery to guide future provision of surgical services.   
The new guidelines suggest conducting outcome surveys at the district level first, 
interpreting the results and then conducting additional surveys at the sub-district-level where 
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district-level estimates of TF are below 10% (WHO, 2010). In each zone, we chose to 
implement surveys in a single exercise to estimate the prevalence of TF among children 
aged 1-9 years at the sub-district level in all districts eligible for outcome surveys. Using 
aggregate data from sub-districts allowed us to generate trachoma prevalence estimates at 
the district level simultaneously. We chose this strategy for one main reason: to obtain a 
definite answer for all areas in the two zones within a timeframe feasible for mobilising and 
implementing an annual MDA.   
 
4.4.  Methods 
4.4.1. Ethics Statement 
The study protocols for surveys in both South Wollo and South Gondar were reviewed and 
approved by the ethical review committee of the Amhara Regional State Health Bureau. 
Additionally, the study activities were approved by Emory University Internal Review Board 
under protocol 079-2006. Due to the high rate of illiteracy, verbal informed consent was 
obtained and recorded prior to data collection rather than written information and a signed 
statement. Consent for trachoma examination and household interview was obtained from 
heads of households, individuals, and parents of minors according to the principles of the 
declaration of Helsinki.  
 
4.4.2.  Study Site and Time Frame 
Widespread implementation of the full SAFE strategy to all endemic areas in Amhara was 
initiated in 2007, which included outreach camps to provide surgery in addition to the 
existing static service; annual MDA with antibiotics; promotion of facial cleanliness and 
hygiene in schools and communities by health extension workers; community-level 
promotion of latrine construction and use through the health extension workers and 
environmental health officers. Provision of improved water sources was simultaneously 
supported by the development sector.  
Previous data indicate that 6-12 months since the last round of MDA is the ideal time 
to conduct impact surveys to assess trachoma (Ngondi et al., 2010). The outcome survey in 
South Wollo was conducted in December 2010 in 13 woredas (districts) which had received 
a third consecutive round of MDA in April of 2010. The remaining eight woredas in South 
Wollo had not yet received three rounds. In South Gondar, training and field collection 
activities were conducted in the rainy season from late June to early August 2011 covering 
all 12 woredas in the zone. All woredas in South Gondar had received at least five rounds of 
MDA, the last round of which took place in November 2010. 
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Figure 4.2. Administrative levels and respective population structure of Amhara National 
Regional State, Ethiopia  
 
4.4.3.  Sampling Methodology and Sample Size 
The administrative levels of this area of Ethiopia and the respective population at each tier 
are presented in Figure 4.2 with the woreda being the district-level equivalent. From the 3rd 
GSM report, a sub-district is defined as three or more villages with combined total population 
of at least 30,000 persons (WHO, 2010). Since no existing administrative level matched this 
description exactly, we joined geographically adjacent health clusters in groups to create a 
sub-district evaluation unit of approximately 50,000 cumulative population. Gotts are the 
smallest administrative unit for which there is population data available, which we used as 
our primary sampling unit or cluster. For each evaluation unit surveyed, gotts were selected 
from a line list arranged according to geographical distribution using a standard methodology 
(UNICEF, 2006a). Gotts are broken down into smaller administrative units called 
development teams (DT), which made ideal segments on which to base a modified 
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segmentation design for equal probability sampling (UNICEF, 2006a). One DT was randomly 
selected in each gott and all persons present or absent residing in all households within the 
selected DT were registered and those present examined. Absent households were 
registered as non-consenting and were not replaced. Heads of household (or their adult 
representative) were interviewed in consenting households. Physical characteristics were 
recorded from direct observation. 
To detect whether the prevalence of TF was 3% with 2% precision, we calculated a 
sample size of 558 children aged 1-9 years per sub-district. This was based on a 5% level of 
significance, design effect of 2, five persons per household with children aged 1-9 years 
composing 30% of the total population. To obtain the target sample size, population-based, 
cluster random sampling was utilised for both surveys. We surveyed 10 clusters per sub-
district, including 40 households per cluster, which, based on our assumptions, would allow 
for an 8% non-response rate in children.  
 
4.4.4. Training and Quality Control 
Prior to the survey data collection, teams participated in a 7-day, applied training and skills 
examination. Trachoma graders were responsible for diagnosing the clinical signs of 
trachoma using the simplified trachoma grading system (Thylefors et al., 1987). Potential 
graders were trained to classify signs of trachoma using digital photographs, followed by 
examination with a standardised set of photographs where agreement was calculated for all 
signs. Poor performing participants were given additional instruction or assigned other 
duties. Remaining participants practiced examination and diagnosis of trachoma for at least 
two days in volunteer subjects of all ages resident in communities not selected for the 
survey. Finally, the participants took a reliability exam to measure their agreement with the 
“gold standard” grading of volunteer subjects. The “gold standard” was the consensus grade 
of the course trainers (ophthalmologist, trachoma programme director, and trachoma survey 
consultant) experienced with the simplified trachoma grading system. Additionally, in South 
Wollo, digital photos were taken of each eye included in the inter-observer exam and 
reviewed to obtain consensus when trainers’ grades were discordant. The agreement for all 
signs was generated, but selected graders were those achieving greater than 84% 
agreement and a Kappa ≥0.7 on grade TF. Training for data recorders consisted of 
classroom instruction and field practice, which included testing and refining the data 
collection tools, applying the sampling strategy in the field, and taking geographical 
coordinates of survey households. Persons trained to serve as data recorders were also 
evaluated to assess their ability to follow protocol, perform the interview, and record 
responses correctly. The top performers were selected to work with selected graders to form 
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the final survey teams. A total of 21 teams were deployed in South Wollo and 13 teams 
deployed in South Gondar. 
 
4.4.5. Data Collection, Management, and Analysis 
Each head of household was interviewed to assess demographics of the households and 
uptake of the SAFE strategy. All household residents were examined for the presence or 
absence of all five clinical signs of the simplified trachoma grading system in both eyes using 
a 2.5x binocular loupe and adequate light (Thylefors et al., 1987). Additionally in 99 gotts of 
South Gondar, DNA specimens of the tarsal conjunctivae of one randomly selected child 
aged 1-5 years per household were collected using ocular swabs for detection of infection 
with Chlamydia trachomatis by polymerase chain reaction (PCR) (results not yet 
available).The surveys also included non-trachoma indicators to measure outcomes of 
integrated programme interventions for malaria in South Wollo and intestinal parasites in 
South Gondar. These data will be presented elsewhere. 
Data were collected by recorders on paper survey forms in South Wollo zone. Forms 
were reviewed for completion by a team leader prior to leaving the gott.  Data in South 
Gondar were collected electronically using tablet computers operating on the Android 
platform (Google Inc.). In South Gondar, data recorders reviewed survey data after 
completing each household prior to initiating the next house. In both zones, supervisors met 
with each team at least once per two clusters surveyed to provide needed materials and 
collect completed forms. Data collected electronically were copied to an external micro SD 
card and downloaded every 2-3 days by the team’s supervisor.  
Paper-based survey data were double-entered in Microsoft Access by separate entry 
clerks, compared for discordance, and corrected with the original hard-copy. Electronic data 
was downloaded at the end of the survey separately for each team and converted from html 
to csv format. Data were analysed using SAS version 9.3 (SAS Institute Inc., Cary, United 
States of America). The inverse of the selection probabilities was calculated and used to 
weight the data in the analysis.  Additionally, the data were adjusted for correlation within the 
data due to clustering by using a robust method to estimate the standard error and inflate 
confidence limits. Current prevalence estimates were compared with a regional baseline 
survey that provided zonal level trachoma prevalence in 2006 (Emerson et al., 2008) and in 
South Gondar, from cross-sectional trachoma surveys prior to pilot interventions. The 
statistical significance of differences were assessed with a chi-square (Χ2) statistic 
accounting for the survey designs. 
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4.5. Results 
Teams successfully surveyed 714 of 720 communities from 72 evaluation units across the 
25 woredas in the two zones. The six gotts not surveyed were all in South Gondar and 
inaccessible during the rainy season. Figure 4.3 shows the geographical distribution of the 
714 communities in the two zones of Amhara National Regional State, Ethiopia. A total of 
89,735 residents were registered from 21,327 households of whom 72,452 (80.7%) were 
examined for clinical signs of trachoma. A summary description of the sample stratified by 
zone is shown in Table 4.1. Less than 2% of households encountered in selected gotts 
refused to participate in the survey. A higher proportion of residents were not available for 
examination (absent from the house) in South Gondar than in South Wollo (Χ2=1,725, p 
<0.001). The proportion of enumerated residents examined was lowest among the adult 
male population (data not shown). Among the target population, children aged 1-9 years, 
95.8% and 94.9% of the enumerated children in South Wollo and South Gondar were 
examined respectively.  
 The prevalence of TF in the target age group for the combined area in South Wollo 
zone was 26.4% (95% confidence interval (CI) 23.7-29.1%; range by woreda 0.9-67.0%; 
range by evaluation unit 0.9-76.9%) [Table 4.2]. Prevalence of trachomatous inflammation 
intense (TI) was 4.3% (95% CI 3.2-5.4%; range by woreda 0.7-22.0%; range by evaluation 
unit nil-28.6%). The mean number of children in the 1-9 year age group sampled in each 
evaluation unit was 269.7 (standard deviation (SD) 50.6). The mean number of persons 
examined of all ages in each evaluation unit in South Wollo was 938.9 (SD 192.0). Among 
all residents, the prevalence of TT was 1.3% (95% CI 1.1-1.5%; range by woreda 0.0-3.1%; 
range by evaluation unit nil-4.3%).   
 In South Gondar [Table 4.3], TF prevalence among children was 25.9% (95% CI 
23.8-27.9%; range by woreda 8.6-44.9%; range by evaluation unit 8.6-55.7%). Prevalence of 
TI was 7.0% (95% CI 6.2-7.8; range by woreda 4.3-10.7%; range by evaluation unit 1.4-
13.4%). The prevalence estimates at the evaluation unit were based on a mean sample size 
of 487.0 (SD 45.8) children 1-9 years of age and 1073.7 (SD 106.8) total persons examined 
per evaluation unit. The prevalence of TT was 1.8% (95%CI 1.6-2.0%; range by woreda 1.0-
3.5%; range by evaluation unit 0.6-4.2%) among the total examined population. 
In South Wollo, the prevalence of TF among children aged 1-9 years for the 
combined 13 woredas was higher than the baseline zonal-estimate in 2006 (p=0.013, Figure 
4.4). The prevalence of TI in the current survey was lower than the 10.6% estimate in 2006 
(p=0.053). Compared to estimates from two previous, cross-sectional, cluster random 
surveys in South Gondar, the prevalence of TF among children decreased from 2003 (p 
<0.001) but did not change significantly from the estimate in 2006 (p=0.509). The current TI 
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prevalence among children in South Gondar was lower than previous estimates, 35.8% in 
2003 (p<0.001) and 23.3% in 2006 (p<0.001). 
 The woreda-level and evaluation unit prevalence of TF, classified as <5%, 5-9%, and 
≥10% is shown for both zones in Figure 4.5. Overall, the prevalence of TF among children 
aged 1-9 years was below 5% in six evaluation units and between 5-9% in an additional 
three evaluation units in South Wollo (Table 4.4.). According to the proposed WHO 
guidelines, where the woreda-level TF prevalence is <10%, MDA with azithromycin may be 
stopped in evaluation units where TF prevalence is less than 5%. In two woredas (Albuko 
and Mehal Saiynt), at both the evaluation unit and woreda levels, the prevalence of TF was 
below the 5% threshold and warranted stopping MDA in the entire woreda. One additional 
evaluation unit in Tenta woreda also warranted stopping MDA under the guidelines. The 
additional evaluation unit with TF prevalence below 5% in Legambo, while not identified in 
the suggested way of district then sub-district surveys, meets the UIG criteria, but would not 
have been found if assessment was conducted first at the district and subsequently at the 
sub-district level. Neither at the woreda-level nor in any single evaluation unit was the 
prevalence of TF below 5% among children in South Gondar. Targeted MDA at the sub-
district level is recommended in three woredas (Tenta and Mekidela in South Wollo, Debre 
Tabor in South Gondar) where TF prevalence was between 5% and 9%. For all 20 other 
woredas across the two zones, guidelines suggest continued MDA with azithromycin.  
In only one woreda (Albuko), were no cases of TT identified and thus the point 
estimate for the prevalence of TT is assumed to be below the elimination threshold of less 
than 0.1% among the total population. In all other woredas the prevalence of TT is greater 
than 0.1% and programmes to provide surgery to correct TT should continue. An estimated 
total of 21,376 (95% CI 11,499-31,356) TT patients in the 13-woreda area of South Wollo 
and 37,784 (95% CI 23,060-52,710) TT patients in South Gondar zone need to be operated 
on to meet the elimination threshold for TT prevalence of less than 1 per 1,000 total 
population.  
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Table 4.2. Prevalence* of trachoma clinical signs by sub-district evaluation unit (EU) and woreda in 
South Wollo 2010 
South Wollo EU Children TF TI All ages 
TT 
woredas 1-9 years % 95% CI % 95% CI % 95% CI 
Adjibar Saiynt 
1 284 27.2 6.1-48.2 2.2 0.0-4.6 1011 1.5 0.6-2.4
2 206 15.2 2.3-28.1 4.8 0.0-10.4 638 1.4 0.1-2.8
3 257 56.9 49.5-64.4 9.2 6.3-12.1 721 4.3 2.6-5.9
woreda-level 747 30.7 18.9-42.5 4.6 2.4-6.9 2370 2.1 1.3-2.9
Albuko  1 203 1.0 0.0-2.6 4.8 0.3-9.3 769 . .2 226 0.9 0.0-2.0 3.6 0.4-6.7 735 . .
woreda-level 429 0.9 0.0-1.9 4.2 1.4-7.1 1504 . .
Borena  
1 284 15.7 10.7-20.8 2.3 0.0-5.5 1066 1.7 0.7-2.6
2 352 16.2 12.2-20.2 2.1 0.8-3.4 1191 1.2 0.6-1.9
3 335 12.8 5.5-20.1 0.5 0.0-1.4 1103 0.7 0.0-1.3
woreda-level 971 15.1 12.0-18.2 1.7 0.6-2.8 3360 1.2 0.7-1.7
Jamma  
1 303 18.5 0.3-36.7 3.8 0.0-8.0 1095 3.5 1.6-5.5
2 368 25.0 7.8-42.2 6.6 3.8-9.4 1388 0.3 0.0-0.7
3 294 23.3 16.9-29.7 6.1 3.8-8.4 1139 0.6 0.2-1.0
woreda-level 965 21.8 11.5-32.2 5.3 2.8-7.7 3622 1.7 0.8-2.6
Kelala 
1 214 19.6 13.3-25.9 1.8 0.0-3.9 778 2.8 2.2-3.4
2 260 26.4 13.8-39.1 3.8 0.2-7.4 876 1.5 0.8-3.3
3 237 36.7 25.7-47.8 2.4 0.0-5.6 761 2.3 1.3-3.2
woreda-level 711 28.9 21.4-36.4 2.6 0.7-4.4 2415 2.3 1.7-2.8
Kutaber 1 190 20.8 10.2-31.3 7.7 0.0-16.5 821 1.7 0.0-3.72 261 22.4 12.7-32.1 0.7 0.0-1.7 977 0.5 0.2-0.8
woreda-level 451 21.7 14.6-26.7 3.8 0.0-8.2 1798 1.1 0.1-2.1
Legahida  1 281 76.9 66.0-87.8 28.6 13.5-43.7 917 2.0 0.8-3.32 212 55.7 39.7-71.6 7.1 2.3-11.9 808 0.6 0.1-1.1
woreda-level 493 67.0 55.0-78.9 22.0 10.5-33.6 1725 1.6 0.7-2.5
Legambo  
1 243 4.2 0.7-7.6 0.0 . 889 . .
2 217 7.5 3.9-11.0 0.0 . 723 . .
3 259 38.4 28.8-48.0 2.6 1.2-4.0 887 0.7 0.0-1.3
4 233 24.4 19.5-29.2 1.8 0.0-3.9 780 0.5 0.1-0.9
woreda-level 952 20.7 14.6-26.7 1.3 0.5-2.1 3279 0.3 0.1-0.6
Mehal Saiynt  1 313 1.1 0.0-2.7 2.4 0.1-4.7 1005 1.0 0.3-1.72 309 3.5 1.1-5.8 2.5 0.4-4.5 937 1.2 0.0-2.7
woreda-level 622 2.2 0.5-3.8 2.4 0.8-4.0 1942 1.1 0.4-1.9
Mekidela  
1 384 10.4 1.5-19.2 0.4 0.0-1.0 1429 0.2 0.0-0.4
2 319 6.9 2.5-11.3 1.2 0.1-2.3 1070 0.8 0.1-4.2
3 353 13.7 0.5-26.9 2.1 0.1-4.1 1320 0.1 0.0-0.2
woreda-level 1056 9.5 4.7-14.2 1.2 0.5-2.0 3819 0.5 0.1-0.9
Tenta  
1 219 15.1 8.3-22.0 0.4 0.0-1.0 776 2.5 0.7-4.2
2 222 3.6 1.0-6.3 1.2 0.1-2.3 833 0.7 0.0-1.3
3 216 7.8 2.5-13.1 2.1 0.1-4.1 740 0.3 0.0-0.8
woreda-level 657 8.5 4.9-12.1 0.7 0.0-1.5 2349 1.1 0.4-1.7
Wogedi  
1 313 30.8 18.7-42.9 7.2 0.0-14.6 1048 3.0 2.0-4.1
2 273 23.0 9.6-36.4 5.4 1.8-9.0 858 2.7 1.6-3.9
3 255 40.8 32.9-48.6 11.7 4.1-19.3 808 3.7 2.6-4.9
woreda-level 841 30.9 23.2-38.6 8.0 4.2-11.7 2714 3.1 2.4-3.8
Woreillu  
1 241 48.3 38.3-58.4 3.7 0.9-6.4 903 1.3 0.6-2.0
2 280 61.8 54.2-69.5 3.7 0.7-6.6 961 1.4 0.1-2.7
3 292 38.0 29.2-46.9 1.1 0.1-2.1 1039 0.6 0.1-1.1
woreda-level 813 46.5 40.0-53.0 2.3 1.1-3.5 2903 0.9 0.5-1.4
*estimates weighted according to selection probabilities adjusted for correlation in the data due to clustering; 
CI, confidence interval 
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Table 4.3. Prevalence* of trachoma clinical signs by sub-district evaluation unit (EU) and 
woreda in South Gondar 2011 
South Gondar EU Children 1-9 yr 
TF TI all 
ages 
TT 
woredas % 95% CI % 95% CI % 95% CI 
Debre Tabor 1 519 8.6 2.1-15.1 3.9 0.5-7.3 1109 1.0 0.0-2.2
Dera 
1 606 31.0 15.6-46.4 6.9 4.4-9.3 1188 1.3 0.6-2.0
2 447 30.1 17.7-42.5 2.7 1.3-4.1 954 2.4 1.3-3.6
3 550 23.0 14.3-31.6 2.5 0.3-4.7 1133 1.0 0.2-1.8
4 524 26.1 13.4-38.8 5.5 1.8-9.2 1075 0.8 0.0-1.7
woreda-level 2128 27.3 20.7-33.8 4.5 2.9-6.2 4350 1.3 0.8-1.8
East Estie 
1 353 18.3 11.4-25.3 3.9 3.1-4.6 705 2.7 1.3-4.0
2 474 24.5 19.3-29.6 9.2 3.0-15.4 1008 1.7 0.5-2.9
3 486 14.5 9.5-19.5 5.6 3.1-8.2 1004 0.6 0.0-1.2
4 514 16.7 9.1-24.3 3.9 0.4-7.3 1144 1.1 0.7-1.4
woreda-level 1828 18.9 15.7-22.2 6.1 3.7-8.5 3861 1.4 0.8-2.0
Ebinat 
1 538 31.7 19.1-44.2 7.9 4.8-11.0 1173 1.9 0.9-2.8
2 446 44.8 35.0-54.7 12.7 8.8-16.7 991 3.4 1.5-5.3
3 506 55.7 48.0-63.4 13.4 5.5-21.3 971 1.9 0.5-3.3
4 537 43.4 35.2-51.5 8.4 0.6-16.2 1121 1.1 0.4-1.8
woreda-level 2036 44.9 38.7-51.1 10.7 7.1-14.3 4256 2.0 1.3-2.6
Farta 
1 458 22.3 16.2-28.4 6.0 2.5-9.4 962 2.0 0.6-3.3
2 516 10.6 7.2-13.9 1.4 0.7-2.2 1206 1.2 0.6-1.7
3 487 21.5 13.0-30.1 4.9 2.2-7.7 1159 2.4 1.4-3.4
4 446 22.2 17.8-26.6 7.1 3.8-10.3 921 2.1 0.8-3.4
woreda-level 1907 17.8 14.2-21.4 4.3 2.8-5.8 4248 1.8 1.3-2.4
Fogera 
1 437 28.9 23.1-34.7 6.0 3.8-8.2 1108 1.2 0.0-2.3
2 518 39.1 22.6-55.6 9.8 5.4-14.1 1227 2.2 1.1-3.2
3 444 28.7 22.4-35.1 8.1 2.7-13.5 1080 1.5 0.5-2.5
woreda-level 1399 33.3 25.2-41.3 8.1 5.6-10.6 3415 1.7 0.9-2.4
Lay gayint 
1 487 14.3 4.9-23.7 4.6 0.1-9.0 1142 1.1 0.4-1.8
2 512 15.3 10.9-19.8 7.8 5.3-10.3 1077 2.4 0.5-4.3
3 489 16.8 5.6-27.9 4.4 1.8-7.0 1246 1.6 0.7-2.5
4 481 30.0 15.9-44.0 8.4 4.2-12.7 1032 1.7 1.1-2.2
woreda-level 1971 18.8 12.8-24.8 6.2 4.3-8.2 4497 1.6 1.1-2.2
Libokem 
1 474 20.2 10.3-30.0 7.3 3.6-11.1 1048 1.2 0.3-2.1
2 496 19.1 12.2-25.9 6.0 2.3-9.8 1087 1.8 1.2-2.3
3 512 32.3 20.1-44.6 6.5 3.5-9.4 1154 1.3 0.6-1.9
woreda-level 1482 24.3 17.3-31.4 6.5 4.4-8.5 3289 1.5 1.1-1.9
Simada 
1 430 24.5 16.2-32.9 8.1 4.5-11.7 1043 4.2 2.3-6.0
2 503 25.0 19.4-30.5 10.3 5.9-14.8 1100 4.0 1.8-6.2
3 447 24.5 15.5-33.5 13.0 8.9-17.1 1115 2.2 0.6-3.8
4 416 21.3 11.3-31.3 2.7 1.0-4.4 877 4.5 2.9-6.0
woreda-level 1800 23.9 19.7-28.1 8.8 6.4-11.2 4135 3.5 2.5-4.6
Tach gayint 1 455 36.5 23.4-49.6 10.5 5.5-15.5 1091 1.4 0.7-2.12 482 31.1 12.6-49.5 9.0 1.5-16.5 1094 2.7 1.1-4.3
woreda-level 937 33.8 22.1-45.5 9.7 5.1-14.4 2185 2.0 1.1-3.0
West Estie 1 508 31.5 23.3-39.6 7.0 3.1-10.9 1169 1.1 0.6-1.52 501 29.1 17.1-41.1 11.8 5.7-18.0 1011 3.0 1.8-4.1
woreda-level 1009 30.6 23.3-37.9 9.5 5.7-13.2 2180 2.0 1.3-2.7
Woreta town 1 543 17.2 9.1-25.4 6.7 3.1-10.2 1127 1.0 0.0-2.1
*estimates weighted according to selection probabilities adjusted for correlation in the data due to 
clustering; CI, confidence interval 
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Table 4.4. Summary of survey findings and recommended programmatic strategy for 
trachoma elimination in South Wollo and South Gondar Zone 
  South Wollo South Gondar 
EU* with TF <5%  6 / 36 0 / 36 
EU* with 5% < TF < 
10% 3 / 36 1 / 36 
woreda TF <5% 2 / 13 0 / 12 
woreda 5% < TF < 
10% 2 / 13 1 / 12 
woreda TT<0.1% 1 / 13 0 / 12 
TT case backlog** 21,376 (11,499-31,356) 37,784 (23,060-52,710) 
Recommended 
Programme 
Strategyǂ 
Stop MDA in 2 / 13 woredas and 
2 additional EU with TF <5%. 
Conduct targeted MDA in 2 other 
woredas TF 5-9%.  Continue 
district-wide MDA in 9 woredas 
for 3 more years.   Provide 
surgery to 21,376 estimated TT 
cases. 
Conduct targeted MDA in 1 woreda 
with TF 5-9%.  Continue district-
wide MDA in 11 woredas for 3 
more years.  Provide surgery to 
37,784 estimated TT cases. 
*sub-district evaluation unit (EU) 
**total number of TT patients targeted for provision of corrective surgery in order to achieve less than 
1 per 1000 population (95% confidence interval) 
ǂ interpretation of WHO guidelines 
 
4.6. Discussion 
Implementation of the full SAFE strategy, including five consecutive, annual mass 
azithromycin distribution campaigns did not result in a reduction of TF prevalence below the 
elimination target in any sub-district within the trachoma hyper-endemic setting of South 
Gondar in Ethiopia. The impact on TF after three consecutive years of SAFE implementation 
was not as clear in South Wollo, where the overall prevalence of TF was higher than the 
zonal-level prevalence estimated prior to SAFE interventions. Yet, TF prevalence in a 
fraction of the sub-districts assessed and two of 13 districts were below the 5% threshold. 
According to WHO guidelines these areas are eligible to stop MDA for trachoma. Our 
sample of 9,708 children aged 1-9 years across 360 communities in South Wollo provided 
much more accurate and precise estimates than at baseline surveys. Indeed, the baseline 
prevalence estimates for the entire zone of South Wollo were derived from 484 children 
across 16 communities (Emerson et al., 2008). The 12.6% estimate for South Wollo in 2006 
was the lowest for all 10 zones in the region and the only zone estimated below 20% TF 
prevalence. In South Wollo, the observed difference in TF prevalence compared to the 
baseline survey was likely the results of an underestimate of the true TF prevalence at 
baseline due to chance.  Four of the randomly selected communities in 2006 were 
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from woredas where the current prevalence was lowest which might have contributed to a 
lower prevalence estimate if TF prevalence was also less common at baseline in these 
areas. 
Additional prevalence data from South Gondar prior to 2006 suggest a decline of TF 
prevalence since the initiation of the programme (Figure 4.4), but a reduction in TF from 
2006 to 2011 was not observed in the recent survey. Reduction in TF below 5% among 
children aged 1-9 years has been documented in other programmes after SAFE 
implementation, but in those settings the prevalence of TF at baseline was lower than in 
Amhara (Solomon et al., 2008; Yayemain et al., 2009). TF prevalence in South Sudan (also 
hyper-endemic for trachoma) was reduced to below 5% after high community uptake of 
SAFE interventions but this was observed only in one of four intervention sites (Ngondi et al., 
2006b).  
One conclusion that could be made from the results is that a lack of reduction in TF 
indicates that trachoma has not been controlled and continued MDA is needed. Alternatively, 
trachoma research studies from another region of Ethiopia have documented a delay in the 
resolution of clinical signs after MDA has successfully reduced infection (Keenan et al., 
2011). In one study, although a mean prevalence of 43.5% TF was measured among 
children post 3 years of azithromycin MDA, in a third of the participating communities there 
was no evidence of C. trachomatis infection (Keenan et al., 2012a). A separate study from 
the same area found infection prevalence of 2-3% in the context of 35% TF and/or TI 
prevalence after three years of either annual or biannual MDA of azithromycin (Gebre et al., 
2012). These studies suggest TF alone may not be a suitable marker for impact after 
multiple rounds of MDA on which to determine stopping antibiotic distribution. A reduction in 
the more severe active trachoma grade, TI, was observed in our surveys compared to 
baseline in both zones. A reduction in TI was also documented in the first impact 
assessment conducted in five woredas after 3 years of SAFE implementation in Amhara 
(Ngondi et al., 2009a). An ordinal analysis of that data suggested a combination of TF and TI 
might serve as a better impact indicator than TF alone, which is also supported from a recent 
study in Tanzania (Ngondi et al., 2007; Muñoz et al., 2011). A recent latent class analysis 
concerning trachoma diagnosis concluded that TF was sensitive but not specific whereas TI 
lacked sensitivity but had high specificity indicating usefulness of both signs(See et al., 
2011).   
 According to current WHO guidelines, all woredas of South Gondar warrant ongoing 
MDA with antibiotics (WHO, 2006b). After having received five rounds of MDA, the 
prevalence of C. trachomatis infection is uncertain, but data from other studies in the 
Amhara region raise the question of whether additional rounds will provide further specific 
trachoma-related benefits (Ngondi et al., 2009a; Gebre et al., 2012; Keenan et al., 2012a). In 
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hyper-endemic communities from a different region where region-wide trachoma control 
interventions are not yet underway, a rebound of C. trachomatis infection was observed 6-24 
months after no evidence of infection could be determined post azithromycin distribution 
(Lakew et al., 2009). In the Amhara setting where there is region-wide intervention and fewer 
opportunities for exposure to reinfection, infection data will provide crucial, additional 
evidence for MDA decisions even though relative stopping thresholds based on infection 
have only been suggested from mathematical models (Ray et al., 2009). We have not had 
the ability to process the collected conjunctival DNA swabs to date due to constraints in the 
local availability of reagents and national policies regarding exporting clinical specimens; 
reasons which might suggest why assessing infection has not been included in WHO 
guidelines.    
 Recommendations of the 3rd GSM report suggested that after woreda-level surveys 
indicated a prevalence of TF below 10% among children aged 1-9 years, sub-district-level 
estimates indicating the same were then required before making a decision to stop MDA 
(WHO, 2010). Planning and implementing impact surveys are vital but compete for time and 
resources against the ongoing implementation of programme interventions which require 
decisions for planning well ahead of scheduled activities. For instance, submission of the 
application for donated azithromycin and planning of its distribution occurs 8-20 months in 
advance of the intended distribution. Instead of having a scenario where two surveys need to 
be completed prior to the forecasting of drug needs, we felt a single survey, powered to 
estimate the prevalence of both the sub-district and the district was preferred. The 
experience from implementing these large-scale surveys in both zones, demonstrates that 
such surveys designed to simultaneously measure disease prevalence at the sub-district 
and district levels to evaluate impact of an elimination programme are indeed feasible. 
However, the process was neither without challenge nor the outcome without limitations. 
Over 50 people were required to implement each survey, including data recorders, clinical 
examiners, drivers, supervisors, logisticians, and a coordinator.  During the training in both 
zones, only about half of the clinical examiners met our pre-set criteria to participate in the 
study even after several days of applied training. The final number of survey teams is 
dependent on the number of examiners who can accurately apply the trachoma grading 
system. If fewer examiners meet the criteria, fewer teams can be deployed, which increases 
the number of clusters each team must cover and the total number of days in the field. In 
Amhara, the majority of gotts are accessible only on foot or horseback. Once in the 
community, teams walked long distances between houses within a selected development 
team to survey each household and often slept overnight in the community to repeat the 
process the next day. Accessibility in the field is further constrained when surveys are 
conducted in the rainy season; however, due to MDA forecasting needs and programme 
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implementation schedule, carrying out the survey in the rainy season was unavoidable in 
South Gondar. In South Wollo, around 12,000 paper-based surveys were distributed to 
survey teams for data collection. The printing, sorting, labeling, and distributing of these 
forms took 18 person-days. Double data entry, comparison and correction took over 200 
person-days and seven rental laptop computers. Electronic data collection in South Gondar 
streamlined data management and saved substantial time and resources, as has been 
documented in other programmes (Yu et al., 2009; Rajput et al., 2012; Wilcox et al., 2012). 
Overall, from planning to data analysis, each of these surveys took approximately three 
months to complete, including 30 days of field work. Our survey cost estimates are 
incomplete until the ocular swab specimens are processed, but a generalisable median cost 
per cluster of US $ 311 for conducting population-based prevalence surveys of trachoma 
clinical signs was estimated previously (Chen et al., 2011).  
 Although these surveys are a landmark for trachoma control, our results should be 
interpreted in the context of the following limitations. The actual sample size achieved at the 
sub-district level was lower than the estimated sample size desired. We assumed a 
household size of five persons based on prior experience, when in fact the mean household 
size was smaller, (four). The number of households in a development team was not 50 
households as projected, but varied greatly within a district. In South Wollo, we found the 
development teams to be much smaller than anticipated. To correct for this observation in 
South Gondar, multiple development teams were randomly selected in each cluster. Yet, 
even in South Gondar the actual sample size did not meet expectations. Selecting different 
numbers of segments per cluster results in unequal probability sampling which had to be 
adjusted for by weighting the analysis according to the selection probabilities and doing so 
decreases the precision of the estimates. If the actual point prevalence findings for TF at the 
sub-district level had been near the stopping threshold, then this may have been a reason 
for concern; however, most of the sub-districts were well above 5% so this should not bias 
decisions regarding MDA implementation. Another limitation inherent with utilising clinical 
signs of the simplified trachoma grading system is that diagnosis is subjective and has high 
variability between examiners of the same patients (Miller et al., 2004b). While we took every 
means possible to select the most capable, reliable graders, there will always be the chance 
of systematic misclassification. Taking photographs of the everted lid has been shown to 
provide an objective measure of findings in some studies, but not in all settings and not at 
the scale of the current study (West and Taylor, 1990; Solomon et al., 2006; Roper and 
Taylor, 2009). We used photographs only during the standardisation of the graders but 
capable cameras were not deployed with any of the 34 survey teams. With the rapid 
development in technology of devices which are used for electronic data collection, it might 
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be useful to explore the capability of the device to capture photos of the tarsal conjunctivae 
(Bhosai et al., 2012).  
 The decision to stop MDA is not straight forward. Strictly following WHO guidelines, 
Amhara Regional Health Bureau could stop MDA in six evaluation units in South Wollo. 
Programmatically, planning and coordination of interventions is done by the district and it is 
very difficult (politically and logistically) to exempt part of the district while the other part 
continues to receive a perceived benefit from the intervention. Scientifically, these six 
evaluation units are within woredas geographically surrounded by areas where the 
prevalence of TF warrants continued MDA (Figure 4.5). The spatial distribution of trachoma 
and correlation of trachoma between sub-districts may have implications on how stop MDA 
decisions are made. Additionally, identification of factors at the community and geographical 
level associated with trachoma might assist in the prediction of the presence or absence of 
trachoma post-intervention and perhaps help minimise the amount of communities to be 
surveyed.    
The total cumulative output of SAFE activities through December 2010 in Amhara, as 
reported by the Health Bureau include: 192,922 persons operated to correct trichiasis, 50.9 
million doses of azithromycin distributed, 3,428 kebeles with ongoing trachoma-specific 
health education and over 1.8 million household latrines constructed [unpublished data]. 
Facial cleanliness was specifically promoted in 1,324 schools but the proportion of children 
with clean faces is not routinely recorded because a clean face is not a good predictor of a 
washed face (King et al., 2011a). Field reports of antibiotic coverage ranged from 80-95% in 
each round, but these administrative reports were not validated (Cromwell et al., 2012). In 
addition to clinical evaluation criteria on which to determine trachoma elimination, the 
compliance with the SAFE interventions, particularly hygiene and sanitation should be 
required. Low prevalence of clinical trachoma signs in areas with low compliance of F and E 
interventions might be interpreted differently than areas where household latrine coverage, 
water access, and use for face washing is high. Such indicators have been measured in 
these zones (reported elsewhere) and show increases in household sanitation and water 
access. Additional investigation is warranted to determine whether high coverage of 
household-level access to water and sanitation supports sustained reduction of trachoma 
prevalence after MDA has stopped. Given the current situation, a district-level randomised 
clinical trial might be possible, to compare both clinical signs and infection between woredas 
stopping and continuing MDA and measured uptake of F and E interventions. 
 In conclusion, this study demonstrated that our methodology was capable of 
providing estimates at both the district and sub-district levels in a single survey, although 
minor adjustments would be needed to consistently meet the required sample size at the 
sub-district level. Implementing the survey at the sub-district level irrespective of the district-
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level TF prevalence might identify sub-districts which have met the elimination threshold for 
TF when the district level prevalence remains above 10% such as we found in Legambo 
woreda of South Wollo. However, to obtain the sub-district level estimates, 360 communities 
in a single zone had to be surveyed. While more feasible than surveying every village as 
suggested by the previous WHO recommendations, this number of clusters surveyed in 
each zone was greater than that surveyed in some national-level standardised surveys such 
as the multiple indicator cluster survey and malaria indicator survey. Realising the logistical 
challenges posed by carrying out sub-district-level surveys and our feeling that TF alone 
may not be sufficient to confidently make programme decisions, begs the question: is there a 
more efficient way to determine whether MDA could be stopped?   
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Figure 5.1. Data collector conducting a household interview using tablet computer (courtesy of 
the author)  
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5.1. Abstract 
Background: Large cross-sectional household surveys are common for measuring indicators of 
neglected tropical disease control programmes. As an alternative to standard paper-based data 
collection, we utilised a novel paperless technology to collect data electronically from over 
12,000 households in Ethiopia. 
Methodology: We conducted a needs assessment to design an Android-based electronic data 
collection and management system. We then evaluated the system by reporting results of a pilot 
trial and from comparisons of two, large-scale surveys conducted seven months apart; one with 
traditional paper questionnaires and the other with tablet computers, including accuracy, 
person-time days and costs incurred. 
Principle Findings: The electronic data collection system met core functions in household 
surveys and overcame constraints identified in the needs assessment. Pilot data recorders took 
264 (standard deviation (SD) 152 sec) and 260 sec (SD 122 sec) sec per person registered to 
complete household surveys using paper and tablets, respectively (P=0.77). Data recorders felt 
a lack of connection with the interviewee during the first days using electronic devices, but 
preferred to collect data electronically in future surveys. Electronic data collection saved time by 
giving results immediately, obviating the need for double data entry and cross-correcting. The 
proportion of identified data entry errors in disease classification did not differ between the two 
data collection methods. Geographic coordinates collected using the tablets were more 
accurate than coordinates transcribed on a paper form. Costs of the equipment required for 
electronic data collection was approximately the same cost incurred for data entry of 
questionnaires; whereas repeated use of the electronic equipment may increase cost savings. 
Conclusions/Significance: Conducting a needs assessment and pilot testing allowed the 
design to specifically match the functionality required for surveys. Electronic data collection 
using the Android-based technology was suitable for the large-scale health survey, saved time, 
provided more accurate geo-coordinates, and was preferred by recorders over standard paper-
based questionnaires. 
 
 
 
 
 
 
 
5. Novel electronic data collection system 
 
62 
 
5.2. Introduction 
Large-scale national and sub-national surveys are needed to map the distribution of a health 
condition, establish baseline prevalence and incidence data for planning, and monitoring the 
impact of neglected tropical disease control interventions (Emerson et al., 2008; Brooker et al., 
2009; Baker et al., 2010; Dorkenoo et al., 2012). These surveys often involve collection of a 
combination of geospatial and disease prevalence data from multiple households within multiple 
communities across many different regions of a country. Sample sizes vary according to 
programme-specific methodologies, but typically thousands of individual, household, school, 
and community records are obtained on paper forms (Sturrock et al., 2009; Bamani et al., 
2010b; King et al., 2010; Kabatereine et al., 2011; Forrer et al., 2012; Gosoniu et al., 2012). 
Paper forms must be printed, transported to the field, distributed, filled in, collected, organised, 
collated, and kept secure prior to data entry. Once data have been collected, forms must then 
be entered manually into computer databases. To ensure quality of stored data, the forms 
should be entered twice by separate data entry clerks and then compared to remedy discordant 
entries against the original hard copy forms. Finally, in good practice, the paper forms must be 
stored securely for a minimum time period (no less than 2 or 5 years after publication) according 
to national and international regulations (WHO, 2002b; IEA, 2007). 
 As neglected tropical disease control and elimination programmes seek to assess 
impact of interventions (e.g., elimination), large sample sizes are required to have the power to 
determine low levels of disease (WHO, 2011). For example, while 10 communities may be 
acceptable for estimating the need to initiate control interventions to over a million population in 
a “super district” suspected hyper-endemic for trachoma, 10 or more clusters per 50,000 
population in a sub-district are required to document low-level disease before stopping 
interventions (WHO, 2010). Applying sub-district-level surveys in only two zones (population of 
3.8 million) of the Amhara National Regional state in Ethiopia required collecting data from over 
21,000 households in 714 communities(King et al., at review). A 4-page paper survey tool was 
employed and administered to each household. Needless to say that paper-based surveys at 
this magnitude require significant time, financial and human resources, and physical storage 
space. 
 Electronic data collection has been proposed as a solution to the challenges posed by 
paper-based surveys and several advantages have been discussed (Lane et al., 2006). Devices 
such as mobile phones, using short message service (SMS), have been effectively used to 
manage drug-stock in rural health facilities, push health communication messages to target 
populations and for disease surveillance (Barrington et al., 2010; Jian et al., 2012; Deglise et al., 
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2012). However, the amount and complexity of the data collected and sent with SMS is limited 
(Hillebrand, 2010). Personal data assistants (PDAs) allow the capture of more complex data 
and efficient use of PDAs has been documented in disease surveillance and clinical research, 
as well as national surveys (Dale and Hagen, 2007, Blaya et al., 2008, Yu et al., 2009, Jima et 
al., 2010). With the development of the Android (Google Inc.) platform, applications such as 
Open Data Kit (ODK, www.opendatakit.org) and EpiCollect (www.epicollect.net) have 
broadened the options in mobile data collection in public health to so-called ‘smart’ devices 
(primarily touch-screen mobile devices, such as smart phones and tablet computers) (ODK, 
Aanensen et al., 2009). Many of these devices offer the additional advantage of having built-in 
global positioning systems (GPS) to automatically capture geographic coordinates from external 
GPS devices, as opposed to transcribing coordinates to paper-surveys from external GPS 
devices, thus minimising transcription errors in the field. 
 The purpose of this study was to evaluate the use of a novel electronic data collection 
system for use on tablet computers operating on the Android platform, and to determine 
whether this system was feasible and as effective as standard paper-based forms in collecting 
data in large-scale household surveys in a remote area of Ethiopia with poor infrastructure. 
Additionally, an effort was made to estimate person-time days and cost incurred by the two 
approaches of data collection. 
 
5.3. Materials and Methods 
5.3.1.  Ethics Statement 
The pilot study reported here was integrated into a training exercise for the trachoma impact 
assessment surveys approved under Institutional Review Board protocol 079-2006 of Emory 
University and by the Amhara National Regional Health Bureau ethical review committee. Data 
obtained from these surveys and used for the current comparison are the property of the 
Amhara National Regional State Health Bureau and The Federal Ministry of Health of Ethiopia 
and made accessible to The Carter Center under a memorandum of understanding, but are not 
publically available. Details of the ethical consideration for these surveys and training have been 
explained elsewhere (King et al., at review). Participants involved in needs assessment 
discussions were aware of the intent to publish from the outset of the discussion, are authors on 
the present paper and have consented to the contents of this paper. 
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5.3.2. Study Preparation 
We consulted freelance volunteers (senior computer science undergraduates) with experience, 
expertise, and interest in seeking to apply their technical skills in a philanthropic project. In a first 
step, we conducted a needs assessment prior to proposing an electronic data collection system 
aimed at improving efficiency in large-scale household surveys. This involved group discussions 
with the volunteer computer scientists, epidemiologists, and public health programme 
professionals with extensive experience in cross-sectional household surveys to identify core, 
functional needs of both hardware and software when implementing a survey and identifying 
potential constraints of electronic data collection under typical field conditions in resource-
constrained settings. Next, we piloted a proposed, novel electronic data collection system in a 
setting where such a system would be deployed to further refine the design and provide 
developers first-hand experience of real constraints faced in the field. This pilot involved the 
following activities: training data recorders experienced in paper-based surveys to use an 
Android device and electronic questionnaire; recording the time required for data recorders to 
collect data using the same household questionnaire by either paper and pencil, or 
electronically on a tablet computer; and finally, documenting the perceptions of the data 
recorders about using the electronic data collection system. The hardware and software used 
for electronic data collection in the study activities are described in Box 5.1. 
 
5.3.3.  Training and Study Implementation 
The pilot survey team consisted of eight members who had previously been deployed in a large-
scale trachoma survey in Ethiopia. The same survey tool (paper questionnaire, see Appendix 
S1) that was used by the teams in the large-scale survey was designed electronically and 
loaded onto tablet computers.  
 The data recorders were trained for one day in a classroom on how to operate the tablet 
computer and collect data using the Android application, including capture of geographic 
coordinates. This was followed by one day of practice in a nearby community whereby the eight 
members were split into two teams of four (two data recorders and two trachoma examiners) 
and followed the exact protocol of previous surveys. At each household, one data recorder 
administered the questionnaire and collected data using the tablet, while the other recorded 
data on the paper questionnaire. The recorders took turns using the tablet and alternating lead 
interview roles at each household for a total of 20 households. The next two days the same 
process was repeated in two separate communities. Without the data recorders’ knowledge, the 
team supervisors recorded the time required for the data recorder to implement the survey at 
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each house and whether it was administered by paper or tablet. On each day of applied training, 
the participants’ perceptions on using either paper-questionnaires or electronic questionnaires 
were documented through focus group discussions (FGDs). Using a grounded theory approach, 
these discussions were semi-structured around a core set of questions (Appendix S2) and new 
themes identified in one FGD were explored in subsequent FGDs until saturation of themes was 
reached (Glaser et al., 1967). Additionally, the participants were given the same questions on 
individual questionnaires and were asked to share any comments they felt were not adequately 
discussed or did not want to openly share in the discussion. Two observers entered separately 
the responses and any additional comments provided by the participants which were compared 
for consistency. The discussion notes were reviewed by the coauthors and emerging common 
themes extracted as has been done in other programmes (King et al., 2011b). The findings from 
the FGDs were used to revise the survey instrument and functionality of the data collection 
programme, and were re-tested among the study participants.  
 
5.3.4.  Data Comparison 
The electronic data collection system was further refined and implemented in a large-scale 
trachoma prevalence survey using the same protocol and questionnaire as implemented seven 
months prior in a neighboring zone of the same region of Ethiopia. The methods and results of 
these surveys are described in detail elsewhere (King et al., at review). Of note, the cluster size 
was increased in the survey using electronic data collection by randomly selecting one segment 
of 40 rather than 30 households as done in the previous survey in order to meet the target 
sample size for estimating prevalence of trachoma among children aged 1-9 years.  
 The first survey collected data on standard paper-based questionnaires and the other 
utilised the modified electronic data collection system both using the survey tool (Appendix S1). 
The survey tool consisted of one interview per household to obtain household characteristics, 
head of household demographics, knowledge of trachoma, knowledge of prevention measures, 
reported behaviour of face washing and household indicators of water, sanitation, and hygiene. 
Nested within the household interview, data was collected from all individual household 
residents including demographics, reported school attendance among children and participation 
in antibiotic mass distribution, and clinical examination for trachoma, hence creating the 
hierarchical structure of parent (household) to child (individual resident). An additional 
questionnaire was employed for one randomly selected school-aged child per household by 
branching to a separate electronic form linked to the parent and child data with a unique 
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identification number. This additional questionnaire was not used in the survey employing paper 
questionnaires and thus is not compared in the analysis. 
 
5.3.5. Analysis 
We assessed the raw data sets from the two large-scale trachoma impact assessment surveys 
conducted 7-months apart. We compared the difference in frequencies of survey refusals and 
identified data entry errors using a Χ2 test and t-test corrected for the survey design where 
appropriate. We focused on data entry errors that could have the most impact on disease 
prevalence estimates: number of blank fields (i.e., missing data where data should have been 
recorded according to protocol); age and sex of participants; availability for examination; 
incorrect unique identifying number; a blank field in the classification of trachoma clinical signs, 
or an impossible combination of clinical signs (e.g., no signs and clinical signs recorded for the 
same eye). 
 Geographic coordinates as recorded by the GPS were collected for every household, in 
each community cluster, for both surveys. Using the recorded household coordinates, we 
calculated the median location for each community surveyed to serve as the cluster centroid. 
We then computed the distance between the coordinates for each household to the cluster 
centroid, and compared the two surveys with a t-test. The Euclidian distance was calculated 
using the Haversine formula (Sinnott, 1984), and cross-checked in ArcGIS version10 (Esri; 
Redlands, CA, United States of America) by re-projecting the latitude and longitude (in decimal 
degree) into Northing and Eastings (in meters, UTM Zone 37). We also compared the frequency 
of obvious outlying household coordinates, defined as ≥ 4 km away from the cluster centroid. 
Finally, we mapped all households linked to their cluster centroid to visually assess the 
differences in accuracy of each data collection method. Statistical tests were conducted in Stata 
version 12.0 (Stata Corp.; College Station, TX, United States of America).  
  To estimate costs associated with paper-based data collection, we used 10.9% of a 
median cost per cluster of US$ 311 (inter-quartile range [IQR]: US$ 119-393) estimated from a 
previous study of trachoma prevalence surveys in 165 districts across eight countries (Chen et 
al., 2011). This was the overall proportion of total costs due to data entry of paper 
questionnaires. An additional 1.5% of total cluster cost was assumed to cover the cost of the 
paper and printing for questionnaires. For a conservative estimate of the cost of electronic data 
collection, we simply took the sum of equipment costs for the tablet computer and accessories, 
assuming a one-time use. 
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Table 5.1. Needed functionality of electronic data collection in household surveys and the 
solutions implemented 
 Description of need Final solutions implemented 
Software   
Creation 
 Simple design of new surveys 
 Update of existing surveys 
 Display multiple languages 
 No Internet connection required for design, 
drag and drop survey builder  
 Create and save templates for fast production 
of new surveys 
 Entry of multiple translations in form builder 
 Export labels for faster, bulk translation  
Collection 
 Simple entry of data 
 Accommodate skip patterns 
 Generate unique identification numbers 
for each household and individual 
 Maintain parent‐child relationships of 
household‐level and individual‐level data  
 Generate random samples of entered 
records 
 Track external specimens 
 Minimise errors 
 Input text in multiple languages 
Android application with base functionality of 
Open Data Kit plus: 
 Ability to generate relational databases so 
that data entered once applies to all related 
records 
 User defined survey preferences 
 Generation of unique record identification 
 Select enumerated residents randomly 
 Save listing of absent persons for ease of 
review and completion 
 Side‐by‐side view of enumerated residents 
and repeating data fields (Figure 5.2) 
 Capture input from internal or external GPS 
and camera  
 Language specific keyboards 
Management 
 Efficient distribution of survey forms 
 Minimal risk of data loss 
 Append data from multiple devices 
 Convert data to a generic file format for 
broad compatibility 
 Reduce time to data availability 
 Data written to external storage on device 
 Without Internet or mobile network 
connection, from a local desktop user‐friendly 
interface:  
1. Distribute forms  
2. Upload and append collected data 
3. Convert data to useable format   
Hardware   
Durability 
 Withstand heat, cold, moisture, and dust; 
 Battery life for at least 1 working day 
 Ease of recharging 
 Android tablet computer 7” display 
 Internal battery minimum capacity 6‐8 hr  
 Protective case 
 Portable external battery pack 
 AC and DC to multiple USB plugs for charging 
Capability 
 Capacitive touch screen 
 Visible display in bright sunlight 
 Collection of geographic coordinates 
 Camera for scanning barcodes  
 Recoverable data 
 Tablet computer with 3.5 mega pixel camera  
 Auto‐brightness display setting 
 Internal GPS  
 Removable, external micro SD cards 
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5.4. Results 
5.4.1.  Design of Electronic Data Collection System 
The summary of the findings of the needs assessment and developed solutions are listed in 
Table 5.1. In brief, the proposed electronic data collection system incorporated a desktop user-
friendly interface, which readily allowed survey planners to design, modify, and update 
electronic questionnaires, without the need for Internet connection, in an intuitive drag-and-drop 
form builder. Additionally, the Android application to collect data was able to capture recurring 
data from individuals within a data record collected from the household. Unique identification 
numbers were generated based on survey preferences set on the tablet in the home screen of 
the application and from minimal input of the data recorder. Data fields for each individual 
enumerated in a household record were arranged alongside the list of enumerated individuals, 
which allowed flexibility of alternating between individuals as a survey team encountered each 
one for examination (Figure 5.2). From this same display, the random selection functions were 
accessible, allowing random selection of an eligible individual enumerated in the household 
record for additional assessment (e.g., submission of stool sample for the diagnosis of intestinal 
parasite infection). Eligibility was defined as set by the user in survey preferences accessed 
from the home screen. To manage the survey, the user interface allowed the distribution of 
created forms, uploading, and appending collected data through USB connection without 
Internet connection. 
 With regards to hardware (Box 5.1), during the pilot testing, we used a tablet computer 
with a 7-inch resistive touch screen display with exchangeable batteries. The resistive screen 
was tough, but not sensitive to normal touch and the external batteries proved problematic to 
exchange on-the-go and keep charged. Hence, for the full deployment, we used a tablet with 7-
inch capacitive touch display enabling softer touches to the screen and a more responsive user 
experience.  The deployed tablet had an internal battery providing 6-8 hours of use, which could 
then be recharged through a USB connection to AC/DC or external battery pack charging units. 
An internal GPS allowed the direct capture of geographic coordinates. To minimise errors in 
linking results to household and individual records and maintain privacy of survey volunteers, a 
camera with autofocus allowed use of an application (Barcode Scanner 4.3.1; see 
http://code.google.com/p/zxing) to capture of random identification numbers from 0.25”x0.25” 
QR codes on 1.18”x0.5”labels used to uniquely link external specimens (in this case, stool 
specimens; see Figure 2). Data were stored on an external micro SD card to reduce risk of data 
loss. 
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Figure 5.2. Example screen shot: looping fields for members grouped within a household 
record. As seen in a novel Android application for collecting data in household surveys 
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Figure 5.3. Collecting the identification number from a barcode-labeled stool specimen. 
Integrated survey of neglected tropical diseases in Amhara National Regional State, Ethiopia 
(courtesy Aisha Stewart) 
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5.4.2. Results from Pilot Investigation 
A total of 40 households were surveyed over two days in two separate communities during pilot 
testing. There was no difference in the time required to collect data between the paper-based 
and electronic method over the 2-day observation period (Table 5.2). The time taken to enter 
data when the survey was administered with tablets was 48 sec per person more on the first 
observed day (day 2) and 54 sec per person less on the second observed day (day 3) 
compared to paper surveys. These differences, however, were not statistically significant 
(P=0.20 and P=0.50, respectively). 
 
Table 5.2. Time to complete paper-based and Android-based electronic questionnaires during a 
pilot trial in Ethiopia 2011 
 Paper* Tablet* H0: Paper = Tablet** 
Day 2                                                        
Total number of households surveyed 
                        
10 
                     
10  
Mean number of residents per 
household  4.9 (1.8) 4.5 (2.9)  
Mean time (sec) to enter data  per 
person registered 268 (101) 320 (119) 
z=-1.29               
P=0.20 
Day 3                                                        
Total number households surveyed 
                        
10 
                     
10  
Mean number residents per household 3.8 (1.2) 3.9 (1.2)  
Mean time (sec) to enter data per 
person registered 260 (197) 201 (97) 
z=0.68                  
P=0.50 
Combined 2-Day Results                       
Mean time (sec) to enter data  per 
person registered 264 (152.4) 260 (122) 
                                    
z=-0.30                    
P=0.77 
* SD- standard deviation 
**Wilcoxon rank-sum test 
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Table 5.3. Data recorders’ perceptions of electronic data collection post 3-day pilot trial in 
Ethiopia 
Aspect explored Summarised perceptions   
Time  ▪Paper questionnaire took less time to complete than the electronic questionnaire 
Preparation ▪No printing, sorting, stapling, and labeling with unique numbers is required with electronic data collection 
Transporting ▪Tablet computers were portable, lighter, and less bulky than paper 
Communication 
with respondents 
▪Less eye-to-eye contact with respondent, but was less of a 
problem once familiar with the tablet computer 
Recording data 
▪Transcribing GPS coordinates onto paper forms was a difficult 
task and the direct capture of GPS coordinates via the tablet was 
preferred ▪Writing district, village, and community names on a 
paper form for every household was tedious                                   
▪No writing necessary for electronic data collection                         
▪Recorders must be attentive to skip patterns on a paper form, 
but the skip patterns were automatic on the electronic form            
▪Entering text, moving the cursor, and editing text fields were 
most challenging tasks using the tablet computers                          
▪Accidental selections on single select (i.e., yes or no) questions 
when the question did not apply could not be de-selected only 
switched to either option                                                                   
▪Mistakes on paper forms can be erased and corrected                  
▪More difficult to return to a completed electronic form and add 
information than a paper form (i.e., an absent person presents 
for examination after the survey team has moved to a new 
household)  
Data management 
▪Risk of losing the data was greater for tablets than for paper 
forms because paper is tangible                                                      
▪Paper forms are difficult to keep clean, dry, and in order 
Training 
▪Ability to use tablets may be enhanced by experience in using 
computers                                                                                         
▪Data recorders should become familiar with questionnaires first 
before using tablets                                                                          
▪Power management must be covered 
General concerns ▪Keeping device charged where there is no access to electricity 
General 
preferences 
▪Enjoyed learning new technology                                                   
▪Questions on the electronic form and entry of data in Amharic 
(native language) are preferred                                                       
▪Use electronic data collection rather than paper questionnaires 
in future trachoma surveys
 
  After the field work, recorders shared their perceptions concerning electronic data 
collection with key findings summarised in Table 5.3. Recorders felt the paper survey took less 
time to complete, but they enjoyed learning the new technology and preferred to collect data 
electronically in future surveys. Recorders expressed a lack of connection to the respondent 
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when first learning to use the data collection device due to less eye-to-eye contact while 
administering the questionnaire. The training curriculum was modified to address attentiveness 
and connection to the respondents in future surveys. The greatest concern about using 
electronic data collection was the ability to keep the electronic device charged under field 
conditions. We also included modules in future survey trainings to address power management 
and common data collection mistakes or difficulties as reported by the pilot data recorders 
(Table 5.3). 
  Data loss with paper surveys was perceived less risky than with electronic data 
collection since the paper questionnaires were tangible, enabling the immediate review, 
identification and correction of mistakes. Paper surveys were also perceived to be easier to 
manipulate, to add or change data, including an absent household member who was later 
encountered by the survey team. To address these concerns the Android application was 
modified to allow identification of absent persons in a household, and aggregate these people in 
an absent list that facilitates finding the correct household record and completing the necessary 
fields of the presenting absent person. 
 
5.4.3. Results from Large-Scale Surveys 
Outcomes from the paper-based and electronic data collection in separate, large-scale surveys 
utilising the same sampling methodology and questionnaire are presented in Table 5.4. The 
surveys were equivalent in scope and scale. Refusals to participate in the survey were rare, but 
significantly more common among household residents when using the electronic device (0.8%, 
95% confidence interval (CI), 0.7-1.0%) compared to paper-based surveys (0.3%, 95% CI 0.2-
0.4%) (P<0.01). The number of empty entries for the fields age, sex, and availability of 
enumerated household residents was fewer with electronic data collection than paper-based 
collection by 0.2% (P=0.01). There were fewer errors identified in the unique identifying 
numbers of each household in the electronically collected data set (1.8%) than the paper-based 
data set (2.3%, P=0.09). There was no difference in the amount of errors made when recording 
the trachoma clinical diagnosis between the two data collection approaches (0.2% vs. 0.2%, 
P=0.26). 
 When comparing the capture of geographic coordinates, 0.5% more empty fields were 
observed in the data collected with tablets than in the paper-based data (P<0.01). Outliers, 
defined as household coordinates ≥4 km from the median geographic coordinate in the 
surveyed cluster or more than 1000 m elevation from median elevation in the cluster, were more 
common in paper-based collection than electronic collection (1.4% vs. 0.6%, P<0.01). The 
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mean distance from a household in a cluster to the cluster centroid was 400 m greater in the 
survey where coordinates were transcribed to paper questionnaires compared to electronic 
survey application (P<0.01). Variability of this distance is seen in Figure 3, where each point 
represents a household and each solid circle represents the cluster centroid. Each household is 
connected by a line to its cluster centroid circle. The displayed size of the circle is proportional 
to the maximum distance between a household and the centroid in that cluster. 
  The total time taken to prepare, implement, and process the data was 511 and 790 
person-days for electronic and paper-based data collection, respectively. The proportion of time 
taken to complete activities involved with data collection is presented in Figure 5.5 for both 
surveys. The two survey methods required approximately the same amount of time to develop 
the questionnaire, obtain translations and edit.  An additional person day was required to 
convert the paper-questionnaire to an electronic platform.  For either method, the length of 
training was approximately one full week. The paper-based questionnaires (over 9,000 in total) 
took 18 person-days of preparation to print, collate, staple, and distribute prior to deploying 
teams for actual fieldwork. Preparing the electronic survey and loading to 20 electronic 
collection devices took less than one person-day. Collecting data in the field in South Wollo 
(paper-based survey) took 21 survey teams 26 days to complete, while in South Gondar 
(electronic survey) it took13 teams 38 days which was 52 less person-days. Including the time 
required for survey teams to access the selected clusters, one cluster was completed every one 
and half days per team in both surveys. Upon completion of field work, data collected 
electronically was uploaded to the survey coordinator’s computer, appended, and converted to a 
usable data set in less than one day using the desktop interface. Completed paper 
questionnaires were collected from all teams, transported back to a central office where 14 data 
entry clerks working 8-10 hours per day for 14 days double-entered the data into separate 
databases. An additional 5 days was required to compare the duplicate data sets for discordant 
records, find the respective hard-copy questionnaires, and identify the correct entry before a 
final data set was available. Together, these data entry and correction activities accounted for 
26.6% of the total time spent on the paper-based survey. 
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Table 5.4. Data comparison of paper-based and electronic data collection from two large-scale, 
cluster surveys in Ethiopia 
Indicator compared Paper-based data collection 
Electronic      
data collection 
Χ2 or t-test       
(p-value) 
Sample                          
Clusters 360 354 NA
Households surveyed 9,263 12,064 NA
Individuals enumerated 38,851 50,858 NA
Individuals examined 33,800 38,652 NA
Refusals                         
Individual-level 0.3% (N=38,852) 0.8% (N=50,884) 27.96 (P <0.01)
Identified data entry errors     
% Individuals enumerated 
with at least 1 blank field in 
census record                   
(age, sex, availability) 1.7% (N=38,851) 1.5% (N=50,858) 6.61 (P =0.01)
% households with incorrect 
unique identifying  number 2.3% (N=9,433) 1.8% (N=12,112) 6.83 ( P =0.01)
Disease classification 0.2% (N=33,800) 0.2% (N=38,652) 1.28 ( P =0.26)
Geographic coordinates          
Blank entries 0.6%(N=9,263) 1.1% (N=12,064) 12.14 ( P <0.01)
Outlying entriesǂ 1.4% 0.6% 38.92 ( P <0.01)
Mean household distance in 
meters to cluster  centroid 
(SE) 687 (81) 288 (7) t=-5.53 ( P <0.01)
ǂDefined as recorded households with coordinates more than 4 km from cluster centroid, or 
more than 1,000 m elevation from median elevation of the cluster  
NA, not applicable 
 
5. Novel electronic data collection system 
 
77 
 
 
  
 
Fi
gu
re
 5
.4
. D
is
ta
nc
e 
be
tw
ee
n 
th
e 
re
co
rd
ed
 lo
ca
tio
n 
of
 a
 s
ur
ve
ye
d 
ho
us
eh
ol
d 
an
d 
th
e 
cl
us
te
r c
en
tro
id
. H
ou
se
ho
ld
s 
su
rv
ey
ed
 in
 tr
ac
ho
m
a 
im
pa
ct
 a
ss
es
sm
en
ts
 in
 S
ou
th
 W
ol
lo
 (p
ap
er
-b
as
ed
 q
ue
st
io
nn
ai
re
 2
01
0)
 a
nd
 S
ou
th
 G
on
da
r 
(e
le
ct
ro
ni
c 
da
ta
 c
ol
le
ct
io
n 
20
11
), 
E
th
io
pi
a 
 
5. Novel electronic data collection system 
 
78 
 
 
Figure 5.5. Proportion of total time (person days) required to complete survey activities by 
collection method. Time as implemented using paper-based questionnaire and Android-based 
electronic form in two large-scale (360 clusters each) trachoma impact assessments in Ethiopia 
2010 and 2011. 
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5.4.4.  Cost Estimates 
Costs associated with paper-based data collection in the compared survey were US$ 13,883 
(IQR US$ 5,312-17,543), which included an estimated cost of US$ 1,679 (IQR, US$ 642-2,122) 
for paper and printing of questionnaires plus US$ 12,204 (IQR US$ 4,670-15,421) for entering 
the data from questionnaires twice by separate data entry clerks into a database. The 
incremental survey costs associated with electronic data collection were US$ 10,320, which 
included 24 tablet computers (US$ 299 per piece), carry cases (US$ 15), micro SD memory 
card for external data storage (US$ 12), two external batteries for charging the tablet in absence 
of electricity (US$ 40 each), AC-USB adapter for charging with electricity (US$ 12), and DC-
USB adapter for charging in a vehicle (US$ 12). These equipment costs assume a single use, 
which, more realistically, may be used for multiple surveys thus lowering incremental costs.  
Additionally, four of 24 tablet computers were not needed and never deployed during the 
survey. 
 
5.5. Discussion 
In this study, electronic data collection was at least as accurate as data collected using 
conventional paper-based questionnaires. Importantly, the novel electronic data collection 
system was less time consuming and our preliminary cost evaluation suggests that it is less 
costly. There was no evidence of differences in the amount of data entry errors identified by the 
two data collection methodologies. However, the differences in accuracy and precision 
observed between the captured geographic locations of surveyed households were significant, 
which, in turn, could affect subsequent spatially explicit data analysis. The accuracy of data 
entry using the electronic system could be further enhanced with additional logic statements and 
by blocking impossible combinations of entered data. The costs of the equipment required for 
electronic data collection was approximately the same cost required for data entry of paper-
based questionnaires in a single survey, which was a conservative estimate. Use of the 
electronic data collection equipment in additional surveys would further reduce costs.  
  In the pilot study, there were no differences in time to completion of the household 
surveys between the methods, which was also reported in a comparison of smartphone 
administrated interviews among attendees of maternal health clinics in the People’s Republic of 
China (Zhang et al., 2012). In comparing the two large-scale surveys, more households and 
individuals were examined in the electronic survey because of a modification in protocol to 
select more households per cluster. Yet, even with the increased work load, teams collected 
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more data in less time, as expressed in person-days to collect data using electronic capture. A 
total of 265 person-days were gained when using the electronic data collection system. The 
majority of time saved came from obviating the need for post-field collection data entry and 
translated into having the final data set available for analysis nearly one month sooner. Time 
saved is invaluable in programme settings, as it allows for immediate reporting of results to 
decision makers within the health system and creates lead time for preparation of needed 
interventions or importation of commodities such as donated drugs. Because impact surveys 
where data is collected electronically requires less time than conventional paper-based 
methods, the flexibility of when the survey is conducted within the programme schedule is 
increased. This is a critical advantage in neglected tropical disease control programmes due to 
the tight and often complex calendar of planning annual mass drug administration campaigns 
and other community-based interventions (Rotondo and Seligson, 2011; WHO, 2012c; Hanson 
et al., 2012; Knopp et al., 2012). 
  Pilot testing was crucial and identified additional flexibility needed in the electronic data 
collection system and further insight into the type of hardware required. It also introduced us to 
the perspectives of the experienced data recorders from previous paper-based data collection, 
which raised important issues that were addressed in the final system and provided insight to 
the training curriculum used in the large-scale deployment. We tailored the selected Android 
device to fit the needs of the survey and field conditions, which required extended battery life, 
internal GPS, touch screen, no stylus or external keyboard, and automatic adjustment of display 
brightness. 
  We applied a novel electronic data collection system in this study that did not require 
short-cuts or redesigning the survey forms to absolute minimum requirements due to limited 
functionality, as observed in use of PDA and SMS-based systems (Carroll et al., 2002; 
Kuntsche and Robert, 2009). The software was designed to fit the need, rather than the survey 
designed to fit the capabilities of the electronic system. The Android application for collecting 
data was designed to mimic the protocol of the survey team and offer sufficient flexibility to 
match the dynamics of interactions with household residents, which may have been contributing 
factors to explain why experienced, paper-based data recorders wished to use electronic data 
collection in the future. For example, household information needed entry only once for each 
individual in a household. Each household resident could be registered regardless of availability 
and data collection could occur for each resident in any order simply by selecting the person in 
the side-by-side view and entering the individual’s trachoma signs (or other information). This 
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system also provides the flexibility to have multiple translations and input data in multiple 
languages, like Amharic, which was a cited preference of the pilot data collectors. 
  The desktop user interface allowed a multi-level survey prepared first on paper, to be 
transferred to an electronic form and applied in an application on any Android device within a 
day, without requiring mobile phone or Internet connections. Forms can be uploaded to survey 
devices for deployment in minutes while simultaneously downloading collected data held on the 
device. Data are protected securely on the device using a log-in code or pattern, stored on an 
external disc housed within the collection device minimising risk of data loss. We were not able 
to compare the frequency and type of lost data between the paper-based and electronic-based 
surveys, and therefore cannot address the perceptions from data recorders of the greater risk of 
data loss with electronic collection. We had three out of 24 devices temporarily power-off and 
fail to reboot, though data was recovered by removing and downloading data stored on the 
external SD card. The devices were set aside, but most importantly, all three rebooted after a 48 
hour charge and remained functional even though not needed for the rest of the survey. Data 
were downloaded to the password-protected laptops of supervisors at least every second day, 
which further minimised risk of data loss should the device be stolen or lost, or the SD card not 
be retrievable at the end of the survey. In the future, encrypting the data on the SD card would 
enhance data security, whereas storing data both on internal and external memory would further 
minimise risk of data loss. At completion of the survey, records were downloaded to local 
computers, staying in country without having to be transmitted over mobile phone networks or 
the Internet to a foreign server, maintaining sovereignty and physical possession of the data set 
by the host country. 
 There are alternatives to data storage, such as uploading to a cloud server via 
telecommunications networks or the Internet, or downloading from an internal disk on the device 
to a local computer. Each alternative has strengths and limitations. Methods for data collection 
must be designed to function within the limits of the local infrastructure and adherence to local 
guidelines on data management and security is mandatory. At the time our survey was 
conducted, the Internet connectivity infrastructure in Ethiopia has been given a score of 1 (thin) 
on a scale of 0 (non-existent) to 4 (immense) (ITU, 2002). The software we used had the 
capability of web-based form design, deployment and data transfer, but our experience with 
connectivity during the pilot activities motivated us to pursue an off-line solution.  
 There were limitations in our study and these are offered for discussion. First, the 
comparisons made between data entry errors identified were from two different surveys 
implemented in different zones at different times of the year. Second, inherent to electronic data 
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collection, there is little opportunity to confirm collected data by field teams simply by reviewing 
the data set as we did to identify errors. Yet, this same limitation applies to paper-based 
questionnaires; we assume that the recorded data were the actual response. Third, time to 
administer the survey as recorded in the pilot might be affected by factors other than the 
recorder’s ability to use the data collection tool, i.e., survey is interrupted by a neighbor or the 
respondent goes out to collect his/her children. We assumed that these external factors were, 
on average, the same for the two methods during the 2 days of observation, and hence do not 
affect the overall results. Fourth, the differences in mean distance to the cluster centroid should 
be interpreted with caution. Either households in South Wollo were simply more dispersed 
within community settlements than in South Gondar or the household distances from the cluster 
centroid were inflated due to systematic inaccuracies in transcribing household coordinates to 
paper in several clusters. The plots on Figure 5.4 and greater proportion of outlying households 
recorded in South Wollo suggest the latter. Finally, in estimating cost, we did not include the 
value of the time volunteered by the computer scientists (approximately 4 months of part-time 
work) to design and refine the system. Our reasoning was that free electronic data collection 
systems have now become available, although with less specific functionality, but could be 
deployed for survey use with only the added equipment costs and possibly training of survey 
coordinators on designing electronic forms and managing collected data. We also did not 
include the long-term value of the electronic equipment, which has continued to serve four other 
large-scale surveys in multiple countries at the time this manuscript was prepared for 
submission. Additional costs not considered were potential import duties levied on data 
collection devices and accessories as the regulations and amounts are setting specific, but 
should not be ignored when budgeting. 
  In summary, use of a novel system for electronic survey design, collection on an Android 
platform, and local management was feasible in a large-scale trachoma impact assessment 
survey. Electronic data collection saved time, was less costly, was at least as accurate as 
standard paper-based questionnaires, and was preferred by experienced paper-based data 
recorders. These advantages were similar as those advertised in recent applications of Android-
based data collection applied to animal health and surveillance of zoonotic diseases (Karimuribo 
et al., 2012; Madder et al., 2012). Such systems could be readily applied to other large-scale 
neglected tropical disease control surveys as well as national initiatives, such as the malaria 
indicator surveys (MIS), the demographic and health surveys (DHS), the UNICEF multiple 
indicator cluster survey (MICS), or the regular household surveys done by the health 
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demographic surveillance systems (HDSS) of the INDEPTH net-work (USAID, 2012; UNICEF, 
2006a; INDEPTH). 
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Figure 6.1. Trachomatous scarring (TS) as observed in the tarsal conjunctiva of an Ethiopian 
girl (courtesy Mary Rose King) 
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6.1. Abstract  
Background: An integrated package of surgery, antibiotics, facial cleanliness, and 
environmental improvements, known as the SAFE strategy is prescribed for the elimination of 
blinding trachoma. Previous studies have assessed the impact of the SAFE strategy on 
trachoma transmission by monitoring infection and trachomatous inflammation among children. 
We aimed to determine whether any impact on cicatricial trachoma was evident among children 
living in a hyper-endemic area of Ethiopia since the implementation of SAFE. 
Methods: Data from four cross-sectional, cluster randomised surveys conducted between 2000 
and 2011 were analysed to determine age-specific patterns of trachomatous scarring (TS) 
among children aged 1-10 years. Impact was assessed by comparing the odds of TS among 
children having lived under the SAFE intervention with those assessed in surveys prior to this 
intervention in a multi-level logistic regression model, controlling for secular variation between 
survey years, various potential confounder variables, and random effects due to clustering at 
community and household levels. 
Findings: The prevalence of TS has reduced from 24.9% in 2000 to 2.2% in 2011 among 
children aged 1-10 years. Having lived during SAFE implementation was associated with 
reduced odds of TS for children aged 1-9 years (range odds ratio=0.27-0.66). Children aged 5 
years in 2011 had the lowest odds ratio of TS (odd ratio=0.27, 95% confidence interval (CI) 
0.18-0.40) when compared to 5-year-old children before interventions began. Interventions 
independently associated with reduced odds of TS were living in a household reporting frequent 
face washing and where round-trip water collection took less than 30 min. 
Interpretation: Our results provide optimism that the SAFE strategy is preventing the risk of 
blinding trachoma by reducing the development of scarring among the most vulnerable age 
groups.   
Funding: The Lions Club International Foundation, The Lions Club Ethiopia and The Carter 
Center (surveys). Swiss Tropical and Public Health Institute (analysis and interpretation).
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6.2.  Introduction 
Trachoma is the leading infectious cause of blindness responsible for 3% of total blindness 
worldwide (WHO, 2012a).  In 2010, trachoma was responsible for an estimated 334,000 
disability-adjusted life years (Murray et al., 2013). The severe, disabling sequelae of trachoma 
are the end result of an immunopathogenic response prompted by repeat episodes of ocular 
infection with Chlamydia trachomatis inducing severe inflammation (Grayston et al., 1985; West 
et al., 2001b; Mabey and Fraser-Hurt, 2003). Resolution of inflammation leads to development 
of fibrosis in the subtarsal epithelium, which can be seen as white lines, bands, or sheets of 
scarring. Further progression alters the anatomy of the normal lid margin rotating eyelashes 
inwards until lashes eventually contact the globe and abrade the cornea, a condition called 
trachomatous trichiasis (TT) (Mabey et al., 1992; Mabey and Fraser-Hurt, 2003). Scarring 
trachoma also impairs the function of meibomian glands to protect the tear film which, in 
combination with abrading lashes create opportunity for other bacterial and fungal infections of 
the cornea, leading to ulcers and fibrosis as infections resolve resulting in corneal opacities 
which impair vision and ultimately lead to blindness (al-Rajhi et al., 1993; Guzey et al., 2000). 
Ocular infection and inflammation due to C. trachomatis are most prevalent in children, 
most probably because children have copious contact with infectious material; via ocular and 
nasal discharge on fingers, fomites and flies (Dawson et al., 1976; West et al., 1991; Taylor, 
2008). Less severe infection is observed with increasing age, due to immunity or reduced 
exposure to C. trachomatis (Bailey et al., 1999; Wright et al., 2008). Trachomatous scarring (TS) 
and TT increase with age, and hence are more often observed in adults (Dawson et al., 1976; 
Schemann et al., 1998). However TS has been observed in 6% to 19% of children below the 
age of 11 years in trachoma hyper-endemic areas of Tanzania and the Republic of South Sudan 
(Wolle et al., 2009a; Ngondi et al., 2005, 2006a; King et al., 2008). Moreover, incidence of TS in 
children has been shown to be as high as that in adults in hyper-endemic communities of 
Tanzania (Wolle et al., 2009a). Preventing scar development in childhood is perhaps the most 
effective target for preventing future blindness in at-risk populations. 
Trachoma is targeted for elimination as a public health problem by 2020 through an 
integrated package of interventions to treat, control, and ultimately prevent new cases of 
blinding trachoma, known as the SAFE strategy: surgery (S), antibiotic distribution (A), facial 
cleanliness (F) and environmental improvements (E) (WHO, 1997a; Bailey and Lietman, 2001). 
Although widely propagated for eliminating blinding disease, evidence on the impact has been 
demonstrated mostly on reducing infection and inflammation due to C. trachomatis. In this study 
we assessed the impact of at least five years of region-wide implementation of the SAFE 
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strategy on the presence of TS in children in a hyper-endemic area in Ethiopia. Specifically we 
aimed to determine whether young children born into an environment of trachoma control 
interventions were at lower odds of TS compared to young children with no exposure to control 
interventions, and whether any impact observed was cumulative over the years of life lived 
since the concerted control efforts were implemented.   
 
6.3. Methods 
6.3.1.  Study design and participants 
Data for the study were obtained from four cross-sectional population-based cluster surveys 
conducted in 2000, 2003, 2007, and 2011 in the South Gondar zone of the Amhara Regional 
State in Ethiopia. Details of the sampling methodologies of each survey are described 
elsewhere.(Ngondi et al., 2009a, King et al., at review) In brief, probability sampling was used to 
randomly select communities (clusters) and households within selected communities. All 
residents within selected households were examined for clinical signs of trachoma. Surveys in 
2000 and 2003 determined the baseline, district-level prevalence of clinical signs of trachoma 
for all 10 districts in the zone prior to any SAFE interventions. Four districts in 2000 were 
prioritised for assessment due to historical data suggesting these had the highest burden of 
trachoma (Assefa et al., 2001). These four districts were drought-prone areas and considered 
the least developed of all 10 districts. The remaining six districts were surveyed for the first time 
in 2003.  
The SAFE strategy was fully implemented in the first four districts surveyed starting in 
2005 and by 2006 the strategy was being implemented at scale in all districts. Implementation of 
SAFE activities included outreach camps to provide surgery in addition to the existing static 
service; annual, community-wide mass drug administration (MDA) with antibiotics; promotion of 
facial cleanliness and hygiene in schools and communities by health extension workers; and 
community-level promotion of latrine construction and use through the health extension workers 
and environmental health officers. Provision of improved water sources was simultaneously 
supported by the development sector. The 2007 survey aimed to estimate impact of the SAFE 
strategy on trachoma infection and clinical signs in three of the four districts surveyed in 2000 
after three rounds of MDA in those districts (Ngondi et al., 2009a). Finally, a large-scale impact 
assessment was conducted in 2011 to estimate the prevalence of trachoma at sub-district level 
after all 10 districts had received five annual rounds of MDA (King et al., at review).   
The study protocols were reviewed and approved by the ethical review committee of the 
Amhara Regional State Health Bureau. Additionally, the trachoma surveys in 2007 and 2011 
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were approved by Emory University Institutional Review Board (protocol #079-2006). Verbal 
informed consent in these surveys was approved and recorded prior to data collection rather 
than written information and a signed statement due to the high level of illiteracy. Consent for 
trachoma examination and household interview was obtained from heads of households, 
individuals, and parents of minors.  
 
6.3.2. Procedures 
In each survey a brief interview was conducted with the head of household or designated 
respondent and all household residents were examined for the presence or absence of all five 
clinical signs of the simplified trachoma grading system in both eyes using a 2.5x binocular 
loupe and adequate light (Thylefors et al., 1987). If multiple signs were present in either or both 
eyes, all were recorded. Training prior to each survey followed guidelines put forth by the World 
Health Organization (WHO), which included a rigorous selection process of trachoma graders 
based on ability of graders to apply the trachoma grading system (WHO, 1993a, 2006b). In 
each survey an inter-observer reliability study was conducted among trachoma patients where 
all signs were recorded. The best performers, defined as achieving agreement with a “gold” 
standard of ≥80% (2000 and 2003 surveys) or a kappa ≥0·7 (2007 and 2011 surveys), were 
selected for clinical grading during the survey. 
For this study, we included the outcome measure of the presence or absence of WHO 
simplified trachoma clinical sign TS only among children 1-10 years of age inclusive. Scarring 
once developed may not resolve, thus differences in prevalence rates of TS in adolescents and 
adults may be difficult to interpret. Limiting the analysis to children allows a clinical description of 
the population with various length of life exposure to the SAFE strategy. For example in the 
2011 data set, children less than six years of age represent a cohort of children who have grown 
up in the context of ongoing concerted efforts to implement the SAFE strategy. Children aged 6-
10 years have lived part of their life in the absence of trachoma control interventions and part of 
their life in an environment where SAFE interventions were being promoted. 
 
6.3.3. Statistical analysis 
Data were analysed in Stata version 12.0 (Stata Corp.; College Station, TX, USA). First we 
plotted TS prevalence by age, based on survey-specific multilevel logistic regression models 
adjusting for clustering within communities and involving a fractional polynomial function of age, 
stratified by district groups 1-3 (baseline survey in 2000) and 4-10 (baseline survey in 2003) to 
control for any systematic difference at baseline. Robust variance estimation for proportions and 
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means was used to adjust for clustering at the household and community level through the 
survey data commands in Stata. Statistical comparisons between proportions were adjusted 
also for the cluster design utilising the second-order corrected Pearson statistic (Rao and Scott, 
1984). We then determined the relationship between TS and exposure to SAFE interventions in 
a multi-level, logistic regression model adjusted for the survey year, covariates, district, and 
clustering at both the household and community level. The covariates in the models included 
age, sex, presence or absence of trachomatous inflammation intense (TI) in the child, number of 
children 1-10 years of age in the household, the presence of a TT case in the household and 
educational attainment of the head of household (any school attended versus none). We 
defined exposure as the number of years lived during which the SAFE strategy was 
implemented. To determine any cumulative effect of exposure, we weighted each year of 
exposure with a factor w determined by the age of the child in the respective year. This factor 
was modeled as a cubic function of age, i.e. w (age) = c0 + c1*age + c2*age2 + c3*age3. We 
combined survey data for the exposure analysis giving all exposure terms a value of zero for 
surveys in 2000 and 2003 prior to any implementation of SAFE activities.  Children surveyed in 
2007 were exposed for a maximum of three years and in 2011, children had a maximum of 
seven and at least five years exposure respectively due to the different onset of interventions in 
each district. 
Finally, potential associations between TS and indicators of the antibiotic distribution, 
facial cleanliness and environmental improvement components were assessed using the 2011 
data for children 1-5 and 6-10 years of age separately controlling for covariates and clustering at 
household and community level. The following indicators were used: (i) individual antibiotic 
compliance calculated as the ratio between the number of years for which taking antibiotics 
during the MDA was reported (number of times taken) and the number of years with such MDA; 
(ii) the mean of individual compliance of household members; (iii) frequency of washing the 
faces of children less than six years of age as reported by the caregiver at the time of the 
survey; (iv) an observed household latrine with evidence of use at the time of the survey; (v) an 
improved primary source of water as reported by household interview respondent defined as 
water from a borehole or capped protected well, protected natural spring, or piped water; and 
(vi) ability to depart the household, collect and return with water within an estimated time of 30 
min. Age-group-specific interaction terms with the above indicators of interest were generated 
and introduced in separate models including all covariates and other indicators. The coefficient 
estimates and confidence limits of each interaction term were extracted and odds ratios were 
plotted. 
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6.3.4. Role of the funding source 
Funds for implementing the surveys were provided by an ongoing collaboration between 
Lions Club International Foundation, Lions Club Ethiopia, The Carter Center and the Amhara 
National Regional State Health Bureau which also provide necessary support for 
implementation of the SAFE interventions in the region. The statistical analysis and 
interpretation of the data was supported by the Swiss Tropical and Public Health Institute, which 
has no affiliation with the ongoing trachoma control activities in Ethiopia.  
 
6.4. Results 
6.4.1. Survey data sets 
The data sets included in the analysis are characterised by each survey in Table 6.1.  Data 
were collected from 589 communities and 12,285 households with child residents 1-10 years of 
age. A total of 25,221 children were examined for clinical signs of trachoma in the combined 
surveys. The surveyed children were of the same sex distribution. Children surveyed in 2007 
were slightly younger than those in baseline surveys as data from children aged 10 years were 
not available (t=-3.64, p<0.001). The prevalence of TS was higher among the children in the first 
three districts surveyed in 2000 compared to districts surveyed in 2003 at baseline (F=79.12, 
p<0·001).  
The description of the household conditions under which the sampled children lived is 
presented in Table 6.2. From baseline studies to 2011 there was an increase in the proportion 
of children living in a household whose head of household had received some school education 
(F=15.75, p<0.001 districts 1-3; F=55.80, p<0.001 districts 4-10) and where there was a 
household latrine (F=656.86, p<0.001 districts 1-3; F=99.35, p<0.001 districts 4-10).  After the 
introduction of MDA, the proportion of children living in a household where every resident 
reported taking antibiotics at least once during an MDA increased from 56·6% in 2007 to 83·2% 
in 2011 in districts 1-3 (F=53.35, p<0.001). In districts 4-10, 63.2% of the children lived in a 
household where all residents reported taking antibiotics at least once. Mean individual 
compliance in MDA among children aged 1-10 years was 67.2% (95%Confidence Interval (CI) 
61.7-72.6%) in 2007 and decreased to 48.8% (95%CI 46.7-50.9%) in districts 1-3 (t=-6.19, 
p<0.001). Mean household compliance increased from 38.1% (95%CI 35.0-41.2%) in 2007 to 
51.2% (95%CI 49.1-53.0%) in 2011 after two additional rounds of MDA (t=7.03, p<0.001).  
 93
 
    Ta
bl
e 
6.
1.
 D
es
cr
ip
tio
n 
of
 tr
ac
ho
m
a 
cl
us
te
r r
an
do
m
 s
ur
ve
ys
 fr
om
 2
00
0 
to
 2
01
1 
in
 S
ou
th
 G
on
da
r Z
on
e,
 E
th
io
pi
a 
S
ur
ve
y 
S
ur
ve
y 
ty
pe
 
D
is
tri
ct
s 
co
ve
re
d 
C
lu
st
er
s
H
ou
se
ho
ld
s 
   
w
ith
 c
hi
ld
re
n 
   
 
1-
10
 y
ea
rs
 o
f 
ag
e 
C
hi
ld
re
n 
1-
10
 y
ea
rs
 
of
 a
ge
 
M
ea
n 
ag
e 
of
 
ch
ild
re
n 
1-
10
 
ye
ar
s 
of
 a
ge
 (S
D
)
P
er
ce
nt
 
gi
rls
 
%
Tr
ac
ho
m
at
ou
s 
sc
ar
rin
g*
 
(9
5%
 C
I) 
20
00
 
B
as
el
in
e 
m
ap
pi
ng
 
1-
4 
11
9 
10
09
 
23
39
 
5.
4 
(2
.8
) 
50
.1
 
24
.9
 (2
1.
2-
29
.1
)
20
03
 
B
as
el
in
e 
m
ap
pi
ng
 
5-
10
 
89
 
14
82
 
31
09
 
5.
2 
(2
.9
) 
51
.7
 
6.
0 
(4
.4
-8
.1
) 
20
07
**
 
3-
ye
ar
 o
ut
co
m
e 
1-
3 
27
 
61
9 
13
81
 
5.
1 
(2
.7
) 
51
.2
 
6.
9 
(5
.2
-9
.0
) 
20
11
 
5-
ye
ar
 o
ut
co
m
e 
1-
10
 
35
4 
92
73
 
18
39
2 
5.
5 
(2
.6
) 
51
.6
 
2.
2 
(1
.9
-2
.6
) 
*e
st
im
at
es
 a
dj
us
te
d 
fo
r c
or
re
la
tio
n 
in
 th
e 
da
ta
 d
ue
 to
 c
lu
st
er
in
g;
 C
I, 
co
nf
id
en
ce
 in
te
rv
al
; *
*d
at
a 
no
t a
va
ila
bl
e 
fo
r c
hi
ld
re
n 
ag
ed
 1
0 
ye
ar
s 
 94
 
  Ta
bl
e 
6.
2.
 D
es
cr
ip
tio
n 
of
 h
ou
se
ho
ld
 c
on
di
tio
ns
 o
f c
hi
ld
re
n 
1-
10
 y
ea
rs
 o
f a
ge
 fr
om
 2
00
0,
 2
00
3,
 2
00
7 
an
d 
20
11
 b
y 
di
st
ric
t c
oh
or
t i
n 
S
ou
th
 G
on
da
r Z
on
e,
 E
th
io
pi
a 
 
In
di
ca
to
r*
 
D
is
tr
ic
ts
 1
-3
 
D
is
tr
ic
ts
 4
-1
0 
20
00
 
(%
, 9
5%
 C
I) 
20
07
 
(%
, 9
5%
 C
I) 
20
11
 
(%
, 9
5%
 C
I) 
20
00
**
 
(%
, 9
5%
 C
I) 
20
03
 
(%
, 9
5%
 C
I) 
20
11
 
(%
, 9
5%
 C
I) 
P
ro
po
rti
on
 o
f c
hi
ld
re
n 
w
ho
se
 h
ea
d 
of
 
ho
us
eh
ol
d 
ha
d 
so
m
e 
ed
uc
at
io
n 
6.
5 
 
(4
.2
-9
.9
) 
13
.7
  
(9
.2
-2
0.
0)
 
15
.5
  
(1
3.
2-
18
.1
) 
2.
3 
 
(0
.8
-6
.2
) 
10
.3
  
(7
.0
-1
4.
9)
 
25
.6
  
(2
2.
9-
28
.6
) 
A
ll 
ho
us
eh
ol
d 
re
si
de
nt
s 
re
po
rt 
ta
ki
ng
 
an
tib
io
tic
 a
t l
ea
st
 o
nc
e 
du
rin
g 
M
D
A
 
N
il 
56
.6
 
(4
9.
1-
63
.7
) 
83
.2
  
(7
9.
6-
86
.2
) 
N
il 
N
il 
63
.2
  
(5
8.
7-
67
.5
) 
M
ea
n 
ho
us
eh
ol
d 
co
m
pl
ia
nc
e 
in
 
ta
ki
ng
 a
nt
ib
io
tic
s 
du
rin
g 
tra
ch
om
a 
M
D
A
 
N
il 
38
.1
  
(3
5.
0-
41
.2
) 
51
.2
  
(4
9.
4-
53
.0
) 
N
il 
N
il 
47
.5
  
(4
5.
1-
49
.8
) 
P
ro
po
rti
on
 o
f c
hi
ld
re
n 
in
 h
ou
se
ho
ld
s 
w
he
re
 y
ou
ng
 c
hi
ld
re
n’
s 
fa
ce
s 
w
er
e 
re
po
rte
d 
w
as
he
d 
at
 le
as
t o
nc
e 
pe
r 
da
y 
 
N
A
 
96
.9
  
(9
3.
4-
98
.6
) 
87
.0
  
(8
2.
3-
90
.6
) 
N
A
 
48
.3
  
(3
9.
5-
57
.2
) 
91
.5
  
(8
8.
7-
93
.6
) 
P
ro
po
rti
on
 li
vi
ng
 in
 a
 h
ou
se
ho
ld
 w
ith
 
a 
la
tri
ne
 
0.
3 
 
(0
.0
-1
.0
) 
39
.2
  
(2
8.
4-
51
.2
) 
50
.1
  
(4
4.
8-
55
.4
) 
0 
7.
1 
 
(3
.9
-1
2.
8)
 
40
.7
  
(3
6.
3-
45
.2
) 
P
ro
po
rti
on
 in
 h
ou
se
ho
ld
 u
si
ng
 a
n 
im
pr
ov
ed
 w
at
er
 s
ou
rc
e 
 
16
.6
  
(1
0.
9-
24
.3
) 
30
.0
  
(1
7.
7-
46
.2
) 
35
.6
  
(2
8.
4-
43
.6
) 
23
.2
  
(1
3.
9-
36
.0
) 
31
.6
  
(2
3.
5-
41
.1
) 
39
.5
  
(3
3.
7-
45
.6
) 
P
ro
po
rti
on
 li
vi
ng
 in
 a
 h
ou
se
ho
ld
 
w
ith
in
 3
0 
m
in
  a
cc
es
s 
fo
r r
ou
nd
-tr
ip
 
co
lle
ct
io
n 
of
 w
at
er
 
30
.9
  
(2
4.
2-
38
.6
) 
82
.1
  
(6
8.
5-
90
.6
) 
78
.2
  
(7
1.
4-
83
.7
) 
42
.3
  
(2
7.
9-
58
.2
) 
73
.0
  
(6
4.
7-
80
.0
) 
76
.5
  
(7
1.
8-
80
.6
) 
*e
st
im
at
es
 a
dj
us
te
d 
fo
r c
or
re
la
tio
n 
in
 th
e 
da
ta
 d
ue
 to
 c
lu
st
er
in
g;
 C
I, 
co
nf
id
en
ce
 in
te
rv
al
; *
*D
is
tri
ct
 4
 o
nl
y;
 N
A
-n
ot
 a
ss
es
se
d 
6. Impact of the SAFE strategy on TS among children 
 
95 
 
Mean compliance among children in districts 4-10 in 2011 was 44.3% (95%CI 41.5-47.0%). 
Nearly a two-fold increase (48·3-91·5%) in the proportion of children living in households 
reporting washing the faces of young children at least once per day occurred since 2003 in 
districts 4-10 (F=140.29, p<0.001). A statistically significant increase was observed in the 
proportion of children living in households reporting the use of an improved water source in 
both district cohorts (F=12.66, p<0.001 districts 1-3, F=5.11, p=0.024 districts 4-10). Also, 
more children lived in households reporting access to water within 30 min of collection in 
2011 than at baseline in the three least developed districts (F=81.26, p<0.001). At baseline, 
the proportion of surveyed households in districts 4-10 had less TT cases (F=11.83, 
p<0.001), more educated heads of household (F=5.31, p=0.022), higher latrine coverage 
(F=59.01, p<0.001), higher reported improved water sources (F=6.76, p=0.010), and greater 
access to water within 30 min (F=48.84, p<0.001) as households in the districts 1-3. 
 
6.4.2. TS in children 
The prevalence of TS by age is plotted in Figures 6.2 and 6.3 for each survey according to 
the respective districts surveyed. TS was less prevalent in the 2007 and 2011 surveys 
compared to the baseline surveys. In all surveys, TS increased with age; however, the 
increase appears slower in the two impact assessment surveys conducted after three and 
five years of SAFE implementation than observed in baseline surveys. Odds ratios of TS for 
exposed and unexposed children are predicted by each year of age at the time of survey in 
Figure 6.4 based on the age-dependent exposure weight terms in the multivariable random 
effects model. The odds of TS with SAFE exposure are significantly lower than the odds of 
TS at baseline for each year of age except for 10-year-old children. The odds ratio 
decreased with each additional year of age among children aged 1-5 years. Children aged 
five years after the intervention versus children aged five years prior to any intervention had 
the lowest odds ratio point estimate (odds ratio=0.27, 95% CI 0.18-0.40). The odds ratio of 
TS between children having lived under the implementation of SAFE and children without 
this exposure increased again after the age of five years but remained significantly lower 
than 1.0 up to the age of nine years.    
 Older children 6-10 years were much more likely to have TS than their younger 
counterparts (odds ratio=6.6, 95% CI 4.8-9.0, p<0.001) examined in 2011. Odds ratios of TS 
for each intervention factor are plotted in Figure 6.5 for children 1-5 and 6-10 years of age in 
2011. TS was not significantly associated with individual or household-level compliance in 
MDA. 
 
 
 
6. Impact of the SAFE strategy on TS among children 
 
96 
 
 
 
   
 
 
 
 
Fi
gu
re
 6
.2
. T
S 
pr
ev
al
en
ce
 b
y 
ag
e 
20
00
/2
00
3 
an
d 
20
11
 in
 d
is
tri
ct
s 
4-
10
 
6. Impact of the SAFE strategy on TS among children 
 
97 
 
 
  
 
 
 
 
 
Fi
gu
re
 6
.3
. T
S 
pr
ev
al
en
ce
 b
y 
ag
e 
20
00
, 2
00
7 
an
d 
20
11
 in
 d
is
tri
ct
s 
1-
3 
6. Impact of the SAFE strategy on TS among children 
 
98 
 
Children aged 1-5 years living in a household where the respondent reported washing 
children’s faces at least once per day compared to <1 time per day had lower odds of TS 
(odds ratio=0.47, 95% CI 0.23-0.97, p=0.041). TS was less likely among 6-10 year-old 
children living in houses where respondents reported washing children’s faces twice or more 
compared to other households (odds ratio=0.62, 95% CI 0.42-0.90, p=0.012). The odds of 
TS did not differ between children living in a household with and without a latrine.  A lower 
odds of TS was observed for children living in a household reporting use of an improved 
source of water and with round-trip collection of water within 30 min, but the effect was not 
statistically significant for either age group specifically. TS was less likely among children 
aged 1-10 years combined when living in a household with round-trip collection of water 
within 30 min (odds ratio=0.70, 95% CI 0.51-0.95, p=0.024). In these age-group specific 
effect models, living in a house with a case of TT (odds ratio=1.8, 95% CI 1.2-2.9, p=0.008) 
and having TI (2.7, 95% CI 2.0-3.7) were associated with higher risk of TS.  
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6.5. Discussion 
The prevalence of TS has significantly reduced among children aged 1-10 years since 
baseline survey in all districts of South Gondar, Ethiopia. This decline coincides with the 
implementation of the SAFE strategy, including five annual rounds of MDA with 
azithromycin. The exposure analysis, adjusted for secular variation, suggests a dose-
response in children born since the start of interventions with the greatest impact seen in 
children born within the year the intervention activities were first implemented.  This effect 
became less significant in those children having increased years lived prior to the 
introduction of interventions. This suggests that the children born since the interventions 
began have benefited the most from the integrated control measures and older children had 
not received the same benefits when they were younger. The apparent delay in presentation 
of TS in children moving out of the period of highest ocular promiscuity (under 10 years) 
predicts reduced or delayed presentation of cicatricial trachoma which may have the 
greatest impact in preventing blinding trachoma given that infection and intense inflammation 
occurs most frequently in that age group.     
Chronic trachomatous inflammation which happens most frequently in childhood can 
persist among adults with repeated exposure to C. trachomatis or other bacterial pathogens 
leading to worsening of scarring (Bobo et al., 1997; Muñoz et al., 1999; Burton et al., 2011b; 
Hu et al., 2011). Considerably less inflammation was found in post-intervention surveys 
compared to baseline surveys suggesting less frequent and severe infection and scarring 
development (Ngondi et al., 2009a; Wolle et al., 2009b; King et al., at review). MDA using 
azithromycin has been shown to reduce C. trachomatis infection in hyper-endemic areas in a 
similar area in Ethiopia and low levels of infection were observed in the 2007 survey (Ngondi 
et al., 2009a; Gebre et al., 2012). This would suggest that distribution of antibiotics has had 
a similar effect in South Gondar. However, we found no linear association between the 
presence of scarring in children and individual or household indicators of antibiotic coverage. 
It is perhaps due to scarring being a chronic condition, rather than an acute indicator of 
transmission such as the presence or absence of infection which is directly susceptible to 
antibiotics. However, the lack of correlation to scarring might be explained by below-target 
compliance at the individual and household level. While 80% of the population may have 
taken at least one round of antibiotics, the children in these impact surveys reported taking 
azithromycin in less than 60% of the available distribution rounds. Despite the low coverage, 
the exposure effect on TS observed may well be measuring a herd effect of the MDA 
reducing C. trachomatis infection prevalence even in the untreated population as found with 
frequent azithromycin distribution in another part of Ethiopia, but we have no infection data 
currently available to support this hypothesis (Chidambaram et al., 2004; House et al., 
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2009). What was certain is that children living in households within close proximity to water, 
regardless of time period and exposure, were less likely to have TS. Additionally, younger 
and older children were less likely to have scarring when living in households reporting the 
promoted behaviour of face washing at least once or twice daily, respectively.  This finding 
further supports the presumption that using water for face washing (the F component 
enabled by access to water) has a persistent, independent effect of preventing trachoma 
(Emerson et al., 2000b). 
 Our study design does not allow us to infer causality. Trachoma was eliminated from 
Europe and the USA over time without antibiotic distribution or concerted interventions which 
is likely the result of social and economic development (Taylor, 2008). While we adjusted for 
the temporal variation between the surveys, we have collected only limited data at the 
household and community level. Hence we have no information on the socio-economic and 
development changes that might have occurred in the ten-year time span. However, we 
have reported elsewhere increases in household access to water and improved sanitation in 
South Gondar, changes that have paralleled secular declines in active trachoma observed in 
Malawi and a community in the Gambia in the absence of trachoma-control specific 
interventions (Dolin et al., 1997; Hoechsmann et al., 2001; King et al., in press). Secular 
declines in trachoma are not consistent within the literature and trachoma has been 
observed to remain unchanged in a more similar epidemiological setting of Tanzania with 
persistent, incident scarring development among children (House et al., 2007; Wolle et al., 
2009a). Our study is also limited by the potential variation in inter-observer reliability in 
diagnosing TS between the different surveys. The assumption is that any measurement bias 
introduced was non-differential. Inter-observer agreement for the clinical sign of TS was high 
(kappa >0·7) in the development of the grading system (Thylefors et al., 1987). While the 
decision to select the best trachoma graders in each survey was based upon correct grading 
of trachomatous inflammation follicular (TF) and TT (clinical signs on which programmatic 
decisions are made according to WHO guidelines), all signs of the simplified grading system 
were taught and included in the reliability studies of both photographs and patients during 
the survey training. 
Based on the following Bradford Hill criteria (Hill, 1965), we attribute the observed 
decrease in odds of TS with cumulative exposure to a non-specific combined effect of 
implementing the SAFE strategy. The model for the exposure analysis establishes 
temporality and included a term for the year of the survey which would have captured any 
unmeasured, secular variation over the time period. There was also clear observation of a 
dose-response for years lived under the intervention package. In addition to biologic 
plausibility, the association is coherent and analogous with the impact of the interventions on 
C. trachomatis infection and inflammation. Additional support for our conclusion might come 
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from repeating the analysis with temporal data from other areas under SAFE interventions. A 
question beyond causality is determining what impact stopping these concerted SAFE 
interventions, including MDA, will have on cicatricial trachoma.  
To determine the need for SAFE interventions and measure programme success, the 
WHO recommends estimating the prevalence of TF in children aged 1-9 years. TF was 
suggested as a standardised indicator of transmission of C. trachomatis in the community, 
yet the presentation of follicles is known to persist for months in communities without 
demonstrable C. trachomatis infection (Muñoz et al., 2011; Gebre et al., 2012;, Keenan et 
al., 2012a). After implementing the SAFE strategy for years in this zone, including five 
annual rounds of MDA, TF has not been reduced to below recommended elimination 
thresholds (King et al., at review). Other studies have shown successful reduction of TF and 
infection with the introduction of SAFE interventions including three rounds of MDA 
indicating reduced transmission (Ngondi et al., 2006b; Roba et al., 2011). Our study 
demonstrates a decline in disease progression due to trachoma among children and 
suggests that TS provides additional evidence to measure programme impact. As designed, 
TS indicates the amount of cicatricial trachoma in the community (Thylefors et al., 1987). 
However, there has been no discussion of an elimination threshold as a measure of 
programme success based on prevalence of TS, but in the absence of cicatricial trachoma, 
there can be no risk of blinding trachoma.  
Our method of using age-dependent exposure weights has been inspired by 
polynomial distributed lag models as they are frequently used to assess effects of cumulative 
exposure in environmental health studies (Zanobetti et al., 2000; Liu et al., 2011; Mehta et 
al., 2012). We applied this methodology for the first time to measure potential cumulative 
impact of years lived in an environment where the SAFE interventions were being 
implemented. By weighting each year of exposure with a cubic function of the age of the 
child in that year, we were able to observe a potential dose-response of decreased odds of 
TS with each year lived after the SAFE strategy was implemented. The observed patterns 
also suggest that the highest benefit of the intervention occurred in the first years of life. This 
method may have broader applications to other neglected tropical disease control 
programmes involving repeated interventions. 
In this area of Ethiopia, a significant reduction of scarring has occurred in the most 
vulnerable age groups and likely has significantly prevented disability due to trachoma in the 
years to come. These data give great optimism that the implementation of the SAFE strategy 
is having the desired effect against the risk of blinding trachoma, even though the current 
indicator of programme success (TF) remains above prescribed elimination thresholds. 
Additionally, the environmental improvements promoted through SAFE have ancillary 
benefits such as reduced helminthiasis, which has also been observed in this zone recently 
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(Ziegelbauer et al., 2012, King et al., in press). Together, these results predict a long-term 
beneficial effect of a time-limited, intensive control programme. 
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Figure 7.1. School children in Ethiopia (courtesy Lisa Rotondo, The Carter Center) 
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7.1.  Abstract 
Background: School surveys provide a convenient platform to obtain large child 
cohorts from multiple communities and are widely used as a proxy to determine 
community prevalence of neglected tropical diseases. The purpose of this study was 
to compare trachoma prevalence between preschool- and school-aged children and 
children who attend and do not attend school. 
Methods: We analysed data from community-based trachoma surveys conducted 
from 2008–2011 in Ethiopia, Mali, Niger and Nigeria. The surveys utilised a cross-
sectional, randomised cluster design. Individual-level data on school attendance was 
collected. 
Results: Overall, 75 864 children aged 1-15 years from 2100 communities were 
included in the analysis. The prevalence of trachomatous inflammation follicular (TF) 
among these children in surveyed districts was 19.1% (95% CI 17.9–20.2%) in 
Ethiopia, 6.2% (95% CI 5.4–6.9%) in Niger, 4.6% (95% CI 4.2–4.9%) in Mali and 
4.2% (95% CI 3.5–4.9%) in Nigeria. Controlling for age, sex and clustering, the odds 
ratio of TF for school-attendees compared to non-attendees was 0.64 (95% CI 0.56–
0.73) in Ethiopia, 0.67 (95% CI 0.56–0.80) in Mali, 1.03 (95% CI 0.81–1.16) in Niger 
and 1.06, (95% CI 0.65–1.73) in Nigeria. 
Conclusion: Estimating the prevalence of trachoma through examination of only 
school-going children risks underestimating the true prevalence. 
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7.2.  Introduction 
Surveys are required for mapping, monitoring, and the evaluation of neglected tropical 
diseases (NTDs) that are targeted for control and elimination by preventive chemotherapy 
and integrated intervention packages (WHO, 2006a; Brooker et al., 2009; Chammartin et al., 
at review). For example, the prevalence of clinical signs of trachoma is typically measured 
through cluster randomised household surveys to determine the need for, or monitor the 
impact of, control programmes (WHO, 2006b). Community-based household surveys 
generate prevalence estimates of trachomatous inflammation follicular (TF) based on a 
representative sample of the community on which programmatic decisions are based 
according to guidelines issued by the World Health Organization (WHO) (WHO, 2006b). This 
type of survey is recommended, as it is feasible to implement, requires reasonable financial 
input, but needs considerable human resources (Ngondi et al., 2009b; Chen et al., 2011; 
King et al., at review). Recent efforts to integrate mapping of multiple NTDs have utilised or 
suggest utilising school-based surveys (King et al., 2009; Baker et al., 2010; Koukounari et 
al., 2011; Pelletreau et al., 2011). Indeed, school-based surveys are often used as a proxy to 
determine community prevalence in NTD control programmes such as schistosomiasis, soil-
transmitted helminthiasis, and lymphatic filariasis as they provide the convenience of a 
readily accessible and assembled cohort of children from multiple communities (Lengeler et 
al., 2002; WHO, 2002a, 2011).  
In this study we utilise large-scale community-based survey data from trachoma 
control programmes in four African countries to determine whether trachoma prevalence 
differed among preschool-aged and school-aged children and, among the latter, to 
determine whether the prevalence differs between those who attend school and those who 
do not. Additionally, we explore whether school-attendees and non-attendees differ in 
gender, having a clean face and participation in mass distribution of antibiotics for trachoma 
control. The implications of our findings are discussed concerning estimating the true 
prevalence of trachoma for starting, implementing, and evaluating control or elimination 
efforts. 
 
7.3.  Materials and methods 
7.3.1.  Ethics statement 
The study protocols were reviewed and approved by Emory University Institutional Review 
Board (IRB protocol #079-2006). Additionally, the surveys were approved by the local ethical 
review committee from the health administrations in each country. Verbal informed consent 
in these surveys was approved in the protocol and recorded prior to data collection rather 
than written information and a signed statement due to the high level of illiteracy in the 
surveyed populations. Consent for trachoma examination and interview was obtained from 
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heads of households, individuals, and parents/guardians of minors. In addition to parental 
consent, oral assent for examination and interview was obtained from school-aged children.   
 
7.3.2.  Sampling methodology 
Box 7.0 defines several terms utilised in this paper to help clarify our methods. We analysed 
data from cross-sectional, community-based surveys conducted in 2008-2011 in Ethiopia, 
Mali, Niger, and Nigeria. The surveys were designed to measure the prevalence of trachoma 
clinical signs at the district or other implementation units, as part of ongoing trachoma control 
programmes. Details of the sampling methodology of each survey have been described 
elsewhere (Bamani et al., 2010b, Bamani et al., 2010a, King et al., 2010, King et al., at 
review). In brief, probability sampling was used to randomly select communities (clusters) 
and households within selected communities aligning with other standardised household 
survey protocols (Turner et al., 1996, UNICEF, 2006a). At each household an interview was 
conducted with the head of household or designated respondent. All household residents 
were examined for the presence or absence of all five clinical signs (TF, trachomatous 
inflammation follicular; TI, trachomatous inflammation intense; TS, trachomatous scarring; 
TT, trachomatous trichiasis; and CO, corneal opacity) of the simplified trachoma grading 
system in both eyes, using 2.5x binocular loupes and adequate light (Thylefors et al., 1987). 
Training prior to each survey followed WHO guidelines, which included a rigorous selection 
process for trachoma graders based on the ability of graders to apply the trachoma grading 
system (WHO, 2006b). Graders achieving agreement with a ‘gold’ standard of ≥80% 
(Nigeria) or a kappa ≥0.7 (Ethiopia, Mali, and Niger) specifically on the clinical sign TF were 
selected for clinical grading during the survey. 
All residents of selected households present at the time of the interview, including all 
children were enrolled in the surveys. Prior to examination, each child was asked whether 
he/she attended school. The definition of school was clarified to exclude religious or informal 
schools. The face of children aged 1-9 years was observed for the presence or absence of 
ocular and nasal discharge. Those children with no ocular and nasal discharge were 
recorded as having a clean face. In districts where the primary purpose of the survey was to 
measure impact after control interventions (Ethiopia, some districts in Mali and Niger), 
children were asked whether they took antibiotics during mass drug administration (MDA) 
campaigns for trachoma. To improve recall, antibiotics distributed in MDA were shown to the 
children (tablets or suspension bottle with description of the suspension). For preschool-
aged children, the responses of their parents/guardians were accepted. 
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Box 7.1. Definitions of common terms referenced 
 
 
7.3.3.  Statistical analysis 
To assess age-specific TF prevalence and reported school attendance, stratified by country, 
we modeled the relationship between age and TF with a polynomial term of age to fit the 
observed estimates. Robust variance estimation for proportions and means was used to 
adjust for clustering at the household and community level through the survey data 
commands in Stata version 12.0 (Stata Corp.; College Station, TX, USA). Statistical 
comparisons between proportions were adjusted also for the cluster design utilising the 
second-order corrected Pearson statistic (Rao and Scott, 1984). We defined statistical 
significance as p-values < 0.05.  Multilevel logistic regression was employed for analysis of 
the association between TF and reported school attendance expressed as prevalence odds 
ratio (OR), controlling for sex, and clustering at both the community and household level 
separately for each country. We adjusted for age by limiting the analysis to only school-aged 
children 6-15 years of age and including age as a continuous variable in the models. A fixed 
effect meta-analysis was then performed using the country-specific odds ratios and 
respective confidence intervals to obtain an overall summary odds ratio of TF between 
school attendees and non-attendees (Harris et al., 2008). 
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We simulated district-level prevalence of TF that might have been identified through 
school surveys by limiting the analysis to only school attendees and classified districts to 
either ≥10% or <10% TF. We then compared these classifications to our ‘gold’ standard 
classifications based on actual district-level prevalence of TF among children aged 1-9 years 
from the surveys as implemented. The following summary statistics and 95% confidence 
intervals (CIs) were calculated in Stata: sensitivity, specificity, positive predictive value (PPV) 
and negative predictive value (NPV). We chose the threshold of 10% as this is the 
prevalence at which the need for mass antibiotic distribution is determined when mapping 
and additional sub-district prevalence investigation is warranted after impact assessment 
surveys. 
 
7.4.  Results 
7.4.1.  Operational results 
In total, 75,864 children were examined in 32,393 households from 2,100 communities 
across the four countries (Table 7.1). Highlighted in Figure 7.2 are 101 districts from where 
the data was collected during either baseline mapping or post-intervention trachoma 
prevalence surveys (impact). Among households with child residents, the mean number of 
children aged 1-15 years was 3.3 (standard deviation (SD) 2.6) in Nigeria; 2.5 (SD 1.6) in 
Mali; 2.2 (SD 1.4) in Niger; and 2.1 (standard deviation (SD) 1.1) in Ethiopia.   
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Table 7.1. Description of data sets by country collected during cross-sectional cluster 
randomised surveys between 2008-2011 
Country Survey type Districts Clusters Households* Children 
examined** 
Ethiopia Impact 25 711 14,211 29,251
Mali Mapping / impact  36 647 9,656 25,262
Niger Mapping / impact 23 452 5,916 12,825
Nigeria Mapping 17 290 2,610 8,526
Total  101 2,100 32,393 75,864
*Households surveyed with children aged 1-15 years; **Children aged 1-15 years 
 
 
7.4.2.  School attendance 
School attendance varied by country. The proportion of school-aged children (6-15 years) 
attending school was 87.1% (5,023/5,766; 95% CI 85.2-89.0%), 64.3% (12,928/20,099; 95% 
CI 62.7-66.0%), 49.7% (9,627/19,381; 95% CI 47.7-51.6%), and 47.1% (5,066/10,764; 95% 
CI 44.9-49.2%) in Nigeria, Ethiopia, Mali, and Niger, respectively. The age-specific school 
attendance is shown in Figure 2 for school-aged children by country. Nigeria had the highest 
attendance rates with >80% of children above age 5 years reporting to attend school. Peak 
attendance was observed for the ages 10-14 years in Ethiopia, 8-13 years in Mali and 7-11 
years in Niger (Figure 2). The proportion of communities surveyed where there were no 
children reporting school attendance was 9.1% (59/647) in Mali, 7.5% (34/452) in Niger, 
1.0% (3/290) in Nigeria and 0.4% (3/711) in Ethiopia. 
 
 
7.4.3.  Description by school attendance 
A description of school-aged children is presented in Table 7.2 for each country by school 
attendance. School attendees were older than non-attendees in Ethiopia (t=37.55, p<0.001) 
and Mali (t=8.78, p<0.001) and younger than non-attendees in Niger (t=-3.23, p=0.001). 
Girls were more likely to report going to school than boys in Ethiopia (F=15.04, p<0.001). 
The opposite was found in Mali (F=48.25, p<0.001) and Niger (F=144.98, p<0.001) with 
significantly more boys attending school than girls. There was no statistically significant 
difference between girls’ and boys’ school attendance in Nigeria (F=1.98, p=0.160).  
Children attending school had cleaner faces than those not attending in Ethiopia 
(F=14.77, p<0.001) and Niger (F=5.44, p=0.020). This difference in facial cleanliness was 
not observed in Mali (F=0.58, p=0.447) and Nigeria (F=3.28, p=0.071). In areas where MDA 
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had been implemented for trachoma control, children attending school in Ethiopia 
(F=246.70, p<0.001) and Niger (F=61.12, p<0.001) were more likely to have ever taken 
antibiotics than children not attending school. School-attending children were more 
compliant in MDA than children not attending school in Ethiopia (t=10.27, p<0.001), but not 
in Niger (t=0.96, p=0.336).   
 
7.4.4.  Prevalence of trachoma clinical signs 
Among children aged 1-9 years the prevalence of TF was 23.4% (4,870/20,835; 95% CI 
22.0-24.7%) in Ethiopia, 8.7% (681/7,858; 95% CI 7.7-9.7%) in Niger, 5.7% (889/1,5725; 
95% CI 5.2-6.1) in Mali and 5.0% (292/5,865; 95% CI 4.1-5.9%) in Nigeria. Age-specific 
prevalence of TF is plotted in Figure 7.4 for each country. The prevalence of TF was highest 
among children aged 2-5 years in Ethiopia and Niger. The same pattern was not as 
pronounced in Mali and Nigeria. Adjusted for clustering and female gender, TF was more 
common in preschool-aged children than school-aged children in all countries (OR=4.34, 
95% CI 3.99-4.71 in Ethiopia; OR=1.18, 95% CI 1.02-1.37 in Mali; OR=4.48, 95% CI 3.64-
5.51 in Niger; OR=1.30, 95% CI 1.01-1.67 in Nigeria). TI was also more common among 
preschool-aged children than school-aged children in Ethiopia (OR=1.84, 95% CI 1.63-2.08), 
Mali (OR=1.52, 95% CI 1.06-2.16), and Niger (OR=3.06, 95% CI 1.96-4.79), but not 
significantly so in Nigeria (OR=2.03, 95% CI 0.83-4.98). Among school-aged children, the 
prevalence of TF was lower among school attendees (Table 2) in Ethiopia (F=69.51, 
p<0.001) and Mali (F=40.88, p<0.001). No difference in TF prevalence was observed in 
Niger (F=0.06, p=0.802) or Nigeria (F=0.04, p=0.835) between school-aged children 
attending and not attending school. TI also differed among school-aged children by school 
attendance in Ethiopia (F=57.48, p<0.001) and Mali (F=4.90, p=0.027). Adjusting for age, 
sex and clustering at the community and household level, the odds of TF among school-
aged children attending versus not attending school are plotted in Figure 7.5. School 
attendees were less likely to have TF than those not attending school in Ethiopia (OR=0.64, 
95% CI 0.56-0.73) and Mali (OR=0.67, 95% CI 0.56-0.80). In Nigeria (OR=1.06, 95% CI 
0.65-1.73) and Niger (OR=1.03, 95% CI 0.81-1.16) there was no statistically significant 
difference in having TF between children who attend and do not attend school. The 
summary odds ratio of TF between school attendees and non-attendees was 0.71 (95% CI 
0.65-0.78). 
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Figure 7.5. Country specific and overall adjusted prevalence odds ratios of TF among 
school-aged children attending versus not attending school 
 
7.4.5.  Simulated diagnostic comparison 
Table 7.3 presents the summary findings of the classification of the 101 surveyed districts 
according to TF prevalence as defined by analysis of only school-attendees versus 
classification based on the actual survey findings. The proportion of districts correctly 
classified as ≥10% TF from analysis of only school-attendees had a sensitivity of 52.8% 
(19/36). The proportion of districts classified as ≥10% TF by school-attendee analysis that 
were also identified as ≥10%TF in the surveys had a PPV of 95.0% (19/20). 
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Table 7.3. Diagnostic summary statistics for the classification of surveyed districts (N=101) 
to ≥10% or <10% trachomatous inflammation follicular (TF) as estimated from analysis of 
school attendees only compared to classification from the true prevalence of TF among 
children aged 1-9 years as determined during community-based surveys 
Districts classified based on all 
children aged 1-9 years as surveyed 
Districts classified based on school attendees only 
≥10% TF <10% TF 
≥10% TF 19 17 
<10% TF 1 64 
Summary    
Sensitivity 52.8% (35.5 – 69.6%) 
Specificity 98.5% (91.7 – 99.9%) 
Positive predictive value 95.0% (75.1 – 99.9%) 
Negative predictive value 79.0% (68.5 – 87.3%) 
 
 
7.5.  Discussion 
Consistent across three of the four study areas, school-attending children differed from their 
non-school-attending counterparts in sex and age. More school-attending than non-attending 
children in two of the three countries where trachoma interventions had been implemented 
had ever taken antibiotics during the community-based MDA. In Ethiopia and Niger, the 
faces of children attending school were observed to be cleaner than children not attending. 
The obvious difference observed between countries was the ratio of reported school 
attendance. We did not observe differences between the school-aged children attending and 
not attending school in Nigeria, as reported attendance in the surveyed areas was uniquely 
high, which is consistent with the findings from a previous study determining no difference in 
TF prevalence estimates between school-based and community-based integrated surveys 
(King et al., 2009).  
Schools are often targeted for disease assessment and interventions due to the ease 
of accessibility and availability of children from multiple communities (Lengeler et al., 2002; 
Brooker et al., 2009; Kihara et al., 2011). School-based survey methodology is also being 
promoted in integrated NTD mapping methodology as operationally more feasible than 
traditional community-based cluster surveys (Pelletreau et al., 2011). However, of immediate 
importance to trachoma is that school-based surveys exclude adults who are also necessary 
for determining whether blinding trachoma is a public health problem and upon which to plan 
sight-saving surgeries. 
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Our findings raise important questions that warrant consideration by trachoma and 
perhaps other NTD control and elimination programmes and these are offered for 
consideration. A first issue is whether school-based surveys provide valid estimates of 
prevalence in the communities. We simulated a school-based sample by limiting analysis to 
only school-attendees and estimating TF prevalence. By doing so, we determined a school-
based survey strategy would have misclassified nearly half of the districts as not warranting 
control interventions when actual TF prevalence among children aged 1-9 years indicated 
control measures were warranted according to WHO guidelines. While school attendance 
likely influenced this outcome, age also plays a factor. Children attending school are not 
always the target age group recommended for prevalence assessment. For example, 
trachoma programme decisions are based on estimates of TF prevalence in children aged 1-
9 years (WHO, 2006b). In this study, the age group with the highest frequency of TF (1-5 
year-olds) is considered too young to attend school. A prevalence estimate based on 
children in school would not provide an estimate of prevalence in the recommended age 
group and more importantly would then underestimate it and perhaps misclassify 
communities as areas not needing control interventions as our analysis suggests. Controlling 
for age-prevalence differences, children attending school in two of the countries included in 
this study were 33-36% less likely to have TF than children not attending. Our data are not 
generalisable to other NTDs as the transmission dynamics and infection patterns are often 
unique for each disease. However, a study in Zanzibar found higher prevalence and twice as 
many intense soil-transmitted helminth infections among younger children not in school 
compared to older children attending school (Montresor et al., 2001b). These findings should 
be taken into consideration so as not to exclude endemic areas from interventions when 
initiating or scaling down disease control programmes. 
Other crucial questions brought to our attention from the secondary data analysis 
presented here, are whether children not in school are benefiting as much as school-going 
children from disease control interventions and whether these control efforts are indeed 
reaching all children in the community. The higher proportion of clean faces observed in 
children reporting to attend school may suggest that the desired behaviour of face washing 
is being practiced more often than among children not in school.  In Ethiopia, Mali, and 
Niger, behaviour change communication for trachoma control is being delivered in primary 
schools as well as through health extension workers and volunteers in the community. MDA 
for trachoma is community-based from central distribution points, rather than school-based 
distribution, yet we found higher reported drug coverage among reported school attendees. 
While it is encouraging to know school-going children may be benefiting from disease control 
interventions, it is discouraging to observe a disparity between children who do not attend 
school. Recent monitoring of another MDA programme targeted to control intestinal 
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helminths in Cambodia similarly found that children who were not enrolled or who did not 
attend school were less likely to receive the drug treatments in a school-based distribution 
strategy (Chesnaye et al., 2011). While school-based MDA strategies in Sierra Leone have 
shown success in reducing intestinal helminth infections among school children, no 
community-based assessment was conducted in parallel to determine whether similar 
impact was observed in children not attending school (Hodges et al., 2012a). Of note, we 
observed a small proportion of surveyed communities in each country that had no children 
reporting school attendance. Hence, school-based disease control programmes must 
identify additional means to ensure that all children benefit as has been discussed in the 
literature and warrants renewed attention (Montresor et al., 2001a; Olsen, 2003; Massa et 
al., 2009) . 
The analysis presented in this study was not the primary purpose of the surveys and 
we were not able to compare results from actual school-based and community-based 
surveys as has been done previously (King et al., 2009). We used community-based 
prevalence data from epidemiological rigorous household surveys employing standardised 
methods basing the analysis on the responses of children and their caretakers of whether 
the child attended school.  The purpose of our study was not to quantify in detail the 
scholarship of school-aged children and we did not attempt to verify school attendance with 
enrolment records at schools, but enrollment rates reported by household surveys are often 
significantly lower than school reports (UNESCO, 2010). Inquiring about the school-aged 
child’s attendance allowed us to make simple comparisons of prevalence, but also to provide 
a quick evaluation of school-based behaviour change communication in some of the 
countries. The response of the child and/or guardian may have introduced bias, but school 
attendance status collected in household surveys aiming to measure health conditions is not 
uncommon and used by standardised household surveys such as Demographic and Health 
Survey (Montressor et al.,2001; Fentiman et al., 2001; USAID, 2012). The amount and type 
of data collected at the household was limited and varied across surveys. Therefore, we are 
unable to control for other potential confounding or modifying factors that may account for 
the differences observed. Although we cannot generalise our findings to other NTDs, we 
encourage the scientific community and disease control managers to investigate potential 
disparities among children to ensure disease control/elimination interventions are reaching 
and benefiting all those in need.   
 
7.6. Conclusions 
In some areas under community-based trachoma control interventions, school attendees 
had cleaner faces, less trachoma and reported higher coverage of MDA. The summary odds 
ratio from our meta-analysis suggests that using a school-based approach to monitor 
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prevalence of trachoma will underestimate true community prevalence, which may result in 
misclassifying trachoma endemic communities as not warranting control interventions, which 
is supported by our diagnostic comparison of simulated school-based surveys. The 
exception was where school attendance is very high and where there is no difference in age-
specific prevalence between preschool- and school-aged children. Similar investigations 
should be conducted to determine whether the finding is consistent across other NTD control 
programmes. 
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Figure 8.1. Household latrines with hand washing containers as promoted in rural areas of 
the Amhara National Regional State, Ethiopia (courtesy The Carter Center) 
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8.1.  Abstract 
Background: The SAFE strategy aims to reduce transmission of Chlamydia trachomatis 
through antibiotics, improved hygiene and sanitation. We integrated assessment of intestinal 
parasites into large-scale trachoma impact surveys to determine whether documented 
environmental improvements promoted by a trachoma programme had collateral impact on 
intestinal parasites.    
Methodology: We surveyed 99 communities for both trachoma and intestinal parasites (soil-
transmitted helminths, Schistosoma mansoni, and intestinal protozoa) in South Gondar, 
Ethiopia. One child aged 2-15 years per household was randomly selected to provide a stool 
sample of which about 1 g was fixed in sodium acetate-acetic acid-formalin, concentrated 
with ether, and examined under a microscope by experienced laboratory technicians.   
Principal Findings: A total of 2,338 stool specimens were provided, processed, and linked 
to survey data from 2,657 randomly selected children (88% response). The zonal-level 
prevalence of Ascaris lumbricoides, hookworm and Trichuris trichiura was 9.9% (95% 
confidence interval (CI) 7.2-12.7%), 9.7% (5.9-13.4%) and 2.6% (1.6-3.7%), respectively. 
The prevalence of S. mansoni was 2.9% (95% CI 0.2-5.5%) but infection was highly focal 
(range by community from 0-52.4%). The prevalence of any of these helminth infections was 
24.2% (95% CI 17.6-30.9%) compared to 48.5% as found in a previous study in 1995. 
Pathogenic intestinal protozoa Giardia intestinalis and Entamoeba histolytica / E. dispar 
were found in 23.0% (95% CI 20.3-25.6%) and 11.1% (95% CI 8.9-13.2%) of the surveyed 
children, respectively. We found statistically significant increases in household latrine 
ownership, use of an improved water source, access to water, and face washing behaviour 
over the past seven years.  
Conclusions: Improvements in hygiene and sanitation promoted both by the SAFE strategy 
for trachoma and health extension programme combined with preventive chemotherapy 
during enhanced outreach services are plausible explanations for the changing patterns of 
intestinal parasite prevalence. The extent of intestinal protozoa infections suggests poor 
water quality or unsanitary water collection and storage practices and warrants targeted 
intervention. 
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8.2.  Author Summary 
Part of the SAFE strategy (surgery, antibiotics, facial cleanliness, and environmental 
improvement) to eliminate blinding trachoma involves improving access to and use of water 
and sanitation. We combined the assessment of parasitic worm and intestinal protozoa 
infections with surveys of trachoma in an area of Ethiopia where the SAFE strategy together 
with enhanced outreach services and the health extension programme had been 
implemented for more than five years. We compared our findings with results from a survey 
conducted in the mid-1990s. We documented significant increases in household access and 
use of latrines and clean water: the F and E components of SAFE as promoted by the health 
extension programme. We found considerably lower levels of parasitic worm infections than 
that documented previously. We also documented-for the first time in this zone-pathogenic 
intestinal protozoa infections, which indicates poor water quality and unhygienic water 
collection and storage practices in the communities surveyed. A plausible hypothesis for the 
decline in parasitic worm infections might be the combined impact of ongoing simultaneous 
health programmes: SAFE strategy for trachoma control alongside the health extension 
programme and regular deworming of preschool-aged children.   
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8.3.  Introduction 
An integrated strategy of surgery, antibiotics, facial cleanliness and environmental 
improvement (SAFE in short) is recommended to eliminate blinding trachoma in endemic 
countries by the year 2020 (WHO, 1998). The F and E components aim to reduce the 
transmission of Chlamydia trachomatis via flies, fingers and fomites within the community 
(Emerson et al., 2000b). Face washing is promoted specifically to keep faces free of 
infectious ocular and nasal discharge, and make them less attractive to eye-seeking flies. 
The construction and use of latrines are promoted as a form of fly control to reduce fly-to-eye 
contact (Emerson et al., 2001; Emerson et al., 2004). Improved accessibility to clean water is 
also promoted, but whether or not water is used for hygiene is more important than absolute 
access to clean water in trachoma prevention. Where water is not readily accessible, 
household use of a limited supply of water may not be prioritised for bathing (West et al., 
1989; Bailey et al., 1991; Polack et al., 2006). These aims of the F and E components go 
beyond trachoma control and align with other major initiatives, such as WASH programme of 
UNICEF and the Millennium Development Goal 7c which, by 2015, aim to provide access to 
clean water and sanitation to all children and to reduce by half the proportion of households 
without access to basic sanitation (UNICEF, 2006b; UN, 2010). 
Improved hygiene, sanitation, and water have a positive and sustained impact on 
several diseases, including many of the neglected tropical diseases (Bartram and 
Cairncross, 2010, Ziegelbauer et al., 2012). Trachoma was eliminated from the United 
States of America (USA),primarily through sustained social and economic development 
(Taylor, 2008). The Rockerfeller Foundation noted the pivotal role sanitation played in the 
elimination of hookworm in the southern parts of the USA some 100 years ago (Stiles, 
1939). Improving water supply and sanitation have been recommended after noting the 
reduction in the prevalence and incidence of parasitic worms such as dracunculiasis and 
soil-transmitted helminthiasis, and diarrhea and an increase in child survival (Esrey et al., 
1991). A recent systematic review and meta-analysis of research studies reporting the 
effects of sanitation on soil-transmitted helminth infections (Ascaris lumbricoides, Trichuris 
trichiura, and hookworm) found that having access and using sanitation was associated with 
an approximately 50% lower odds of any soil-transmitted helminth infection even after 
accounting for random effects between studies (Ziegelbauer et al., 2012).   
These are assumed ancillary benefits of the activities promoted by the F and E 
components of the SAFE strategy, yet these have not been fully documented in the context 
of an ongoing trachoma control programme. The purpose of this study was to determine 
prevalence of intestinal parasites (soil-transmitted helminths, Schistosoma mansoni and 
intestinal protozoa) among children aged 2-15 years to complement a large trachoma impact 
survey in 2011. Our data also allowed us to study changing patterns of parasitic worm 
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infections in the school-aged population by comparing our findings to those obtained in a 
survey conducted in the mid-1990s (Jemaneh, 2000). We aimed also to determine whether 
improvements in household-level access to water and sanitation have occurred in this zone 
of the Amhara National Regional state in Ethiopia after the SAFE strategy had been fully 
implemented for at least five years.  
 
8.4.  Methods 
8.4.1.  Ethics Statement 
The study protocol was reviewed and approved by the ethical review committee of the 
Amhara Regional State Health Bureau. Additionally, the study activities, including oral 
consent, were approved by Emory University Institutional Review Board (protocol no. 079-
2006). According to the principles of the Helsinki Declaration informed consent for the 
interview and for stool examinations was sought. Due to the high rate of illiteracy, oral 
informed consent was obtained from the parent or guardian and recorded in the electronic 
survey form. Additionally verbal assent was obtained from children aged 7 years and above 
and also recorded in the electronic survey form.  Each selected child, regardless of 
participation, was offered a single dose of albendazole during the household visit (400 mg).  
 
8.4.2.  Study Area and Population 
The study was conducted in South Gondar zone of the Amhara Regional state of Ethiopia in 
the rainy season from late June to early August 2011, covering all 10 rural woredas 
(districts) in the zone. The two semi-urban woredas excluded from the survey were the zonal 
capital, Debra Tabor Town and Woreta Town. The total population of South Gondar is 
approximately 2.05 million people with 1.86 million living in the 10 surveyed woredas 
(Ethiopia, 2007). The elevation in the zone ranges from 600 to >4,000 m above sea level 
and is geographically diverse with areas of lake shore, lowlands, highland plateaus, rugged 
mountain peaks, and valleys. People are primarily engaged in subsistence agriculture; rice in 
the lake shore areas, wheat and teff in hill and mountain sides, and animal husbandry in all 
areas. 
 
8.4.3.  Sample Size and Sampling Methodology 
We assumed a null hypothesis of no change in the prevalence of infection with any of the 
following helminths, A. lumbricoides, T. trichiura, hookworm, and S. mansoni as assessed in 
a cross-sectional survey of school-aged children of South Gondar in 1995, when it was 
estimated at 49% (Jemaneh, 2000). In order to detect at least a 20% decline in prevalence 
(from 49% to 29%) at the 5% level of significance and power of 90%, stool specimens from 
800 school-aged children (7-15  years) needed to be examined assuming a design effect of 
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4 for the multi-stage cluster random sampling methodology implemented. We oversampled 
and included children 2-6 years of age to assess the prevalence of helminths and intestinal 
protozoa infections in this age group currently receiving preventive chemotherapy with 
albendazole during biannual campaigns known as enhanced outreach services (EOS) 
(Fiedler and Chuko, 2008). Additionally, given the focal nature of some helminths (e.g. S. 
mansoni); we aimed to select a geographically representative sample from each of 10 
woredas by systematically selecting 10 gotts (communities) from a random starting gott from 
woreda-specific lists arranged geographically. In each gott, one child aged 2-15 years was 
selected randomly in each of 30 surveyed households and asked to provide a stool sample. 
Households were selected randomly using a modified segmentation design, and children 
were selected randomly by the electronic data collection device (see below) after 
enumerating all residents, both present and absent, of the selected household (UNICEF, 
2006a).   
 
8.4.4.  Survey Tool and Stool Sample Processing 
Household sanitation characteristics were determined and recorded at each consenting 
household by observing the presence of a used latrine and hand washing container noted 
with or without water. A used latrine was defined as directly observing faeces in the pit with 
the use of a torch if needed. The head of household or adult representative was interviewed 
about access to, and use, of water. The selected child and the parent/guardian were shown 
the albendazole tablets distributed during EOS campaigns and were asked whether the child 
had received and taken the drug.  
Using small portable scales to measure submitted stool samples, field teams 
recorded the exact weight and fixed approximately 1 g of stool in 10 ml of sodium acetate-
acetic acid-formalin (SAF) solution (Marti and Escher, 1990). Fixed specimens were labeled 
with unique identification numbers (IDs), transferred to a central storage area at room 
temperature and shielded from direct sunlight. Upon completion of the field data collection, 
all specimens were processed at the Amhara Regional Research Laboratory using an ether-
concentration method that has shown good reliability among European reference 
laboratories (Utzinger et al., 2010). The entire sediment was assessed systematically for 
helminth eggs and intestinal protozoa cysts. For helminths, the number of eggs identified 
were counted and recorded as zero up to 100 eggs. Counting stopped above 100 eggs and 
was recorded as 100+. The frequency of intestinal protozoa cysts were recorded as none, 
rare (1-5 parasites per slide), frequent (1 parasite per observing field), and very frequent (>1 
parasite per observing field). 
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8.4.5.  Training and Quality Control 
Prior to the field data collection, teams participated in a 7-day, applied training for data 
collectors (health facility-based laboratory technicians), which consisted of classroom 
instruction and field practice where the protocol and data collection tools were refined, and 
adapted to the local context. Technicians processing the specimens were trained in the 
methodology, reading slides, and identification of parasites at species level. Every tenth 
negative specimen and every specimen where a helminth was identified by a technician was 
reexamined by a senior laboratory technician.   
 
8.4.6.  Data Management and Statistical Analysis 
Survey data were collected electronically using tablet computers operating on the Android™ 
(Google Inc.; Mountain View, CA, USA) platform, and were linked to results of processed 
specimens via the unique ID on each specimen. Laboratory results were recorded on paper 
forms by technicians and then double-entered in Microsoft Access by separate entry clerks, 
compared for discordance, and corrected with the original hard-copy.  
Data were analysed using SAS version 9.3 (SAS Institute Inc.; Cary, NC, USA). 
Selection probabilities were calculated and used to weight the data in the analysis. 
Additionally, the variance of the estimates was adjusted to account for clustering. To 
measure differences in household-level access to, and use of, water and sanitation, the 
current survey data were compared to household survey data collected in 2000 and 2003 
prior to any interventions, and 2006 after interventions in only three of 13 districts. All 
surveys were conducted by the Amhara Regional Health Bureau and The Carter Center 
using the same cluster, randomised survey methodology (Emerson et al., 2008; Ngondi et 
al., 2009a).       
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8.5.  Results 
8.5.1.  Participation and Final Study Sample 
Figure 8.2 shows the geographical distribution of the 99 surveyed communities across 10 
woredas as well as the woredas where schools were surveyed in 1995. A total of 2,355 
(88.6%) stool samples were provided and processed from 2,657 randomly selected children 
aged 2-15 years in surveyed households. Figure 8.3 shows the resulting sample sizes used 
in the analysis. Mean age of children submitting samples was 6.8 years (standard deviation 
(SD) 3.6 years) and 48.0% of specimens were from boys.  
 
8.5.2.  Helminth and Intestinal Protozoa Infection 
Helminth eggs and intestinal protozoa cysts were examined in 2,338 processed stool 
specimens (Figure 8.4). The prevalence of any intestinal protozoa infection (76.8%; 95% 
confidence interval (CI) 73.2-80.4%) was higher than the prevalence of any helminth 
infection (23.0%; 95% CI 18.7-27.4%) in this study. The prevalence of the two intestinal 
protozoa Giardia intestinalis and Entamoeba histolytica/E. dispar was 23.4% (95% CI 20.7-
26.1%) and 11.1% (95% CI 8.9-13.2%) respectively. The prevalence of infections where 
cysts of any intestinal protozoa were identified as very frequent was 11.0% (95% CI 9.5-
12.6%) and the majority of these were Entamoeba coli.  
Among the helminths, A. lumbricoides and hookworm were the most frequently 
observed with point prevalence of 9.9% (95% CI 7.2-12.7%) and 9.7% (95% CI 5.9-13.4%), 
respectively. Including T. trichiura and Strongyloides stecoralis (larvae), the prevalence of 
infection with any of these soil-transmitted helminths was 19.5% (95% CI 15.6-23.4%). At 
the woreda level, the prevalence of any soil-transmitted helminths ranged from 7.9% to 
34.6% (Table 8.1). The prevalence of any soil-transmitted helminth among preschool-aged 
children (Table 8.2) was 17.4% (95% CI 13.0-21.7%) and was not significantly different from 
prevalence among school-aged children (21.4%, 95% CI 16.5-26.4%; p=0.106).The 
prevalence of S. mansoni was 2.9% (95% CI 0.2-5.5%; range by woreda 0-12.5%). In 
surveyed gotts the proportion of children with S. mansoni ranged from nil to 52.4%.  
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8.5.3.  Household Level Water, Sanitation and Hygiene  
A comparison of household-level indicators revealed a statistically significant differences in 
household latrine ownership (Χ2=32.47, p<0.001), use of an improved source of water for 
drinking (Χ2=6.31, p=0.012), reported access to water within 30 min collection time 
(Χ2=34.44, p<0.001), and reported frequency of washing faces of children under the age of 6 
years (Χ2=23.28, p<0.001) compared to the baseline household surveys for trachoma done 
in 2000 and 2003 (Figure 8.4). In 3.8% (95% CI 2.6-5.0%) of households, the presence of a 
container outside of the latrine to hold water for washing hands was observed in 2011, but 
this indicator was not assessed in prior surveys. There has been a 14-fold increase in 
household latrine ownership, a 69.4% increase in reported household use of an improved 
water source, and a 71.3% increase in household access to water as defined by the reported 
round-trip time of less than 30 min to collect water from the source. Among families with 
children younger than 6 years, the proportion reporting to wash the child’s face at least once 
per day has increased by 81.2% since the implementation of the SAFE strategy.   
 
8.5.4.  Reported Albendazole Coverage 
The estimated drug coverage with albendazole is presented in Table 8.3. The proportion of 
children aged 2-6 years (preschool age) reported to have taken albendazole in the past year 
was 14.9% (95% CI 9.3-20.5%; range by woreda 0.8-33.0%) and 35.1% (95% CI 24.3-
45.8%; range by woreda 10.3-68.4%) reported to have ever taken albendazole. The 
proportion of school-aged children reported to have ever taken albendazole was 33.2% 
(95% CI 22.9-43.5%; range by woreda 12.4-65.7%).   
 
8.5.6.  Comparison with Historical Helminth Data 
The estimated prevalence of each, A. lumbricoides, T. trichiura and S. mansoni, infection 
was considerably lower than reported in 1995 (Figure 8.5). The prevalence of hookworm 
infection was not different from the previous estimate. Table 8.4 presents a comparison of 
the historical survey to data in the current study, restricted to children aged 7-15 years both 
within only the six woredas represented in the 1995 study (column 2) and within all 10 
woredas covered in 2011 (column 3). For each of the helminths compared, infections were 
identified in a smaller proportion of communities in the current survey than observed in 1995. 
A. lumbricoides was the only helminth infection for which more than 100 eggs were counted 
per specimen, representing a prevalence of 1.9% (95% CI 0.8-2.9%). Without counting all 
the eggs identified in those specimens, a classification as moderate or high intensity using 
the standardised eggs per gram of stool (EPG) thresholds frequently employed when using 
the Kato-Katz thick smear method is not possible (WHO, 2002a). Even after adjusting for the 
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exact weight of stool preserved, all other infections identified would be classified as low 
intensity infections in contrast to the 1995 findings (Table 8.5.4). 
 
8.6.  Discussion 
Our study done in 2011 revealed a considerably different epidemiological portrait of soil-
transmitted helminths and S. mansoni in South Gondar zone of central Ethiopia than the one 
painted in 1995. Indeed, the infection prevalence of compared helminths has declined 
substantially, except for hookworm, and infection intensities have concurrently declined for 
all the identified helminths. These changes have occurred in the context of the health 
extension programme (HEP), the implementation of the SAFE strategy for the control of 
trachoma, and EOS. The HEP is a major undertaking since 2004 to provide access to 
preventive health services to the rural communities of Ethiopia and serves as the backbone 
of SAFE implementation in the communities (Ethiopia, 2012).  
 The SAFE strategy was implemented by the Amhara National Regional State Health 
Bureau in pilot areas of South Gondar starting in 2003 and, by 2006, the programme was 
operating at scale in all woredas due to simultaneous scale-up of HEP having in place at 
least one health extension worker in each kebele (village). In addition to the ongoing 
promotion of behaviour change communication in 337 kebeles of South Gondar, a total of 
339,913 household latrines have been reported to be constructed since pilot interventions in 
2003 (South Gondar Zonal Health Department reports, unpublished data). We have 
presented evidence (Figure 8.4) from a series of cross-sectional surveys indicating 
statistically significant improvements in reported hygiene behaviour (e.g., washing faces of 
young children), use of an improved water source, improved access to water, and household 
level access to basic sanitation (e.g., presence of a used latrine). If each of the 339,913 
household latrines reported to be constructed were first latrines of households, then the 
estimated latrine coverage should be 72.6%, which is much higher than the 42.2% coverage 
identified in this study. There are several possible explanations for the discordance, which 
may contribute to the difference independently or in combination: health workers double-
counted latrines or reported them as complete before they were, the reports from the 
districts were inflated to exaggerate progress, the collation of reports. at district level was not 
accurate, a proportion of the new latrines reported were actually new replacements for 
households that already had one and therefore would not add to the numerator of 
households with a latrine, or the number of household units and population has grown 
significantly so as to increase the denominator – as previously highlighted to be a challenge 
to meeting the MDG 7c target (Bartram et al., 2012). Whatever the reasons, the discordance 
outlines the importance of periodic household surveys to serve as an independent monitor of 
the uptake of promoted interventions.
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Needless to say, despite improvements in access to sanitation (from 3% in 2003 to 42% in 
2011), interventions are still needed, as more than half of households surveyed were without 
a toilet and using an unimproved source of water. While the presence of a water container 
for hand washing was observed outside a latrine in only a small proportion of households, 
some people are adopting a recently promoted health message even though there is a long 
way to go. These findings might explain the frequent intestinal protozoa infections identified. 
We have no background data to assess any change in protozoa infection prevalence, but 
presence of these infections suggests that the water being used for drinking is of poor 
quality. Whether contamination is occurring at the source, collection, or storage should be 
further investigated, so that adequate mitigation strategies can be implemented.  
Albendazole was distributed to children aged 2-5 years every six months in EOS 
campaigns since 2004. At the national level, it has been reported that up to 9 million doses 
of albendazole have been distributed per round (Fiedler and Chuko, 2008). The programme 
was originally targeted to children in woredas labeled as “food insecure”, but has since been 
expanded. Coverage surveys to evaluate the EOS have reported achievement of 93.8% of 
targeted children for albendazole in 2006 and 92.1% for vitamin A in 2008 (Negash, 2011). 
Since 2009 in South Gondar, a cumulative 945,991 doses of albendazole have been 
distributed to approximately 213,000 preschool-aged children during such campaigns with a 
reported coverage of 100% (range by year 98.3-106%) (South Gondar Zonal Health 
Department, unpublished data). The reported coverage figures are in sharp contrast to our 
survey estimates. Coverage estimates of mass drug administration (MDA) programmes are 
commonly lower than administrative reports (Cromwell et al., 2012, Worrell and Mathieu, 
2012). At the most, only 1 out of every 3 preschool-aged children reported taking the drug 
within the past year. From Table 3, it is evident that the food insecure woredas were likely to 
be Dera, Ebinat, and Farta, which had the highest proportions of children in both age groups 
reporting ever having taken albendazole. If the distribution decisions were determined at a 
level below the woreda, then we may have misrepresented albendazole coverage by 
aggregating the results from non-targeted communities with targeted communities. 
Nonetheless, the findings confirm the importance of independently assessing MDA coverage 
with household surveys. 
 Our survey has some limitations. First, the prevalence estimates of helminths and 
intestinal protozoa are based on a small amount of stool from a single specimen. Helminth 
egg output varies from one day to another and within each stool specimen, hence it is 
probable that we have underestimated the ‘true’ prevalence, although less likely intense 
infections (de Vlas and Gryseels, 1992, Knopp et al., 2008). However, this variation should 
be comparable to the single stool results presented by Jemenah in the mid-1990s which had 
the same limitation (Jemaneh, 2000). Second, we avoided calculating percent decreases in 
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prevalence due to the different diagnostic techniques used in 1995 (fresh stool samples 
using the Kato-Katz technique) and the current study (SAF-fixed stool samples subjected to 
an ether-concentration method) (Katz et al., 1972). Using the Kato-Katz technique may have 
allowed a more direct comparison to the baseline data and a more precise measure of 
infection intensity, but it was not feasible given the logistical challenges posed by 
community-based surveys in the remote settings surveyed here, as described elsewhere 
(King et al., at review). Our comparison of intensity of infection was limited, but in 
determining prevalence, fixing of stool samples in SAF and ether-concentration methods are 
as sensitive as the Kato-Katz technique (Glinz et al., 2010). The Kato-Katz technique has 
also been found to lack sensitivity in detecting low-intensity hookworm infections (Booth et 
al., 2003, Utzinger et al., 2008, Knopp et al., 2009b). Third, we did not assess the 
cleanliness of the observed latrines. While improved sanitation is protective against soil-
transmitted helminthiasis, a latrine with faeces around the drop hole, in theory, may serve as 
a source of hookworm transmission (Stürchler et al., 1980, Cairncross et al., 1996). Fourth, 
our albendazole coverage estimates are subject to recall bias. However, we took steps to 
minimise recall bias by showing the albendazole tablets distributed during EOS campaigns 
and the most recent round of EOS was implemented less than one month prior to the 
survey. Additionally, other MDA participation studies reported that individuals are capable of 
recalling whether they have taken a drug during the distribution (Cromwell et al., 2009b, 
Budge et al., 2011). Albendazole coverage, even in targeted woredas, was very low, which 
we feel provides stronger support to the hypothesis that improvements in F and E were 
largely responsible for the decline in helminths. However, this study was cross-sectional and 
therefore inherently has the inability to link causal associations with improvements in the 
sanitation due to SAFE and preventive chemotherapy due to unmeasured confounding 
factors. An alternative hypothesis is that the recorded, significant improvements in latrines, 
water access, and face washing have had minimal impact on intestinal parasites and the 
decline is due to secular variation. The two surveys compared were conducted nearly 16 
years apart.  We cannot rule out a secular decline in the prevalence and intensity of helminth 
infections, but a national survey of school-aged children in 2006 reported a prevalence of A. 
lumbricoides of 28.0% and of any soil-transmitted helminth of 37.7%, perhaps indicating that 
from 1995 to 2006 there may have been little change in prevalence due to secular variation 
in South Gondar (Hall et al., 2007). Hence, further investigation of predictive factors of the 
observed infections is warranted.  
This study demonstrates the feasibility and success of an integrated neglected 
tropical disease assessment for programmatic decision making. Despite the low intensity of 
identified helminth infections, infection with any of the helminths targeted for control was 
identified in over 80% of the communities surveyed. The woreda-level prevalence of any 
8. Intestinal parasite prevalence after implementing the SAFE strategy  
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soil-transmitted helminth exceeded 20% in East Estie, West Estie, Dera, and Fogera 
woredas, and hence, according to WHO guidelines, warrant preventive chemotherapy 
targeting school-aged children (WHO, 2006a). Additionally, preventive chemotherapy using 
praziquantel against schistosomiasis is warranted in Fogera woreda and other communities 
where the proportion of children infected with S. mansoni was greater than 10%. Through 
this assessment, we were able also to identify several intestinal protozoa infections, some of 
which contribute to morbidity (Becker et al., 2013).  At the least, the high prevalence of these 
infections indicates contamination of water at the point of the source or use and warrants 
further investigation and setting specific interventions. It also suggests that there is much 
more work to be done in improving water quality, hygiene, and sanitation in these mostly 
rural areas of Ethiopia. 
While we cannot directly attribute the decline in helminth prevalence and intensity 
directly to the SAFE strategy, the documented increase in hygiene and sanitation offer both 
a biologically plausible and parsimonious explanation for the decline which is consistent with 
our understanding of the epidemiology of helminth and intestinal protozoa infections. 
Preventive chemotherapy in national helminth control programmes has been shown to 
significantly reduce prevalence and intensity of helminth infections and has likely contributed 
to the observed decline (Sinuon et al., 2007; Keiser and Utzinger, 2008; Knopp et al., 
2009a). However, without environmental changes, there is potential for rapid reinfection and 
continued transmission (Utzinger et al., 2009; Jia et al., 2012). Additionally, participation, 
defined as ever taking albendazole, among the targeted population as reported in this survey 
was much lower than administrative records suggest. Given the simultaneous scaling up of 
both F and E from the SAFE strategy and de-worming in EOP since 2006, one has to 
consider that there has been a synergistic effect of these ongoing interventions even though 
coverage (both household latrine ownership and preventive chemotherapy with albendazole) 
has been below target. There remain opportunities for integrated neglected tropical disease 
control throughout Ethiopia (Tadesse et al., 2008). These results are encouraging and 
present a portrait of what might be expected within an integrated, multi-sectoral package of 
interventions for neglected tropical disease control. 
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9.  Discussion 
Trachoma caused by ocular Chlamydia trachomatis (Ct) is one of the oldest diseases known 
to man and remains a global health burden, accounting for 3% of blindness worldwide 
(Taylor, 2008; WHO, 2012a). The disease is targeted for global elimination by the year 2020, 
and while progress is being made, several countries have yet to identify endemic areas and 
initiate control efforts (WHO, 2012b). Ministries of Health in trachoma endemic countries are 
rolling out a recommended package of control interventions referred to as the SAFE strategy 
that includes: Surgery to alleviate suffering and prevent visual impairment in those currently 
burdened by the disease; Antibiotics to reduce the load of Ct infections in a community; and 
both Facial cleanliness and Environmental improvements to reduce transmission and 
prevent new infections (WHO, 1997a). The GET 2020 (global elimination of blinding 
trachoma by 2020) alliance of trachoma endemic countries, academic partners, corporate 
sponsors, donors, government, and non-government organizations was formed to provide 
concerted advocacy for the elimination (WHO, 1997b). As a member of the alliance, The 
Carter Center directly supports Ministries of Health to implement the SAFE strategy in 
Ethiopia, Mali, Niger, Nigeria, Sudan, and South Sudan by the provision of resources to the 
existing public health programmes. The partnership between the Amhara National Regional 
State Health Bureau and The Carter Center has enabled the successful execution of this 
PhD project.  
 The principles of The Carter Center are not dissimilar from that of the Swiss Tropical 
and Public Health Institute (Swiss TPH). The Carter Center, based on careful research and 
analysis, aims to take action to address difficult problems to alleviate suffering and improve 
health of all people (TCC, 2013). A guiding principle of Swiss TPH is to seek solutions to 
challenges faced by international public health priorities through innovation, validation, and 
application (SwissTPH, 2013). Within both institutions there is mutual commitment to human 
rights, emphasis on taking action based on generated knowledge, and obtaining results, 
which ultimately lead to less disease and improved health of populations. This PhD thesis 
was conducted under the auspices and collaboration of these two institutions and aimed to 
address current, pressing issues within the global programme to eliminate blinding 
trachoma. Specifically, national Ministries of Health implementing the SAFE strategy need to 
know how best to determine whether the interventions are working and what further actions 
are required. The evaluation of performance of programmes is one of the greatest 
challenges for global health (Royston, 2011). We investigated novel approaches to evaluate 
the impact of the SAFE strategy on trachoma. However, given that part of the SAFE 
package of interventions involves improvement in hygiene, water, and sanitation, we 
explored the potential benefits of the strategy beyond trachoma. These foundations of public 
health clearly prevent other neglected tropical diseases, but the documentation of ancillary 
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benefits beyond trachoma has not been demonstrated in the context of the SAFE strategy 
(Esrey et al., 1991; Bartram and Cairncross, 2010). Therefore, we applied an integrated 
approach to the assessment of both trachoma and intestinal parasitic infections. 
Collaboratively, we wanted to validate what works in the field and interpret the findings into 
clear actions targeted to strengthening the ability of Ministries of Health to measure the full 
impact of interventions and identify areas to improve disease control efforts. Table 9.1 
highlights how each of the individual objectives aligned with the joint principles of The Carter 
Center and Swiss TPH.  
 The ongoing trachoma elimination programme of the Amhara National Regional 
State Health Bureau served as a platform for conducting the operational research studies 
presented in this thesis. Operational research has been defined as the search for knowledge 
on interventions, strategies, or tools that can enhance the quality, effectiveness, or coverage 
of programmes in which the research is being done (Zachariah et al., 2009). The need for 
this type of research has been highlighted and specific operational research areas prioritised 
for neglected tropical disease control (Feasey et al., 2010; Boatin et al., 2012; Solomon et 
al., 2012). Figure 9.1 describes my proposal of an ideal process of such operational 
research. When research is conducted collaboratively within the ongoing provision of public 
health services (defined here as the health system), not only do the findings contribute to 
scientific knowledge, but are also directly applicable to meeting the needs of the system 
itself. Hypotheses are developed by identifying challenges through the ongoing activities and 
tested through the routine data collection activities or necessary periodic monitoring and 
evaluation. When conducted in such settings, the detailed analysis of the data generates 
evidence which can be discussed immediately with district, regional and national control 
coordinators for making health system decisions to improve programme strategies without 
having to wait for other important, but often delayed, venues of dissemination, such as 
presentations at conferences, publication in the scientific literature, or WHO guidelines. At 
the same time, the findings of the research contribute to the current scientific understanding 
of the subject under investigation. Hence, the knowledge generated is more applicable when 
derived within the dynamic and uncontrolled programmatic setting, rather than when limited 
to the laboratory or controlled research conditions. This process should be continuous, 
leading to the identification of additional challenges and hypotheses to be tested. After all, 
operational research led to the development of the SAFE strategy and how it is currently 
implemented (Emerson et al., 2006). Maybe this is what Professor Rudolf Geigy realized 
about extending laboratory research to the field and perhaps for all public health research, 
the guiding principle should be innovation transferred into action (Utzinger, 2013).  
 In the remainder of this final chapter, the findings of each of the research objectives 
presented in this thesis will be discussed in terms of the process in Figure 9.1, specifically 
9. Discussion  
 
149 
  
the evidence generated for programme decisions, the public health action recommended, 
the contribution to scientific knowledge and additional research issues identified. 
 
 
 
 
Figure 9.1. Proposed process of implementing operational research in the context of the 
health system 
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9.1. Evaluating the impact of the SAFE strategy on trachoma at the sub-district level 
To meet this first objective we applied new guidelines from WHO on which the decision to 
stop MDA must be made on the basis of documented impact on trachomatous inflammation 
follicular among children aged 1-9 years (TF1-9) after implementation of the SAFE strategy 
(WHO, 2010). The novel approach of the two cross-sectional impact evaluation studies 
conducted were that the prevalence estimates generated were powered to the district level, 
as standard practice, but also to the sub-district level simultaneously. By doing so, health 
system decisions could be made immediately, avoiding the need to conduct two separate 
surveys as suggested in the WHO guidelines (first at the district level, then at the sub-district 
level). The studies were conducted with the highest epidemiological rigor in regards to 
employing probability sampling at all levels, standardisation of trachoma grading, and quality 
assurance of data collection and management.  
 
Evidence generated for health system decisions 
The findings of the surveys provided sub-district-level prevalence estimates of TF1-9 on 
which to determine whether continuing MDA was warranted according to WHO guidelines. 
Additionally, the estimate of trichiasis (TT) prevalence in the total population allowed an 
updated estimate of the total backlog of persons with TT that the health system needs to 
reach and offer corrective surgery. These estimates were more precise than those 
established at the start of the programme based on zonal-level surveys and allow prioritising 
of high-prevalence districts for outreach. The proportion of households with basic sanitation 
(a household latrine), with access to water within 30 minutes of round-trip collection, and 
with an improved source of drinking water was also generated from the household surveys 
(reported in Chapter 8). The data allows measurement against Millennium Development 
Goal 7c, upon which the implementation targets can be made to determine what needs to be 
done to reduce by half the proportion of the population without access to safe drinking water 
and improved sanitation (UNDP, 2005).  
 The studies established the feasibility of conducting sub-district-level surveys on a 
large scale, but the resources required were substantial. While the health system has the 
human resource capacity to implement the field activities, extensive external financial and 
logistic resources were required and should be considered when planning similar impact 
assessments outside Amhara. Based on previous experience in Ghana and Mali, I had the 
assumption that where the baseline TF1-9 prevalence was <30%, a decline inTF1-9 to <5% 
was achievable after implementation of the SAFE strategy (Yayemain et al., 2009; Bamani et 
al., 2010b). Yet in South Wollo, where the baseline TF1-9 prevalence was 12% at the zonal 
level, only six of 36 sub-districts were <5% and the majority of sub-districts had TF1-9 
prevalence higher than the baseline estimate after three years of implementing SAFE 
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activities, likely because these areas were hyper-endemic as in the rest of zones of Amhara 
Region (Berhane et al., 2006; Emerson et al., 2008). In South Gondar, after five years of 
SAFE activities, none of the 36 sub-districts had achieved TF1-9 prevalence of <5%. In this 
setting, only one (in Legambo woreda) of the 72 sub-district-level estimates provided any 
dissimilar evidence of impact from what was estimated at the district level. Within the 
remaining 71 sub-districts, the sub-district estimates varied little from the overall district-level 
estimates but required the assessment of at least 100 additional communities to obtain. 
These overall findings suggest that no other district in the Amhara region needs to be 
evaluated prior to receiving at least five years of SAFE interventions. Also, conducting 
trachoma impact evaluation surveys at the sub-district level are not warranted until further 
evidence of a decline in TF1-9 is noted. However, district-level surveys may still be of value in 
monitoring impact and refining programme targets. 
 
Contribution to scientific knowledge  
The observation that the prevalence of TF1-9 did not decline to prescribed elimination targets 
after five years of implementing the SAFE strategy contributes to the current scientific 
understanding concerning trachoma elimination. To meet current criteria of elimination in a 
similar hyper-endemic area, more than five years of the SAFE strategy as implemented in 
this programmatic setting will be required. Research from hyper-endemic communities in 
Tanzania has suggested that >7 years of MDA may be required before TF1-9 declines below 
the 5% target (West et al., 2011). However, these findings came from research communities 
where programmatic implementation of the SAFE strategy was not to scale, in contrast to 
Amhara, and perhaps less generalisable to a national programme. Research studies in other 
areas have demonstrated reduction of Ct infection from communities receiving only a few 
rounds of MDA (Gaynor et al., 2003; Burton et al., 2005b; Harding-Esch et al., 2009; Ngondi 
et al., 2009a; Gebre et al., 2012; Keenan et al., 2012a). In some of these studies, TF 
prevalence remained above 5% and, according to WHO guidelines, warranted continued 
MDA with antibiotics to treat infections which were rare or absent (Solomon et al., 2004a; 
Harding-Esch et al., 2009; Ngondi et al., 2009a; Gebre et al., 2012; Keenan et al., 2012a). 
Together these findings raise great concerns. Currently, the azithromycin is donated to 
national programmes for the elimination of trachoma. Forecasts of the amount of drug 
needed are based on the assumption that programmes might require a maximum of five 
annual rounds of MDA before the elimination targets are realised (ICTC, 2011). The drug 
donor might not be prepared to produce the amount of drug required for all areas to meet the 
target. Additionally, conducting an annual vertical MDA campaign requires significant 
planning and resources. Knowing that such campaigns are time-limited helps programmes 
and partners estimate the resources required in advance, but when elimination is uncertain, 
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it is much more difficult to obtain continued financial investments (personal communication 
Paul Emerson, Technical Director of The Carter Center Trachoma Control Program, Atlanta). 
More concerning is that if MDA continues with no evidence of Ct infection, there is additional 
risk of introducing antibiotic resistance among other community pathogens (Fry et al., 2002; 
Coles et al., 2013).  
 
Research needs identified 
Determining whether TF is the best indicator on which to measure impact should be a 
research priority for the global trachoma elimination programme. Recent studies from The 
Gambia and Tanzania suggest that the correlation between TF and Ct infection is variable 
across different settings (Harding-Esch et al., 2010). While we do not yet have Ct infection 
results to support the clinical data collected in these cross-sectional studies, once available, 
the correlation with TF prevalence will be assessed to determine whether TF in these study 
areas was indeed a sensitive sign on which to measure the impact of SAFE interventions on 
trachoma transmission. On the other hand, trachomatous inflammation intense (TI) in some 
studies has been more closely correlated to Ct infection and is highly associated with 
scarring development (West et al., 2001b; Burton et al., 2003; Solomon et al., 2003). 
Declines in TI were observed in both South Wollo and South Gondar zones, which, seems 
consistent with studies from different geographical settings (Ngondi et al., 2006b; Bamani et 
al., 2010b). The first WHO guidelines for assessing trachoma prevalence suggested that 
areas with >5% TI warranted antibiotic intervention (WHO, 1993b). What was the evidence 
supporting this guideline and could a reduction in TI to some other predetermined threshold 
below 5% serve as a better indicator of elimination? Additional investigation is warranted to 
determine whether TI might be a better indicator of controlling trachoma transmission. 
Regardless of whether TF or TI is the better clinical sign, clinical signs remain limited by the 
grader’s subjective diagnosis. Only the development of a field-reliable, rapid diagnostic 
assay for detecting Ct infection would lead to direct evaluation of SAFE impact on 
transmission. 
 In regards to the methodology utilised for determining the achievement of elimination 
criteria, either the WHO guideline should be followed conducting district-level impact 
evaluations first, followed by the sub-district if TF1-9 <10% or the value of the additional sub-
district-level survey should be challenged altogether. Support for the latter is more evident 
based on the programme decision that must be made at the sub-district level. The sub-
districts utilised as evaluation units are not existing administrative areas. These were 
logically derived by joining existing health clusters (health catchment areas) by geographical 
orientation until the desired population size was met. If there were any mistakes in the 
geographical listing of health catchment areas in the creation of the survey sampling frame, 
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no distinction between areas would be possible. More importantly, implementation based on 
this created unit poses unique challenges. In both South Wollo and South Gondar, district 
health offices have proved to be resistant to the notion of non-uniform service delivery 
(personal communication Tesfaye Teferi, The Carter Center Trachoma Control Program 
Manager, Ethiopia). The argument stems from the survey results indicating trachoma 
remains a problem around the sub-districts that met the <5% TF1-9 criteria. Reintroduction of 
infection from neighbouring health clusters, as they fear, may increase transmission of 
trachoma if MDA stops in these sub-districts, thus losing any gains that were achieved. 
Previous research studies have postulated that travelers to and from neighbouring 
communities might be reason for the observed return of infection after successful MDA 
campaigns (Shah et al., 2010). Additionally, the ability of the health offices to reach and 
serve the community depends largely on the community’s trust to provide the needed 
service where and to whoever is in need, one of the core functions of primary care (1978). 
Selectively stopping an appreciated service, i.e. the MDA with azithromycin, may jeopardise 
such trust. 
 With the exception of a few districts, estimates of TF1-9 varied little. It would be 
worthwhile to assess the usefulness of the sub-district approach in a different setting when 
limited to districts with <10% TF1-9 to determine whether the additional sampling provided 
any additional information beyond what a district-level survey might provide. A spatial 
analysis might be a further promising approach to identify areas likely requiring ongoing 
interventions, by sampling fewer areas and predicting based on spatial distribution as used 
frequently in other NTD control programmes and recently on a national scale for predicting 
trachoma in Southern Sudan (Raso et al., 2006a; Steinmann et al., 2007; Clements et al., 
2010). However, this method might also be limited by the difficulty in distinguishing 
implementation units on which the health system would need to plan and carry out 
interventions. Application of spatial analysis to identify areas of trachoma clustering in Brazil 
was not successful (Schellini et al., 2010). The usefulness of this method has not been 
demonstrated in areas after interventions, but warrants additional investigation, particularly 
to determine whether the risk of trachoma resurgence might be predicted for sub-districts 
stopping MDA.   
 
9.2. Applying new technology to facilitate data collection in impact evaluation 
surveys  
Upon presenting the results from South Wollo sub-district-level surveys to the Amhara 
Regional Health Bureau, it was the Director of Public Health at the time, Dr. Asrat Genet, 
who said “This (paper questionnaire) methodology and the surveying of so many 
communities seems archaic; there has to be a better way.” While I could not modify the 
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WHO recommended sub-district-level sampling strategy, I did realise that current mobile 
technology may be able to facilitate the completion of the surveys in South Gondar by 
electronic data capture. Within the six month period between field work in South Wollo and 
South Gondar, together with the volunteer assistance of computer scientist undergraduates 
at the Georgia Institute of Technology, we developed and field tested an innovative 
electronic data management and capture system, Swift Insights, which was deployed to 
evaluate the impact of the SAFE strategy in the South Gondar sub-district-level surveys. 
Both qualitative and quantitative methods were used to tailor the system to meet the needs 
of the survey methodology and scientifically document that the data collection was 
comparable to standard paper questionnaires.  
 
Evidence generated for health system decisions 
Results of the sub-district-level impact evaluation surveys were analysed and presented to 
the survey teams two days after the completion of field work and a formal summary report 
presented shortly thereafter to the Regional Health Bureau. Results from South Wollo, which 
used paper questionnaires, were not available for statistical analysis until two months after 
the completion of field work. Overall, the South Gondar surveys took 35% less time to 
complete, were implemented with less survey teams, and achieved a greater sample size 
than South Wollo surveys. Incremental costs of the electronic equipment for use in South 
Gondar were equivalent to costs incurred for double data entry of paper questionnaires in 
South Wollo and the electronic equipment can be used in multiple surveys. This evidence 
supports the conclusion that electronic data capture can facilitate large-scale community 
assessments required to evaluate health system programmes.  
 
Contribution to scientific knowledge  
Through the application of new, Android-based technology on tablet computers, we 
documented that such data collection and management adds efficiency to impact evaluation 
surveys on a programmatic scale. These advantages were similar as those advertised in 
recent applications of Android-based data collection applied to animal health and 
surveillance of zoonotic diseases (Karimuribo et al., 2012; Madder et al., 2012). To our 
knowledge, this is the first quantitative and qualitative comparison of Android-based and 
standard paper-based data collection within the context of an actual NTD control 
programme. Time savings, due to obviating the need for data entry, was the outstanding 
advantage of electronic data collection over standard paper-based questionnaires. There 
were no differences in time to completion of the household surveys between the methods, 
which was also reported in a comparison of smart-phone administrated interviews among 
attendees of maternal health clinics in China (Zhang et al., 2012). In Amhara, obtaining 
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immediate results on which to base health system decisions concerning MDA is crucial in 
trachoma programme management given the preparation required for coordinating two, sub-
region-wide annual interventions targeting over eight million population each which includes 
meeting application deadlines for approval of the drug donation and shipment (Rotondo and 
Seligson, 2011).  
 Perhaps one of the more important contributions to the current scientific 
understanding concerning the application of electronic data capture using tablet computers 
was the qualitative feedback provided by the data recorders who had participated in the 
South Wollo sub-district-level surveys using the paper-based questionnaires. These 
experienced data recorders identified a concern that the use of the electronic devices 
disrupted the connection between interviewer and respondent. Quantitative research 
methods alone could not capture such an important issue potentially affecting the quality of 
responses provided by the interviewee (Creswell, 2003). Identifying the perceptions of the 
end-users allowed for these issues to be addressed in the training of data recorders for the 
South Gondar surveys. We were unable to assess the perceptions of the household 
interview respondents and perhaps how it may or may not have influenced their responses. 
We were, however, able to quantify a statistically significant difference in the increased 
proportion of individuals who refused participation in the surveys, but it is not clear that the 
use of the electronic device was influential in the decision. These findings highlight the 
importance of a mixed-methods approach to operational research.   
 Electronic data collection using the tablet computers led to fewer data recording 
errors compared to paper-based questionnaires in terms of blank entries and incorrect 
unique ID numbers of examined residents and resulted in more accurate recording of 
geographical coordinates. The upfront costs of the tablets and accessories were similar to 
double data entry and validation costs of paper-based questionnaires. Since the first 
deployment in South Gondar, the equipment and system has been reused for impact 
surveys in six other zones of Amhara, all leading to complete data analysis and reporting 
results back to the data collection teams and programme managers within two days. The 
findings of this study verify the continued importance of health informatics for monitoring and 
evaluating disease control programmes. 
 
Research needs identified 
One aspect identified through the qualitative work that warrants further research is the 
interface between the data recorder and the interview respondent. This may be particularly 
important in resource-poor settings where the devices are rare and have yet to reach the 
communities. What are the perceptions of the respondents concerning the novel devices 
utilised?  Do the devices present barriers in communication and could programmes learn 
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how to mitigate any barriers by modified training agendas for data recorders? Additionally, 
the e-health field might be able to learn from the IT industry in terms of how best to train 
persons unfamiliar with the applied technology.  
 The area of e-health, particularly smart-mobile technology, is rapidly developing 
(Mertz, 2012). We integrated the use of a barcode scanning application with Swift Insights 
data collect application to link stool specimens to individual and household data collected 
during the survey through the use of an autofocus camera on the tablet. Given the problems 
identified with the simplified trachoma grading system, there have been recent efforts to 
enable such smart-phone cameras to take photographs of the tarsal conjunctivae for the 
confirmation of field grading (Bhosai et al., 2012). Currently, the resolution provided by 
smart-phone cameras has not been powerful enough for such a task and the add-on devices 
have been cost prohibitive for programmatic use. As the capacity of the devices increase, 
these applications should enable new ideas to be applied to field research like utilisation of a 
smart-phone for microscopy to diagnose helminth infections by our colleagues here at Swiss 
TPH (Bogoch et al., 2013). The ability to diagnose helminth eggs in a wet mount through a 
smart-adapted microscope shortly after collection might save significant resources currently 
expended in logistics of transporting specimens and processing in a laboratory. Perhaps the 
only limit to further applications of e-health is our own imagination. 
 
9.3. Evaluating the impact of SAFE interventions on trachomatous scarring in 
children   
Given the challenges discussed in interpreting TF prevalence after intervention, we 
assessed whether there was any demonstrable impact of SAFE interventions on 
trachomatous scarring (TS). TS at the development of the simplified grading system had 
very good inter- and intra-observer agreement and was intended to be an indicator of past 
trachoma severity within a community (Thylefors et al., 1987; WHO, 1993a). Yet, currently it 
is not a recommended indicator to be measured in prevalence assessments (WHO, 2006b), 
probably because of the assumption that TS develops over time and may not resolve, 
making prevalence difficult to interpret. Analogous to antibodies, once scars are present, 
they might remain and identified at any one point in time it would be difficult to determine 
when the scarring developed.  
 Currently in the global programme to eliminate lymphatic filariasis, one hypothesis 
under investigation is that demonstrating the absence of an antibody response to filarial 
antigens among young children born since the initiation of MDA indicates the interruption of 
filariasis transmission (Gass et al., 2012; Steel et al., 2012). Similarly, the absence of TS 
among children born since the implementation of the SAFE strategy would not only indicate 
reduced transmission, but also blinding disease averted. Therefore assessing TS among 
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children is a novel approach to the evaluation of the SAFE strategy. Also uniquely, we 
applied an approach commonly used in environmental epidemiology to assess any 
cumulative effect of exposure, defined as years lived since implementation of SAFE strategy, 
taking into consideration the age of the child at the start of the interventions.  
  We observed a decline in TS prevalence over time in each of the cross-sectional 
surveys. Either the observed decline has occurred because of inconsistent reliability of 
diagnosing TS across surveys, a secular trend, or the SAFE strategy has been successful in 
preventing disease progression. In each of the surveys, all potential trachoma graders 
participated in extensive training where all signs of the simplified trachoma grading system 
are taught. Prior to initiating data collection, the graders take practical exams where only 
graders with the best diagnostic skills (measured by agreement with instructor’s diagnosis or 
standardised slide set) are selected. Field-testing of the simplified trachoma grading system 
shortly after development, showed very good inter-observer agreement for TS after 
extensive training (Taylor et al., 1987). Hence, variability in the grading of TS is not a strong 
argument for the observed decline. Adjusting for the year of the survey in the model 
measuring effect of cumulative exposure allowed us to control for any secular trend. Even 
after adjusting for the year of the surveys, there was a clear trend of declining odds of TS for 
every year exposed among the children born since the SAFE interventions began. 
Conversely, the reduced likelihood of TS explained by five years of SAFE exposure among 
the children 6-10 years of age became less pronounced for each year lived prior to the 
interventions and was not statistically significant for children aged 10 years. This should not 
be interpreted as children aged 10 years exposed to SAFE interventions are no more likely 
than children aged 10 years having never been exposed. All children aged 1-10 years after 
five years implementation of the SAFE strategy were significantly less likely to have scarring 
(range of decreased odds; OR=0.11 for children aged 5 years, OR=0.42 for children aged 10 
years).  
 
Evidence generated for health system decisions 
The significant decline in TS provides evidence that the SAFE interventions implemented by 
the health system are reducing blinding disease and should continue according to WHO 
guidelines. Additionally, the study suggests that TS among children is a valuable indicator on 
which the programme may track progress towards eliminating blinding trachoma. Ideally, a 
TS prevalence of zero among children born since control interventions would indicate that 
blinding trachoma has been mitigated. Therefore, the health system should continue to 
record TS among all ages in impact evaluation surveys. Additionally, TS should be recorded 
in long-term surveillance activities among young children as a monitor of trachoma 
resurgence in the community once MDA has stopped. 
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Contribution to scientific knowledge  
The findings indicate that SAFE interventions are averting the development of scarring in 
children which is likely to greatly reduce TT incidence in the future. The greatest impact has 
occurred among the children born the same year the interventions began, indicating a 
cumulative beneficial impact for children born after the implementation of SAFE in Amhara. 
The finding that the impact lessens for each year lived prior to the interventions indicates 
that the development of scarring may be influenced by factors occurring during the first years 
of life. This is consistent with the understanding that repeated reinfection and inflammation 
leads to scarring and that infection and inflammation is experienced most frequently, for the 
longest duration and with the highest bacterial loads during the ages 1-5 years (Dawson et 
al., 1976; West et al., 1991; Bailey et al., 1999; West et al., 2005). The findings of the study 
are also consistent with findings from Tanzania indicating that scarring develops at young 
ages and is significantly associated with the presence of intense inflammation (West et al., 
2001b; Wolle et al., 2009a).  
  The lower occurrence of TS among children with close access to water (<30 min 
round-trip collection) in the exposure analysis model using all survey data is biologically 
plausible if those households prioritised the use of water for hygiene that has prevented 
transmission and inflammation due to trachoma in those children. Households in The 
Gambia that used a greater quantity of water for washing children were less likely to have a 
household member with active trachoma (Bailey et al., 1991). When a round-trip collection of 
water takes more than 30 min, the amount of water used in the household declines and 
perhaps along with it, washing Ct contaminated fingers, faces, and clothes (Cairncross, 
1999). Improved access to water could also simply be correlated to an unmeasured factor of 
development that has led to the decline in Ct transmission. However, the additional finding of 
reduced odds of TS among both children aged 1-5 and 6-10 years with household-level face 
washing frequency contributes to the argument that water used for hygiene is, at least in 
part, responsible for the decline in TS. Together, these findings indicate long-term benefits of 
the F component in SAFE. 
  We did not find a significant association between reported individual or household 
participation in the MDA campaigns and TS, but several studies show that MDA with 
antibiotics is effective at reducing Ct infection in the community (Evans and Solomon, 2011). 
Additionally, the presence of a household latrine was not associated with TS among 
children. However, data from Southern Sudan suggested a combined, perhaps synergistic, 
impact of SAFE on active trachoma at the community level (Ngondi et al., 2006b).Therefore, 
the cumulative exposure analysis may have captured such a non-specific beneficial impact 
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of SAFE interventions in the environment on the progression of blinding disease in the 
individual.  
Research needs identified 
The cumulative exposure analysis influenced by studies of air pollution impact on health was 
useful in evaluating the impact of SAFE in this setting. Because this was the first application 
of the method within the trachoma programme, it should be validated in other longitudinal 
data sets from other trachoma endemic areas. The analysis could be repeated in areas with 
similar cross-sectional or longitudinal data where interventions have been implemented for 
multiple years. Substantiating this effect would provide great hope that blinding trachoma is 
indeed being prevented through the SAFE strategy. 
 While the current analysis provides evidence that the SAFE strategy reduces TS 
prevalence, additional analysis is warranted to address two important issues. First, the rates 
of increasing scarring prevalence and age for pre- and post-SAFE intervention determined in 
this setting should be extrapolated to determine an estimated magnitude of blinding 
trachoma averted. Different estimates of the rate of progression from scarring to trichiasis 
observed in other research could be applied to the current data to provide a range for such 
estimates (Muñoz et al., 1997, 1999; Bowman et al., 2001). The second, more important 
issue would be to apply the current rate of scarring with age to estimate the total number 
incident cases of TT which might be expected and over what period of time health systems 
would need the capacity to identify and provide surgery for these cases. Existing 
mathematical models could use estimates generated with this data set as parameters for 
simulations to answer this important programmatic question (Gambhir et al., 2009). 
 
9.4. Exploring a school-based approach to evaluate impact of SAFE interventions 
The utilisation of schools as a venue for preventive health programmes is not novel. Many 
national de-worming campaigns are conducted through the schools in a collaborative effort 
between Ministries of Health and Education as well as partner NGOs and corporate 
pharmaceutical donors (Schroeder et al., 2002; Monse et al., 2010; Kihara et al., 2011). The 
SAFE strategy is recommended for inclusion in the primary school curriculum and some 
trachoma endemic countries have already designed and applied such curricula (Mariotti and 
Prüss, 2001; Zondervan et al., 2004;  WHO, 2006b; Lewallen et al., 2008). Additionally, 
surveys among children in schools are a commonly practiced method on which to determine 
the need for, monitor and evaluate such interventions and are currently recommended in 
helminth control programmes (Brooker et al., 2000; WHO, 2002a; Hodges et al., 2012b; 
Sherkhonov et al., 2013). Most recently, new guidelines on surveillance of trachoma suggest 
the assessment of active trachoma among school children (WHO, 2008). There have been 
few recent studies to determine whether school children are representative of the 
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communities in which they live and whether school-based interventions are reaching all 
children in the community. The novelty of the study conducted in this thesis was to challenge 
the school-based survey approach by assessing whether the prevalence of TF was the 
same between children attending and not attending school.  
  The best way to have tested this hypothesis would have been to actually conduct 
school-based surveys and compare the findings with community-based surveys in each of 
these cross-sectional assessments, similar to what was done in eight districts of Nigeria 
(King et al., 2009). Given the recommendation to incorporate the promotion of the SAFE 
strategy through school health curricula, I included a question concerning school attendance 
during community surveys of trachoma prevalence supported by The Carter Center since 
2008, including the sub-district-level surveys from this thesis project. Therefore, data sets 
from large-scale, community-based trachoma surveys conducted in Mali, Niger, and Nigeria 
were included in this analysis. In each of the surveys a child was asked “Do you attend 
school regularly?” to assess school attendance.  
 
Evidence generated for health system improvement 
School attendance varied across surveyed areas in the four countries in terms of gender, 
school-entering age and age of highest frequency of attendance. Any school-based 
intervention could only expect to reach, at maximum, the proportion of children attending 
school, which in the case of Mali and Niger, would represent less than half of all school-aged 
children. The proportion of school-attending children participating in antibiotic distribution 
and who had clean faces was higher than that among children not attending school. Overall, 
school-attending children were less likely than children not attending school to have TF. This 
finding implies that school-based survey methods to assess prevalence of trachoma will 
likely underestimate the prevalence within the community. Additionally, school-based 
trachoma surveys will not provide estimates of TT prevalence on which to plan surgical 
programmes. While the health system might be encouraged that school children are learning 
and practicing prevention behaviour because of education received at the school, the 
observed disparities may mean that children not in school are not benefiting as much from 
the interventions as their peers attending school. The health system should ensure that 
additional strategies are implemented to reach all children according to their needs. 
Evaluating impact of interventions should not be limited to assessing only children in 
schools. 
 
Contribution to scientific knowledge  
Several issues relevant to the current practice of school-based surveys and interventions 
were addressed. First, the age cohort with peak prevalence of the disease to be assessed 
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may not be the same age cohort attending school. The community-based surveys confirmed 
that TF is most common in children aged 1-5 years who are too young to attend school and 
thus, school-based methods would inevitably underestimate TF prevalence, but the extent 
might vary according to the local epidemiology of the disease. Preschool-aged children were 
only about 30% more likely to have TF than school-aged children in Mali and Niger, which 
had the lowest community prevalence of TF1-9, whereas preschool-aged children in Ethiopia 
and Niger were over 400% more likely to have TF than school-aged children. The finding 
suggests that the accuracy of school-based prevalence estimates might be influenced by the 
local age-specific prevalence of a disease.  
  Second, school children may be systematically different than children not attending 
school in respect to socio-economic status, gender, knowledge, behaviour, and disease 
prevalence. When limiting the analysis to school-aged children and controlling for age and 
gender, TF remained significantly less common among school attendees. The higher 
antibiotic coverage and percent clean faces in school attendees may suggest increased 
awareness and practice of preventive behaviours, but the factors responsible for the 
observed differences in TF cannot be determined with the data collected. A report from a 
WHO technical meeting on trachoma surveillance concluded that two sentinel communities 
per district per year should be assessed for TF among school-entrance-aged children (5-6 
years) where the school attendance rate is >90% with no gender bias (WHO, 2008). 
According to the data observed in this analysis, none of the trachoma endemic locations 
surveyed would have qualified for surveillance activities as suggested by the report, due to 
low attendance, gender bias and a recommended age group that would not have been found 
in schools. Fortunately, an alternative suggestion was to conduct community-based surveys.  
  Finally, the low attendance rates reported by the students is concerning, especially if 
disease control strategies, such as preventive chemotherapy, are school-based because 
coverage of all school-aged children will not be attained. This issue has been addressed in 
the past regarding helminth control programmes by bringing siblings to school on school 
health days (Montresor et al., 2001a). But this strategy assumes that each family has at least 
one child who attends school and who remembers to inform his or her family. The same 
assumption applies to the theory of reaching the family unit with trachoma health education 
through the school child (personal communication Paul Emerson, Technical Director of The 
Carter Center Trachoma Control Program, Atlanta). I did not analyse the proportion of 
households in which no school-aged child attended school, but in several communities of the 
areas surveyed, none of the children among the surveyed households reported attending 
school. Such issues identified by this study warrant further investigation, discussion and 
renewed strategy development. 
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Research needs identified 
Only trachoma data was assessed in this study, but since implementing the sub-district-level 
surveys of South Gondar, stool collection among school-aged children has continued in 
ongoing trachoma impact assessments in seven other zones of the Amhara National 
Regional State and over 7,000 samples have been processed for the identification of 
intestinal parasitic infections. This school analysis could simply be extended to the current 
data to determine whether school children are less likely to have intestinal helminth or 
protozoan infections compared to their counterparts not in school in these areas not under 
school-based helminth control. Furthermore, for current school-based NTD control 
programmes, a useful evaluation of programme impact would be to compare infection 
prevalence, knowledge and behaviour among school-aged children both attending and not 
attending school.   
  Additionally, the assumption that a child’s knowledge of the SAFE strategy from 
school is being transferred to the household and other school-aged child residents should be 
tested. The findings of the current study suggest that children not in school may not be 
benefiting as much as school children from current interventions. Therefore, some 
community-based, mixed-methods research could help identify novel, preferred strategies to 
ensure the benefits of any disease control interventions reach children not attending school.   
 
9.5. Determining the impact of SAFE interventions on intestinal helminths 
Water and sanitation are the foundations of public health. The promotion of water use for 
personal hygiene and the construction and use of household latrines in this area of rural 
Ethiopia is most likely to have impacts beyond the targeted purpose of reducing trachoma 
transmission. Increased access to water is associated with increased use of water for 
hygiene practices, which prevent the spread of infectious faecal-oral, respiratory, and 
contact transmitted diseases (Cairncross, 1999; Prüss et al., 2002; Prüss-Üstün et al., 
2008). Use of an improved, uncontaminated water source for drinking is clearly related to 
reduction in the burden of water-borne diseases (Prüss-Üstün et al., 2008; Hunter et al., 
2010). Improved sanitation has been shown to decrease incidence of diarrhea and is 
significantly associated with a reduced odds of soil-transmitted helminth infections (Mara et 
al., 2010; Ziegelbauer et al., 2012). However, such ancillary impact in an area under SAFE 
interventions has not been demonstrated.  
  We applied a novel approach, integrating both the assessment of intestinal parasitic 
infections and trachoma through community-based surveys, to evaluate the impact of SAFE 
strategy on these infections in South Gondar where prevalence data on intestinal helminths 
prior to interventions existed in the scientific literature. The selection of a cross-sectional 
study design was influenced by the application of the new trachoma impact assessment 
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guidelines from WHO, but also the desire to demonstrate the feasibility of conducting 
integrated NTD surveys through a community-based methodology. While the cross-sectional 
design was useful in determining the current prevalence of trachoma and helminth infections 
establishing causal relationships between the F and E components and any observed 
differences in prevalence from baseline is limited. 
  
Evidence generated for health system improvement 
We documented a significant decline in the prevalence and intensity of Ascaris lumbricoides, 
Trichuris trichiura and Schistosmoa mansoni infections among school-aged children since 
the school-based cross-sectional survey conducted in 1995 (Jemaneh, 2000; King et al., 
2013). Hookworm prevalence was the same as in 1995, but no high infection intensities of 
hookworm infections were identified. These changes in helminth prevalence occurred in the 
context of substantial improvements in household sanitation (14-fold increase in latrine 
ownership), access to water (71.3% increase), use of improved water source for drinking 
(69.4% increase) and reported face washing behaviour (81.2% increase) since the 
implementation of the SAFE strategy. Preventive chemotherapy with albendazole has also 
been targeted to preschool-aged children living in districts considered prone to drought and 
food insecurity through biannual interventions called Enhanced Outreach Services. 
Concurrently with these interventions, the Health Extension Programme has assigned and 
placed trained health extension workers (HEWs) in each kebele (cluster of communities). A 
core function of the HEWs is to provide behaviour change communication concerning 
sanitation and hygiene including the F and E components of the SAFE strategy. 
  The prevalence of any of the soil-transmitted infections exceeded 20% among 
school-aged children and, according to WHO guidelines, warrant preventive chemotherapy 
(PCT) among this age group (WHO, 2006a). District-specific prevalence estimates of soil-
transmitted helminth and S. mansoni infections were generated on which the Regional 
Health Bureau can apply WHO guidelines. Additionally, nearly one of four children had 
giardia intestinalis infection and three of four children had some type of intestinal protozoan 
infection. Identification of these intestinal parasitic infections indicates the potential ongoing 
transmission of pathogenic faecal-oral infections such as Cryptosporidium and Salmonella 
typhi and demands strengthened interventions throughout the zone to improve quality of 
drinking water, sanitation and hygiene.  
  Figure 9.2 presents the current modes of transmission of intestinal parasitic 
infections in South Gondar along with the estimated indicators of household-level practice of 
control interventions. The bold dotted lines indicate points of effective interventions to block 
transmission, but are only partially being practiced. Parasite eggs and cysts via human 
faeces are still contaminating water and soil as only 42% of households in the zone were 
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observed to have a used latrine. Fingers and hands are still being contaminated because 
there is little evidence that residents are practicing hand washing after defecation. Overall, 
only 4% of households were observed to have a hand washing container outside of the 
latrine as promoted by the health services. The majority (89.5%) of households with children 
aged less than six years reported washing their children’s faces at least once a day, 
indicating a high awareness of this promoted hygiene behaviour. In regards to water, 42% of 
households reported using an improved source of water for drinking, indicating that the 
majority of households may be drinking water from a contaminated source. Even in those 
households drinking from improved sources of water, contamination of the water can occur 
while in transport or storage within the household (Jensen et al., 2002). Additionally, the 
Regional Health Bureau should be concerned with the discrepancy between the doses of 
albendazole reported distributed, nearly 100% coverage of preschool-aged children over the 
last six distribution rounds, with surveyed coverage of 14.9% reported to have ever taken 
albendazole. All of these factors suggest transmission of intestinal parasites will continue 
unless improvements are made to fill the gaps within the interventions. 
 
Contribution to scientific knowledge  
The current study provided recent data on intestinal helminth infections that may be 
referenced in future surveys to evaluate impact of improved interventions. Additionally, the 
study documented a high prevalence of intestinal protozoan infections not commonly 
assessed. Whether or not these are locally considered a public health burden, they provide 
clear indication of faecal-oral disease transmission (Becker et al., 2013). Timely assessment 
of stool specimens required by the standard Kato-Katz method for diagnosing helminth 
infections would have not been possible in the rural, remote communities selected randomly 
in this study. Our methods confirmed the field applicability of preserving stool specimens in 
sodium acetate-acetic acid-formalin (SAF) during community-based surveys in such settings 
and assessing intestinal parasitic infections using ether concentration on a programmatic 
scale (Ouattara et al., 2008; Utzinger et al., 2010). Also, the technique provided the 
additional opportunity to detect the protozoan infections (Marti and Escher, 1990). The 
integrated methodology was feasible to implement in population-based surveys utilising 
probability sampling within communities. We have since continued these methods in seven 
other zones in Amhara demonstrating repeatability, which suggest these methods, can be 
used for ongoing monitoring and evaluation of control interventions. Finally, the reductions in 
helminth infections among school-aged children documented here either indicate an 
important secular decline or an ancillary impact of an integrated, multi-sectoral package of 
interventions to control NTDs. 
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Research needs identified 
The cross-sectional design of this thesis study limits our conclusions concerning the effect of 
SAFE interventions on intestinal parasites. Stool samples have now been collected and 
processed from over 300 communities in 8 of the 10 zones of Amhara. A cluster randomised 
control trial could be established by utilising the 300 communities for which we now have 
data on trachoma clinical signs and ocular swabs; intestinal parasitic infections; and linked 
individual, household and community level characteristics. A subset of these 300 
communities could be randomised to receive only the ongoing health system interventions 
as currently implemented or additional intensive interventions providing face washing and 
hand hygiene behaviour change communication; 100% household latrine coverage; 100% of 
households with hand washing containers; and 100% households with access to an 
improved water source within 30 minutes round-trip collection. Follow-up data collection and 
analysis could occur annually at the same time of the year for three years to align with the 
WHO recommended duration of SAFE implementation and impact assessment. Additionally, 
to make the most of the data collected during this thesis, a subset of the 300 sites could 
serve as integrated NTD sentinel surveillance sites to monitor progress of the ongoing 
control interventions. 
  Without any additional funding, the individual, household, and community-level 
factors associated with intestinal parasitic infections should be determined through multi-
level random effects modeling. Identifying such factors along with the geospatial 
determinants of these infections might allow for the prediction of prevalence in areas not 
surveyed in need of enhanced control measures, particularly S. mansoni (Raso et al., 2006a, 
2006b; Vounatsou et al., 2009; Schur et al., 2011). Additionally, an in-depth analysis of the 
current data for associations between combinations of indicators of water, sanitation and 
hygiene at the community level and individual parasitic infections is warranted in particular 
the intestinal protozoan infections.  
 While improvements in water access and sanitation were documented through the 
study, there was little indication of adoption of the promotion of hand washing immediately 
after defecation, evident by the low proportion of households with hand washing containers. 
Indeed, hand hygiene is one of the core objectives supposedly addressed by the HEWs. 
Understanding the factors associated with not adopting or adopting the promoted behaviour 
could lead to the modification of programme strategies to improve practice of the desired 
behaviour. Such operational research would require a mixed-methods approach as 
implemented in Kenya prior to a nationwide hand washing campaign (Schmidt et al., 2009). 
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9.6. Future considerations 
The work carried out for this PhD has highlighted additional opportunities and potential 
issues relevant to sustainable health services. The North-South collaboration between The 
Carter Center, Swiss TPH, and Amhara Regional Health Bureau worked well utilising the 
trachoma control programme activities as the platform for operational research. Efforts 
should be made to extend this partnership to improve the transfer of analytical skills locally 
and to build capacity, an essential ingredient to sustain ongoing operational research to 
improve the delivery of health services (Zachariah et al., 2009; Royston, 2011). Through the 
conduct of the field studies (activity mandated by WHO for trachoma programme evaluation) 
skills were transferred to over 40 integrated eye care workers, 20 lab technicians and 20 
technology students at the local university. Additionally, the zonal-level health department 
programme managers played lead roles in coordinating the field work and participating in the 
training and supervision. However, to improve the capability of the Regional Health Bureau 
to monitor and evaluate the impact of NTD control programmes, key persons should be 
identified who could work with Carter Center staff and survey teams in the design, 
implementation, analysis and interpretation of such large-scale impact evaluations in the 
future. Evaluating the impact of the SAFE interventions would represent an applied training 
which could hence be extended to other health programmes. Such collaboration should also 
be extended to the local university system within Ethiopia with an aim to improve integration 
of the research conducted by the universities with the ongoing activities and needs of the 
Regional Health Bureau. Modules on operational research could be included within the 
health science schools and in existing applied training programmes such as The Ethiopian 
Field Epidemiology and Laboratory Training Program (Jima et al., 2011). 
 Finally, the decline in intestinal helminth infections in South Gondar suggests a 
combined beneficial impact of multiple health system interventions; the SAFE strategy, PCT 
through Expanded Outreach Services and the Health Extension Programme. There are 
opportunities for similar synergies between programmes and across sectors. Our study 
identified very low coverage of the targeted preschool population with albendazole and thus 
potential problems with the delivery strategy. It would be feasible to coordinate the 
community-based distribution of albendazole to preschool and school-aged children during 
the current integrated MalTra campaigns of antibiotic distribution for trachoma and fever 
screening, testing and subsequent treatment for malaria. However, these integrated, but 
vertical campaigns are time-limited and depend mostly on drug donations and external 
financing. While such programmes can be successful, long-term, sustainable solutions are 
required (Utzinger et al., 2009; Ruxin and Negin, 2012). We (speaking as an NGO) need to 
realise that the sustainable provision of health services comes through primary health care 
and sustainable disease prevention comes from changed behaviour enabled by an improved 
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environment. Trachoma was eliminated throughout Europe and the United States with 
improvements in development, as was hookworm from the southern United States (Stiles, 
1939; Taylor, 2008). The hands and feet of the health services delivery system in Ethiopia 
are the health extension workers (HEW). They currently are involved in most community-
based primary care and public health programmes, including immunisations, distribution of 
antibiotics during MDA for trachoma and behaviour change communication for the SAFE 
strategy. Their main focus is to achieve 100% of the households in their kebele with 
indicators of the 17 health “packages,” including safe water containers, latrines, and hand 
washing stations (Ethiopia, 2012). Community led total sanitation (CLTS) has been adopted 
by the Amhara National Regional State Health Bureau and is implemented primarily through 
HEWs (Kar and Chambers, 2008). Improved coordination between the current CLTS, 
UNICEF WASH and the trachoma control programmes might provide additional synergies in 
controlling disease and improving health. This would require the joint planning, 
implementation, supervision, and operational research among Bureaus of Development, 
Education and Health. Improving water quality, sanitation, and hygiene would remove a 
certain dependence of NTD control efforts on drug donations and external resources and 
ultimately fulfill a core component of primary health care (1978).  
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10.  Conclusions 
Through this thesis, novel approaches to evaluate the impact of the SAFE strategy were applied 
in the context of the ongoing disease control programmes of the health system. Each objective 
was successfully addressed adhering to a proposed ideal process of implementing operational 
research. Each study provided the following: information upon which the Amhara National 
Regional State Health Bureau can base decisions to improve delivery of disease control 
interventions; generalisable knowledge concerning trachoma elimination, electronic data 
collection, community-based surveys, and integrated NTD survey methodology; and additional 
operational research issues to be addressed. Listed below are specific conclusions 
substantiated through the findings of the operational research studies presented in this thesis: 
 
 The implementation of the SAFE strategy has reduced severe inflammation and 
scarring due to trachoma among children, which reduces their risk of blinding trachoma 
later in life. However, the WHO targets for elimination have not been achieved. 
Trachoma remains a public health problem in South Wollo and South Gondar zones of 
the Amhara National Regional State of Ethiopia and ongoing interventions are 
warranted to control transmission to prevent incident blinding disease and provide 
surgery for prevalent and incident cases of trichiasis. 
 
 Determining the prevalence of trachoma at the sub-district level was feasible, but 
required significant resources. In the current application of these surveys, conducting 
surveys to estimate prevalence first at the district level would have required less field 
work.   
 
 Large-scale community assessments required to evaluate health system programmes 
can be facilitated through electronic data capture. A mixed-methods research approach 
allowed the technology to be tailored to the functionality required by the survey 
methods, rather than the survey methods constrained by the capabilities of the 
technology. 
 
 Children aged 1-10 years have a substantially, statistically significant, lower risk of 
scarring due to trachoma after having lived in an environment where the SAFE strategy 
has been implemented for five years. The benefit depends on both the number of years 
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lived prior to and during the interventions. Monitoring changes of TS among children 
offers an additional way to monitor impact of the SAFE strategy. 
 
 Children who attend school do not represent the target age group recommended for 
assessment of trachoma prevalence and are less likely to have TF than children who do 
not attend school. Therefore, determining trachoma prevalence through school-based 
sampling methodologies risk underestimating prevalence in the community. 
 
 The prevalence of intestinal helminths among school-aged children has declined 
alongside significant increases in household-level indicators of water, sanitation, and 
hygiene since the implementation of the SAFE strategy in South Gondar. However, 
there is ongoing transmission of intestinal parasitic infections, warranting improved 
control interventions. Community-based surveys integrating both the assessment of 
trachoma and intestinal parasitic infections are feasible.  
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13.  Appendix  
 
 
S1. South Gondar Trachoma Impact Evaluation Survey Questionnaire – Amhara, Ethiopia 2011 
 
 
Team number: |__|__| Cluster Number (1-380): |__|__|__| Household number: |__|__| 
Serial Number: |__|__||__|__|__||__|__| 
      Team             Cluster          Household 
Gott name: 
 
Woreda name:  Health Cluster Name:  
Kebele name: 
 
Development team name: 
 
 
 
Survey Date (DD/MM/YYYY) |__|__|/|__|__|/|__|__|__|__| 
GPS 
Latitude:    (N) |__|__| . |__|__|__|__|__| 
Household interview consent given?  No= 0    Yes= 1 Longitude: (E) |__|__|__| .|__|__|__|__| __| 
Examination of children consent given?    No= 0   Yes= 1 Elevation:        |__|__|__|__| m 
Respondents’ demographics (Adult females: women and mothers of children are the preferred respondents) 
RD1 Name of head of Household Write name _________________________  
 
RD2 
 
Description of Respondent 
Head of household=1 
Wife of head of household=2 
 
RD3 Gender of Respondent Male= M       Female=   F  
RD4 How old are you?             (round months down) (write age in years) |__| __|   
RD5 What is the highest level of school you have attended? 
(If “none,” ask “have you had any non-formal 
education?”) 
None=0 
Religious=1 
Primary school (grade 1-6)=2 
Junior secondary=3 
Senior  secondary=4 
College/University=5 
Non-formal Education=6 
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RD6 What is the HoH’s primary occupation? Farming and Cattle rearing  = 1 
Cattle rearing only = 2 
Farming only = 3 
Formal employment (monthly salary) = 4 
Trade (business) = 5 
Daily labourer = 6 
Other (write in)________________  = 98 
 
RD7 Have you lived in this Gott for more than 4 years? No=0;  Yes=1 Yes go to ES1 
RD8 If no, in which Woreda and Zone did you live recently? (specify) _____________________________  
Household Social Economic Status 
 
ES1 
ES2 
ES3 
ES4 
ES5 
Does your household have any of the following? 
Functioning radio set  
Functioning Television  
Working electricity 
Functioning telephone (landline) 
Functioning mobile phone 
 
No=0;  Yes=1 
No=0;  Yes=1 
No=0 ; Yes=1 
No=0 ; Yes=1 
No=0 ; Yes=1 
 
 
ES6 Observation: what is the main construction material 
for the roof in this household? 
(One response only) 
Corrugated Iron=1 
Thatch =2 
Stick and mud=3 
Other=99 
(specify)_____________________________ 
 
Knowledge  
K1 Have you ever seen anyone with this eye condition?  
(link to show image TTwCO.jpeg) 
No=0;  Yes=1  
K2 What is this condition called? 
Trachoma=1 
Cataract=2 
I do not know=88 
Other=99 
(specify)_____________________________ 
 
K3 Do you know what trachoma is? No=0;  Yes=1 If No, go to HE1 
K4 In the end, what can happen to a person who has 
trachoma?        (multiple response) 
 
(After each response ask ‘anything else?’  Do not read 
choices.  Please mark all responses given.) 
K4.1      Nothing happens □ 
K4.2                  Blindness □ 
K4.3         Reduced vision □  
K4.88         I do not know □ 
K4.99                      Other □  
(specify)______________________________ 
 
 
K5 How can someone protect him/herself from 
trachoma/trichiasis?        
                                        (multiple response) 
K5.1            Face washing/hygiene □ 
K5.2  Take antibiotics or medicine □ 
K5.3                   Trichiasis surgery □ 
K5.4   Keeping environment clean □ 
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(After each response ask ‘anything else?’  Do not read 
choices.  Please mark all responses given.) 
K5.5                    Using pit latrines □ 
K5.88                       I do not know □      
K5.99                                    Other □ 
(specify)______________________________ 
Health Education 
HE1 Have you ever heard health information on trachoma? No=0        Yes=1 If  No go to WS1 
HE2 Where did you hear the trachoma information?     
                       
                         (multiple response) 
 
(After each response ask ‘anything else?’  Do not read 
choices.  Please mark all responses given.) 
HE2.1              Trachoma volunteers □ 
HE2.2        Health extension worker □ 
HE2.3  Mass media (TV, radio, etc) □ 
HE2.4                        Health facility □ 
HE2.5          Community gatherings □ 
HE2.6                                    School □ 
HE2.7                           School child □ 
HE2.99                                    Other □ 
(specify)______________________________ 
 
 
HE3 What information about trachoma did you hear?  
                       
                        (multiple response) 
 
(After each response ask ‘anything else?’  Do not read 
choices.  Please mark all responses given.) 
HE3.1               Causes of trachoma □ 
HE3.2    Transmission of trachoma □ 
HE3.3 Latrine construction and use □ 
HE3.4                        Face washing □ 
HE3.5            Antibiotics treatment □ 
HE3.6                 Trichiasis surgery □ 
HE3.99                                  Other □  
(specify)______________________________ 
 
 
Water source and access (Ask person responsible for water collection) 
WS1 
 
 
 
 
What is the main source of water your 
household uses for bathing? 
 
 
 
 
Unprotected spring=1 
Protected spring=2 
Unprotected dug well=3 
Hand pump/Tube well / borehole=4 
Surface water (river, dam, lake, stream, canal)=5 
Public piped water/ tap/standpipe=6 
Private piped into Yard/dwelling=7 
Rainwater collection=8 
Other (specify)_______________________=99 
 
 
WS2 
 
What is the main source of water your 
household uses for washing clothes? 
 
Unprotected spring=1 
Protected spring=2 
Unprotected dug well=3 
Hand pump/Tube well / borehole=4 
Surface water (river, dam, lake, stream, canal)=5 
Public piped water/ tap/standpipe=6 
Private piped into Yard/dwelling=7  
Rainwater collection=8 
Other (specify)_______________________=99 
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WS3 
 
What is the main source of water your 
household uses for drinking? 
 
 
Unprotected spring=1 
Protected spring=2 
Unprotected dug well=3 
Hand pump/Tube well / borehole=4 
Surface water (river, dam, lake, stream, canal)=5 
Public piped water/ tap/standpipe=6 
Private piped into Yard/dwelling=7  
Rainwater collection=8 
Other (specify)_______________________=99 
 
WS4 How long does a round-trip take to collect 
water from the source of water used for 
bathing? 
<30 minutes=1 
30 minutes to 1 hour=2 
> 1 hour=3 
 
Face washing (Ask mothers or care givers of children) 
FW1 Do you have children under 5 years of age? No=0;     Yes=1 
If No, go to PL1 
FW2 
 
How often are these children bathed? 
                       (Indicate one answer) 
Never=0 
Every other day=1 
Once a day=2 
Twice a day=3 
Three or more times a day=4 
Other 
(specify)_______________________=99 
 
 
FW3 
 
How often are the faces of children washed? 
                       (Indicate one answer) 
Never=0 
Every other day=1 
Once a day=2 
Twice a day=3 
Three or more times a day=4 
Other 
(specify)_______________________=99 
 
 
Pit Latrines 
PL1 
 
PL2 
 
PL3 
 
PL4 
Have you ever had a latrine in this household? 
 
Currently, is there a latrine in this household (observed)? 
 
Is this the first latrine in this household? 
 
How long ago was the most recent latrine built? 
No=0; Yes=1 
 
No=0; Yes=1 
 
No=0; Yes=1 
 
_________YEARS ________MONTHS  ago 
If  No go to LO2 
(note there may still 
be a hand washing 
container in the HH) 
Latrine observations  
LO1 
LO2 
LO3 
LO4 
Evidence of latrine usage (faeces in pit)? 
Hand washing container present? 
Water in hand washing container? 
Location of hand washing container? 
No=0; Yes=1 
No=0; Yes=1 
No=0; Yes=1 
At latrine=1;     At household=2 
If no to LO2, END 
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S2. Questions to prompt group discussion concerning use of electronic and paper 
questionnaires 
 
After using both paper and electronic questionnaire: 
1. What are the advantages and disadvantages of each method? 
2. Which data collection method do you prefer and for what reasons? 
3. What problems did you have when collecting data using either method? 
4. Which data collection method do you think took less time to complete during the 
survey and why? 
5. With which tool do you think an interviewer will make fewer mistakes and why? 
6. How did you feel about using the tablet computer to collect data?  
7. What would you suggest adding or changing in order to make use of the tablet 
computers easier? 
8. Which sections of the electronic questionnaire did you find difficult to use? 
9. In what areas of electronic data collection do you feel you need more training? 
 
